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THE ROLE OF PYROPTOSIS AND ASSOCIATED INFLAMMASOMES DURING
EXPERIMENTAL CYTOMEGALOVIRUS RETINITIS

by
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Under the Direction of Richard D. Dix, PhD

ABSTRACT
Human cytomegalovirus (HCMV) is a species-specific β-herpesvirus that establishes a
lifelong latent infection in ~80% of the world’s population and can cause severe opportunistic
diseases in immunosuppressed patients including those with AIDS. Of these, AIDS-related
HCMV retinitis is a significant ophthalmological problem worldwide. Although the clinical
features of AIDS-related HCMV retinitis are well established, the virologic and immunologic
events that take place during onset and development of this sight-threatening retinal disease
remain poorly understood. Toward this end, an established animal model of murine
cytomegalovirus (MCMV) retinitis in mice with retrovirus-induced immunodeficiency (MAIDS)
that mimics AIDS-related HCMV retinitis was used in the present investigation to test the central

hypothesis that pyroptosis, as a programmed cell death pathway of innate immunity, and
associated inflammasomes contribute to the onset and development of full-thickness retinal
necrosis during MAIDS-related MCMV retinitis. Our findings show (i) intraocular MCMV
infection stimulates key pyroptosis-associated transcripts and proteins within the eyes of
retinitis-susceptible MAIDS mice but not within the eyes of retinitis-resistant mice; (ii) a
deficiency in key pyroptosis-associated molecules and inflammasomes in MAIDS mice results in
an atypical histopathologic pattern of retinal disease within MCMV-infected eyes characterized
by preservation of the neurosensory retina without full-thickness retinal necrosis but with
proliferation of the retinal pigmented epithelium; (iii) MCMV-infected eyes of corticosteroidimmunosuppressed mice display stimulation of key pyroptosis-associated molecules and
inflammasomes similar to that observed for MCMV-infected eyes of mice with MAIDS; (iv)
MCMV infection of IC-21 macrophages and mouse embryo fibroblasts grown in culture
stimulates key pyroptosis-associated transcripts in a cell-type specific manner; and (v) increased
susceptibility to MCMV retinitis during the progression of MAIDS is associated with robust
upregulation of a surprisingly large number of immune response genes that operate within
several immune response pathways. Taken together, these results suggest that pyroptosis and
associated inflammasomes play a significant role during the pathogenesis of full-thickness retinal
necrosis within MCMV-infected eyes during MAIDS. These findings add new knowledge to our
understanding of the contributions of programmed cell death pathways of innate immunity
towards the pathogenesis of AIDS-related HCMV retinitis and may extend to other AIDS-related
opportunistic virus infections.
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Inflammasomes, Murine cytomegalovirus (MCMV), Murine AIDS (MAIDS), Pyroptosis
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1

INTRODUCTION

Human cytomegalovirus (HCMV) is a species-specific β-herpesvirus that establishes
lifelong infection in approximately 80% of the world’s population [1]. Although usually
asymptomatic in immunocompetent individuals, infection with HCMV is often asymptomatic
and can cause severe morbidity in at-risk immunocompromised populations. Specifically, AIDSrelated HCMV retinitis is a sight-threatening manifestation of this virus that remains a significant
ophthalmological problem since access to combination antiretroviral therapy (cART) is not
readily available worldwide and several individuals who do have access fail to adhere or respond
to treatment [2, 3]. Understanding the pathogenesis of this disease is essential to developing new
and effective treatments for its prevention. Although the clinical features of AIDS-related
HCMV retinitis are well established, the direct mechanisms by which HCMV infection results in
severe retinal damage is still unknown. To investigate these direct mechanisms, our lab uses a
well-established, reproducible, clinically relevant mouse model with retroviral-induced
immunosuppression (MAIDS) that results in susceptibility to experimental murine
cytomegalovirus (MCMV) retinitis, which mimics the pathophysiology seen during AIDSrelated HCMV retinitis [1, 4, 5]. Using this model, we have previously found that several
inflammasomes and pyroptosis markers are significantly stimulated in the eyes of mice during
experimental MAIDS-related MCMV retinitis [6]. However, the impact and effect this
inflammatory form of programmed cell death has on the onset and progression of MAIDSrelated MCMV retinitis has yet to be explored.
1.1

Herpesviruses
As obligate intracellular organisms, viruses have adapted several basic structures

necessary for replication inside the cells of living host, and the differences in these essential
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structures differ between the various classes of viruses. All viruses have genetic material that is
either single-stranded (ss) or double-stranded (ds) DNA or RNA and is packaged in a protein
capsid, forming the nucleocapsid. The virus may have an envelope surrounding the nucleocapsid,
which is derived from the host cell, depending on the virus’ evolution for infection. Filling the
space between the envelope and the capsid is an area known as the tegument. The tegument
contains viral proteins that are indispensable for early infection and are released into the host cell
once the virus has gained entry. Entry into the host cell is typically mediated on the surface of
the virus (either the nucleocapsid or the envelope) by glycoproteins that recognize and bind to
specific receptors on the host cell. The target host cells, morphological features, mode of
replication, and pathological consequence of the host organism differ significantly among
different types of viruses, and so the classification of these viruses are phylogenetically
organized based on the similarities of the viruses to each other, and how they are thought to have
evolved [7].
Herpesvirales is one of several orders of viruses characterized as enveloped
dsDNA viruses composed of an icosahedral capsid with a T=16 symmetry, whose target host is
animals. CMV is further classified into the family Herpesviridae due to its preferred infection of
amniotes (birds, reptiles, and mammals). Members of this family replicate and partially assemble
within the nucleus and can establish latency in their host, which often results in reoccurring lytic
infections that destroy the infected host cell [7, 8]. Herpesviruses are extremely widespread
among humans, as at least 90% of adults have been infected and therefore maintain a latent form
of at least one of several herpesviruses. There are nine known human herpesviruses (HHV) to
date referred to as HHV-1 through HHV-8, with HHV-6B being recognized as distinctly
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different from HHV-6A (Table 1.1). These nine human viruses are further classified into
subfamilies based on where they form latency in the host cell [7].
Table 1.1: Human Herpesviruses in the Family Herpesviridae

Adapted from [9]
Alphaherpesvirinae. The α-herpesviruses (HHV-1 through HHV-3) infect several host
species and are known to replicate and spread more quickly than the other subfamilies of
herpesviruses. These viruses initially infect epithelial cells via direct contact and quickly
disseminate to the neurons to establish latency. The Simplexvirus and Varicellovirus genera of
the α-herpesviruses infect humans and establish latency in the sensory nerve ganglia. Most
known of the Simplexvirus genus are herpes simplex type 1 (HSV-1) and HSV-2, which manifest
in the form of orofacial lesions, genital lesions, keratoconjunctivitis, and encephalitis. The
Varicellovirus genus contains the varicella-zoster virus (VZV), which is responsible for the
development of chickenpox in young children and reoccurs as shingles later in life [7].
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Betaherpesvirinae. The β-herpesviruses are classified based on their tendency to
establish latency in lymphoid cells of hematopoietic origin. These viruses also tend to replicate
more slowly than the other herpesviruses and have strict specificity of the host in which they can
replicate. The human herpesviruses that comprise this subfamily include HHV-6 and HHV-7,
which are part of the Roseolavirus genus, form latency in CD4+ T cells, and are responsible for
roseola [10, 11]. Also included in this subfamily is the genus Cytomegalovirus, which includes
HHV-5, or HCMV, and form latency in monocytes and bone marrow cells. HCMV is
responsible for various congenital infections, as well as several infections spanning multiple
organs in immunocompromised individuals [7].
Gammaherpesvirinae. The γ-herpesviruses establish latency within lymphoid
tissues of mammalian hosts. These viruses vary in their rate of replication—which is generally in
B or T lymphocytes—and contain the human herpesviruses HHV-4 and HHV-8. HHV-4, known
as Epstein-Barr virus (EBV), is part of the Lymphocryptovirus genus and is responsible for
infectious mononucleosis. HHV-8 is part of the Rhadinovirus genus and is commonly referred to
as Kaposi’s sarcoma-associated herpesvirus (KSHV) [7].
1.2

Cytomegalovirus
1.2.1

CMV Structure

Because herpesviruses share similar morphological features with other membranes in the
same order, it makes sense that they share similar virion structures and protein functions. A
notable difference of CMV is their 200-230 nm diameter, making them slightly larger than all
other herpesviruses. This size includes their envelope, which is entrenched with virus-encoded
glycoproteins. HCMV is thought to derive its envelope from the host endoplasmic reticulum
(ER), the ER-Golgi intermediate compartment, or endosomes [12-14]. The envelopes of HCMV
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are coated with several glycoproteins, which form complexes that are important for HCMV
replication. One of these complexes consists of a glycoprotein B (gB) trimer, while another
complex is composed of gH and gL, which form the heterodimer gH:gL. Both complexes are
required for viral entry into the host cell. Another complex, gM:gH, is vital for virion maturation
[15].
Beneath the envelope is a thick tegument, which contains most of the proteins encoded by the
genome. The tegument is composed of at least 32 known viral proteins as well as several host
proteins [16] and even host RNA [17]. These tegument proteins are involved in all steps of viral
replication, including entry into the host cell, in which the virion transactivator (VTA) tegument
phosphorylated protein (pp)71 quickly translocates to the nucleus and recruits host cell
machinery to initiate gene transcription [12]. Tegument proteins are also involved with egress
from the host cell, where other phosphorylated proteins can interact with the immune system of
the host.
The tegument encloses a 130 nm, icosahedral nucleocapsid of 162 capsomeres with a T=16
symmetry. The genome of CMV is contained in a core of linear dsDNA and encodes at least 66
known tegument proteins (reviewed in [12], and as shown in Figure 1.1 from [18]). Four of these
virally encoded proteins form the HCMV capsid. These proteins—the major capsid protein
(MCP), triplex subunits 1 (TRI1), TRI2, and smallest capsid protein (SCP)—are essential for the
growth of the virus. As the name suggests, MCP comprises the bulk of the capsid and contains a
specific pore made of the portal protein (PORT), which facilitates the packaging and release of
the virion genome [12].

6

Figure 1.1. Cytomegalovirus virion structure
Representation of the cytomegalovirus virion structure, modified from [18].

The HCMV genome consists of linear dsDNA that is divided into two regions, the unique
long (UL) and the unique short (Us) regions. The ends of these regions are flanked by terminal
inverted repeat sequences and contain internal redundancy sequences [7] (depicted in Figure
1.2). The HCMV genome is roughly 236 kb long, and the genes are numbered according to their
UL or US loci. Additionally, the HCMV genome contains about 200 open reading frames (ORFs)
and can encode at least 167 proteins [19], including structural and nonstructural proteins,
tegument proteins, and glycoproteins.
The genome of the Smith strain of MCMV differs somewhat from HCMV in that it
contains only one long segment of DNA (UL) and lacks internal repeat sequences [20, 21]. The
MCMV genome is also approximately 230 kb long and can encode for roughly 170 gene
products [22]. Despite species-specificity of each, the genomic structures of MCMV and HCMV
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are comparable to one other [20-23]. The sequences of these two CMV strains overlap one
another by about 180 kbps of DNA and contain about 78 homologous ORFs [22].

Figure 1.2. HCMV and MCMV genomic structures.
Comparison of the HCMV and MCMV genome modified from [24]. TR: terminal repeat, TRL:
terminal repeat long, TRS: terminal repeat short, IRL: internal repeat long, IRS: internal repeat
short.
1.2.2

CMV Replication

HCMV and MCMV replication and assembly occur in the nucleus of the host cell, and
both viruses undergo a temporal, step-wise viral gene expression and replication cascade [12].
The interaction of glycoproteins on the envelope of the virus with a complementary host
receptor, such as heparin sulfate, mediates attachment and adsorption. Immediately after
attachment and adsorption, entry into the permissive host cell results from receptor-mediated
endocytosis (endothelial and epithelial cells) or fusion (fibroblasts) of the viral envelop with the
host membrane [25]. Viral tegument proteins are then released into the cell, and some are
believed to be transported to the nucleus of the host cell alongside nucleocapsids via interactions
with the host microtubule machinery. The nucleocapsid interacts with nuclear pores where it
injects viral DNA into the nucleus [7], allowing for the commencement of transcription [26-28].
The transcription and subsequent translation of viral genes follow a specific sequence, starting
with immediate early (IE), also known as α genes. Proteins translated from IE transcripts
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dysregulate cellular functions to allow for viral production. Following transcription of IE genes,
the transcription of early (E), or β, genes, drive viral DNA synthesis and the expression of late
(L), or γ, genes. The L genes encode for most of the tegument and glycoproteins. The
transcription of L genes allows for the assembly of progeny virions, which then egress from the
cell via exocytosis [12] as outlined in Figure 1.3.
CMV can infect epithelial cells, endothelial cells, fibroblasts, and myeloid cells. The
characteristics of CMV infection of several cell types have been widely studied and can differ
with the species of CMV as well as the infected cell type. Viral IE genes immediately begin
transcription once the genome enters the nucleus, and this transcription peaks between 8-12
hours post-infection (hpi) and begins the transcription of E genes, which continues until
approximately 24 hpi [12, 29]. At this point, the expression of L gene transcription can be seen in
HCMV infected fibroblasts [30-33], while MCMV IE gene transcription occurs between 1-4 hpi
in fibroblasts, and as early as 1 hpi in macrophages [32]. The E genes for MCMV are detected at
about 2 hpi and are seen until about 16 hpi in fibroblasts [33], at the point in which MCMV L
gene expression begins and can continue for at least 36 hours [30]. The transcription of these L
genes encodes for most of the viral tegument and glycoproteins, which are involved in capsid
assembly, virion maturation, and egress from the host cell.
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Figure 1.3. Lifecycle of HCMV and MCMV within a host cell.
Depiction of the viral replication of MCMV or HCMV within a host cell. Virion attachment and
adsorption is followed by entry via fusion into the host cell. The nucelocapsid is shuttled to the
nucleus followed by IE, and E gene expression. Genome replication is then followed by L gene
expression, capsid assembly, maturation of virion and ultimately envelopment and egress as the
virion is released from the cell. Figure from [34].
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1.3

HCMV Clinical Disease
1.3.1

HCMV Infection in Immunocompetent Hosts

HCMV infects about 80% of adults in developed countries [1] and passes through direct
contact with bodily fluids, such as saliva, urine, and breast milk. HCMV can be sexually
transmitted and contracted during organ transplants, blood transfusions, and pregnancy.
Following acute infection, most immunocompetent individuals do not show any symptoms,
although occasionally a mild mononucleosis specific for HCMV, has been associated with
primary infection in immunologically normal persons [35]. Although rare, immunocompetent
individuals may develop severe diseases, such as myocarditis [36, 37], pneumonia [38-40],
hepatitis [41-43], encephalitis [44-47], and retinitis [48]. Primary HCMV infection that occurs
during the first trimester of pregnancy can cross the placenta causing congenital HCMV disease
[12]. Infected infants may develop neurological inclusion disease [49], which could result in
manifestations, including microcephaly, the enlargement of ventricles, or cerebral atrophy. Later
in life, those infected could experience neurological ailments, such as hearing or vision loss or
even mental retardation [50].
1.3.2

HCMV Infection in Immunocompromised Hosts

HCMV alters the host defenses by either altering the signaling of the recognition receptors,
weakening the cytokine and interferon activation and suppressing cell death of infected cells,
thus allowing the virus to survive in the cell and reproduce effectively [12]. In healthy
individuals, the primary infection is systemic and asymptomatic [1], and the adaptive T cell
immunity helps to maintain low viral levels [12]. Regardless of the immune response to the
primary infection, the virus remains latent in the lymphocytes throughout the infected
individual's life. Competent immune systems typically suppress reactivation of the virus, but in
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those who are immunocompromised, HCMV becomes an opportunistic infection, and individuals
exhibit a variety of diseases that are dependent on the cause of their immunosuppression.
Recipients of organ transplants or bone marrow transplants are at a high risk of developing
colitis or life-threatening HCMV pneumonitis. Additionally, infection of the transplanted organ
by HCMV can also contribute to the rejection of the organ by the recipient due to reactivation
and uncontrolled viral replication in the latent virus [51]. Those who are immunosuppressed by
HIV-1 infections are particularly susceptible to sight-threatening retinitis caused by HCMV
directly infecting the retinal tissues [1].
1.4

HIV and AIDS
1.4.1

HIV-1 Replication and Tropism

HIV-1 has a roughly spherical structure with a 120 nm diameter and is a member of the
Retroviridae family, meaning that it is an ssRNA virus that changes the genome of the host cell.
Upon entry into the cytoplasm, HIV-1 uses its own viral reverse transcriptase to produce DNA
from its RNA genome. The retroviral DNA is then inserted into the host’s genome by a viral
enzyme, integrase, and is transcribed and translated along with the cell’s own genes. The genome
encodes for gag, pol, and env regions that are translated as one polypeptide chain cleaved by
viral-specific proteases. Gag proteins are major components of the capsids, while Pol proteins
are responsible for viral DNA synthesis and the integration of the viral genome into the host
genome. The Env proteins are essential for entry of the virions in the host cell, and although
there are a few copies of these proteins contained within the viral envelope, the enveloped
nucleocapsid of HIV-1 is composed mostly of lipids obtained from the plasma membrane of the
host during the budding process. The Env proteins present on the envelope consist of a cap made
of three molecules of glycoprotein (gp)120, in addition to a stem formed by a trimer of gp41
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molecules, which anchor this structure to the viral envelope (Figure 1.4). This protein complex is
what allows the virus to attach to the target host receptors, leading to the fusion of the viral
envelope with the host cell membrane and allowing for entry into the cell. HIV-1 is further
classified into the genus Lentivirus, which consist of retroviruses that result in deadly diseases
following long incubation periods. Lentivirus has a wide range of susceptible hosts that are
distributed worldwide. There are five serogroups of known Lentivirus, which are classified based
on the type of host in which they are associated. Primate specific Lentivirus, including HIV-1,
are distinguished, in part, by their use of CD4 as a receptor for viral entry [52, 53].

Figure 1.4. HIV-1 virion structure.
Schematic representation of the HIV-1 virion structure. Modified from [54].

Macrophages, dendritic cells, and CD4+ T cells are the primary targets of HIV-1 due to
the presence of CD4 on the surface of these cells [52, 53]. In addition to gp120 interacting with
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the CD4 molecule on the host cell membrane, HIV-1 also interacts with host cell-specific
chemokine co-receptors, depending on the strain of HIV-1. Macrophage-tropic (M-tropic) HIV-1
are strains of HIV-1 that do not undergo multiple cell fusions, resulting in multinucleated cells
known as syncytia. They use the β-chemokine receptor, CCR5, for entry into host cells. T-tropic
strains of HIV-1 can form syncytia and use the α-chemokine receptor, CXCR4, for entry into
host cells. There are dual-tropic HIV-1 strains that can use both CXCR4 and CCR5 as coreceptors for viral entry into host cells. Following binding of the viral Env proteins to the
specific host receptors and co-receptors, the cell membranes are brought close together, allowing
for a fusion of the membranes and the injection of HIV-1 RNA and enzymes into the host cell,
where the virus begins to incorporate its genome into the host’s genome [52, 53]. Following
transcription, the gp41 and gp120 glycoproteins are again anchored to the host’s plasma
membrane, where the forming virion is then able to bud from the cell as an immature virion. The
Gag polyproteins are then cleaved into the matrix, capsid, and nucleocapsid proteins that
assemble to produce a mature HIV virion, which is able to infect another cell (Figure 1.5) [55].
HIV-1 is capable of infecting cells by two distinct mechanisms. The first is cell-free
spread in which a mature virion enters the blood after recently budding from a host cell and
encounters another permissible cell in which it enters [56]. The other method of HIV-1
dissemination is direct transmission from one cell to another, aptly named cell-to-cell spread.
This direct transmission is either mediated by a virologic synapse [57, 58] or from the help of
antigen-presenting cells [59]. Cell-to-cell spread is generally more efficient at dissemination of
the virus within the body than a cell-free spread [60]. Importantly, infection of a host cell by
HIV-1 results in the destruction of the infected immune cell or obliteration of their immune
function.
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Figure 1.5. Steps in HIV-1 replication cycle.
HIV-1 replication begins by fusion of the HIV-1 virion to the host cell via recognition of the CD4
host receptor. The capsid containing the viral genome enters the cell, is disintegrated, and the
viral reverse transcriptase transcribes the viral RNA into DNA. The viral DNA is then
transported to the nucleus where it is integrated into the host DNA by the viral protein integrase.
The host then transcribes the viral genome along with its own DNA, making more copies of
virus as well as new HIV proteins. The new viral RNA and HIV proteins move to the cell surface
forming a new, immature HIV virus. Once released from the cell the viral protein, protease,
cleaves newly synthesized polyproteins to create a mature infectious virus. Image from [61].

Each HIV-1 virion contains two RNA genomes, and recombination between these two
genomes can occur [62, 63]. This recombination event happens multiple times during each
replication cycle, which rapidly shuffles the genetic information transmitted to the progeny virus
[63]. This viral recombination is thought to be a natural repair mechanism against damage to the
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RNA genome [64]. However, the genetic variability is also compounded with a very rapid
replication cycle with a high mutation rate, resulting in generations that contain multiple variants
in a single day. Additionally, a single cell may also be infected by different strains of HIV-1,
which can result in the progeny being a hybrid of the two strains. The resulting genetic
variability is likely a contributing factor to the difficulties faced by the host’s immune defenses
against infection, as well as targets for therapy [65].
1.4.2

Pathophysiology of HIV/AIDS

HIV-1 was first discovered in the early 1980s [53] and, since its discovery, has reached a
global pandemic in which just under 40 million people worldwide are currently infected, with
about 1.8 million new infections a year. Those infected with HIV-1 shed the virus in bodily
fluids and secretions, such as blood, semen, saliva, urine, or breast milk, and transmission occurs
with direct exchange of the fluids [52, 53]. Infection with HIV-1 can be broken down into three
main stages: acute infection, clinical latency, and AIDS.
Acute Infection. Acute HIV-1 infection occurs during the initial period after
contracting HIV-1, and many individuals exhibit influenza-like symptoms—including fever,
headache, tiredness, throat inflammation, and larger tender lymph nodes—2-4 weeks following
viral exposure. Vomiting, diarrhea, and other gastrointestinal symptoms may also occur.
Approximately 20-50% of individuals may experience a maculopapular rash occurring on the
trunk of the body. Due to their non-specificity, these symptoms are not often recognized as signs
of HIV-1 infection and are even often misdiagnosed as a more common infectious disease [66].
Chronic latency. Following the initial symptoms is a stage of asymptomatic
infection referred to as chronic latency. Without treatment, this stage lasts an average of eight
years but can prolong for over 20 years. Although there are typically little to no symptoms seen
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in the early years of this disease, fever, weight loss, muscle pains, gastrointestinal issues, and
persistent generalized lymphadenopathy are often seen in infected individuals [67] as the
infection progresses to AIDS.
Acquired immunodeficiency symptoms. Without treatment, HIV-1 infection can
progress to AIDS approximately ten years following initial infection. The clinical definition of
AIDS is a CD4+ T cell count below 200 cells/μL of peripheral blood, which is a dramatic
reduction from the normal range of between 1,000 and 1,500 cell/μL of peripheral blood [67].
HIV-induced cell lysis, as well as the killing of infected cells by cytotoxic CD8+ T cells,
accounts for much of the CD4+ T cell loss following the acute stage of infection. As HIV-1
infection progresses through the chronic stages of infection, the regenerative capacity of the
thymus is slowly destroyed by HIV-1 infection resulting in a gradual loss of the CD4+ T cells.
At this point, individuals start to present with conditions such as pneumocystis pneumonia,
cachexia, esophageal candidiasis, and recurrent respiratory tract infections [67]. As the CD4+ T
cells count continues to drop, infected individuals begin to become more susceptible to a myriad
of opportunistic infections (as depicted in Figure 1.6). Susceptibility to HCMV diseases,
including HCMV retinitis, generally occurs when the CD4+ T cell count reaches levels below 50
cells/μL of peripheral blood.
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Figure 1.6. Opportunistic infections with depleting CD4+ T cell counts.
During the progression of AIDS, the CD4+ T cell count depletes, rendering afflicted individuals
vulnerable to diseases by a number of opportunistic infections [68].
1.5

AIDS-related HCMV Retinitis
AIDS patients are particularly susceptible to sight-threatening retinitis caused by HCMV

directly infecting the retinal tissues. Factors that contribute to retinal tissue destruction are virusinduced cytopathology and inflammation mediated by neutrophils and activated macrophages.
Before the availability of cART, 46% of patients with AIDS experienced vision loss and
blindness caused by HCMV retinitis [69-71]. Although treatment with cART has lowered the
number of new cases of HCMV retinitis, AIDS-related HCMV retinitis remains a significant
ophthalmological problem as access to cART is not readily available worldwide and several of
the individuals who do have access fail to adhere or respond to treatment [12, 72, 73]. Although
vaccination is one of the more effective methods for controlling other infectious diseases,

18
attempts at creating an effective vaccine against HCMV have so far been unsuccessful [74, 75].
HCMV replication can generally be controlled by lifelong administration of antiviral drugs, such
as ganciclovir (GCV), yet these drugs may cause harmful side-effects, do not eradicate the virus,
and only slows the progression of ocular damage associated with HCMV infection [76-78].
HCMV-related disease, therefore, remains a severe ophthalmological problem worldwide.
1.5.1

Anatomy of the Eye

The human eye is a complex organ that reacts to light and facilitates vision with the use
of a complex visual system. The eye sits in a protective socket, known as the orbit, and is
attached to the six extraocular muscles that are responsible for moving the eye. These muscles
are attached to the white part of the eye, known as the sclera, which is a strong layer of tissue
that helps maintain the integrity of the organ [79, 80]. Although the anatomy of the eye has an
intricate design and is comprised of multiple layers, the basic anatomy can be separated into two
distinct segments. The anterior segment is the outer portion of the eye and is composed of the
cornea, the anterior side of the uveal tract (consisting of the iris and ciliary body), and the
crystalline lens, which are the components necessary to focus incoming light. Behind the cornea
is the anterior chamber that is filled with a fluid known as the aqueous humor. This fluid
produced by the eye, bathes the crystalline lens, and helps maintain proper ocular pressure in the
eye [79]. Between the lens and the back of the eye lies the vitreous cavity, which comprises a
majority of the posterior segment of the eye. This cavity is filled with a jelly-like substance
consisting of hyaluronic acid, collagen, water, proteins, and regulatory cytokines [81]. Also, a
part of the posterior segment is the posterior side of the uveal tract (the choroid), the retinal
pigment epithelium, and the neurosensory retina. Information that is processed by the retina
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travels to the brain through the optic nerve and allows us to process the information received by
the eye [79] (Figure 1.7).

Figure 1.7. Schematic of the human eye.
Depiction of a sagittal section of the adult human eye [82].
1.5.2

The Neurosensory Retina and RPE

Light first enters the front of the eye through the cornea, where the lens focuses it
towards the back of the eye and onto the retina. The retina itself is composed of several layers
that consist of specific cells: the inner limiting membrane, the nerve fiber layer, the ganglion cell
layer, the inner plexiform layer, the inner nuclear layer, the outer plexiform layer, the outer
nuclear layer, the external limiting membrane, the photoreceptor layer, and the retinal pigment
epithelium (RPE) (Figure 1.8). The inner limiting membrane is the layer closest to the vitreous
cavity, while the RPE is more posterior and lies just next to the choroid. The cells that compose
these layers have a specialized function that aid in the processing of information received by the
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retina. The ganglion cell layer is composed of the nuclei of ganglion cells that run their axons
throughout the nerve fiber layer. The ganglion cells receive signals from amacrine cells and
bipolar cells whose nuclei are within the inner nuclear layer but whose synapses extend into the
inner plexiform layer. Horizontal cell nuclei also compose the inner nuclear layer, and their
dendrites extend into the outer plexiform layer where they can interact with photoreceptors. The
nuclei of these photoreceptors comprise the outer nuclear layer, and the inner and outer segments
of photoreceptors span the external limiting membrane and towards the RPE [80, 83, 84].
The photoreceptors contain proteins that can absorb photons and convert them into
signals to neurons within the retina. There are three main types of photoreceptors in human eyes:
rods, cones, and intrinsically photosensitive retinal ganglion cells. While the rods and cones are
notorious for their role in sight, the function of intrinsically photosensitive retinal ganglion cells
is thought to hone more of a regulatory role important for vision, by supporting circadian
rhythms and pupillary reflexes [85]. The human retina contains about 120 million rod cells
dispersed throughout the retina, that are extremely sensitive to light and are the sole cell type
responsible for vision processing at low light levels. The six million cone cells of the human
retina are concentrated in the fovea and require a more significant amount of light to produce a
signal than the rods. Three different kinds of cone cells respond to light of different wavelengths:
short, medium, or long, referred to as S-cone, M-cone, and L-cones, respectively. The response
of these three distinct signals is perceived as color. In order to process the vast amount of
information fed to the retina, the outer segments of the photoreceptors are shed continuously and
replaced with help from the RPE layer of cells (reviewed in [86]).
The RPE cells are polarized epithelial cells that reside between the retina and choroid and
provide several functions essential for the survival of the neurosensory retina. Some of these
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functions include transporting nutrients to the retina, regulating homeostasis, scavenging free
radicals and reactive oxygen species, and phagocytosis of the rod outer segments following
normal circadian shedding [87]. The RPE cells are connected by tight junctions forming a
physical barrier between the retina and choroid, referred to as the blood-retinal-barrier [86, 88].
This barrier prevents the passage of drugs and other large substances from penetrating the eye,
therefore contributing to the immune privilege of the eye [89].

Figure 1.8. Light micrograph of the human retina.
Light focused from the cornea and the crystalline lens and hits the retina starting at the inner
limiting membrane (ILM) and transverses the retina until it reaches the rods and cones, directly
past the outer limiting membrane (OLM), also referred to as the external limiting membrane
(ELM). Adapted from [90]
1.5.3

Ocular Immune Privilege

Ocular immune privilege essentially means that the eye does not generate a typical
inflammatory immune response to an unknown antigen [91-93]. Therefore, the passage of
nutrients delivered to the retina must be tightly regulated and is delivered by two major blood
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supply routes supplied from either the choroid to the photoreceptors via the choriocapillaris or in
conjunction with the optic nerve [83]. The physical barrier alone is not all that is necessary for
the establishment and maintenance of ocular immune privilege. Another essential feature is the
establishment of a microenvironment that drives the immune cells of the eye into antiinflammatory phenotypes, therefore providing some protection from the damaging effects of
inflammation. One such example is the production of immunoregulatory molecules, such as the
anti-inflammatory molecules, transforming growth factor-β2, somatostatin, and alphamelanocyte-stimulating hormone by the aqueous humor and neurosensory retina, which work to
inhibit T cell activation [94]. Due to the tight regulation in maintaining this microenvironment, it
is no surprise that the neurosensory retina contains its own, specialized glial cells, to help
maintain the integrity of the retina.
Microglial cells are resident, macrophage-like cells, that are distributed throughout the
inner and outer plexiform, the ganglion cell, and the nerve fiber layers of the retina [95]. The
functions of microglial include antigen presentation and phagocytosis during the onset of retinal
injury or infection [96]. Müller cells are macroglial cells that span the entire thickness of the
retina and aid in many functions, including regulating glucose metabolism, maintaining ion
balance through ion channels and transmembrane transporters, and mitigating oxidative stress.
Müller cells are also capable of releasing pro-inflammatory cytokines following retinal insult or
injury. Müller cells then act in tandem with microglial to phagocytize foreign substances or
damaged cells and can alter the retinal blood flow, allowing for the infiltration of leukocytes into
the retina [97].

23
1.5.4

Pathogenesis of AIDS-Related MCMV Retinitis

During AIDS-related MCMV retinitis, the ocular immune privilege of the eye fails, leaving
the eye vulnerable to high levels of HCMV replication and subsequent inflammatory response,
which included the infiltration of activated macrophages and neutrophils [98, 99]. HCMV enters
the eye through the hematogenous spread of infected monocytes that enter the retinal vasculature
and is then capable of penetrating and replicating in all layers of the retina and the contiguous
RPE. [73]. The presence of active viral replication can be confirmed by the appearance of
conspicuous cytomegalic cells, which are characterized as giant cells with eosinophilic type A
intranuclear or “owl eye” inclusions. HCMV replication destroys all layers of the retina,
resulting in a distinctive full-thickness retinal necrosis. Ultimately, a thin white membrane
replaces the areas of retinal destruction, which can be clinically observed, and may be
accompanied by hemorrhaging. Fundus photographs depicting the differences in a healthy retina
and a retina with advanced AIDS-related HCMV retinitis are seen in Figure 1.9. Left untreated,
these areas with irreversible lesion of retinal destruction are capable of merging and may
consume the whole retina within six months [100].

Figure 1.9. Fundus of the human retina during AIDS-related HCMV retinitis
Fundus photograph of a normal human retina (A), from [90], and a retina during AIDS-related
HCMV retinitis (B). Present are white areas of retinal necrosis and red areas of associated
hemorrhaging, from Drs. Dix and Cousins, Bascom Palmer Eye Institute, Miami, FL.

24
1.6

Animal Models of MCMV Retinitis
A murine model of experimental CMV retinitis is valuable to study the mechanisms

responsible for the retinal destruction involved in the pathogenesis of AIDS-related HCMV
retinitis. As CMV is a species-specific virus, HCMV is unable to establish a productive infection
in animal models [101], but MCMV offers a viable substitute to explore the pathophysiology of
CMV retinitis [12]. As with humans, MCMV infection of mice is generally not as productive in
immunologically normal mice, and these mice are often resistant to developing MCMV retinitis
[4, 102-104]. However, if the mice are immunosuppressed and injected with a high enough titer
of MCMV into the subretinal space (Figure 1.10), MCMV retinitis typically manifests with
frequencies higher than 75% [1, 105, 106], although exact frequencies depend on the strain of
mouse used [4, 105-109]. Two methods of immunosuppression are successful in establishing
susceptibility to MCMV retinitis: corticosteroid-induced immunosuppression [105, 106, 109]
and the administration of a mixture of mouse-specific retroviruses (LP-BM5) [110, 111], which
results in the established of immunosuppression that confers susceptibility to MCMV retinitis in
C57BL/6 mice 8-12 weeks following the onset of immunosuppression [5, 112, 113].
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Figure 1.10. Schematic mouse eye depicting site of subretinal injection.
Representation of the subretinal injection site for MCMV by 1 30-gauge needle. A 2-uL volume
in injected into the subretinal space, followed by an air bubble to prevent back flow. Figure from
[114].
1.6.1

Corticosteroid-Induced Immunosuppression

Corticosteroid-induced immunosuppression results in a rapid, acute decline in the
immune system, which develops over several days resulting in dysfunction of several types of
immune cell populations [115, 116]. Specifically, corticosteroid-induced immunosuppression
results in a rapid loss of macrophages within days of immunosuppression [115], and the number
and function of CD4+ and CD8+ T cells are also dramatically reduced. This model, therefore,
results in a dampened immune response by suppressing inflammatory cytokines expressions,
such as IFN-γ, TNF-α, IL-2, and IL-1β [116].
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1.6.2

Murine Acquired Immunodeficiency Syndrome (MAIDS)

Retroviral-induced immunosuppression (MAIDS) is established by intraperitoneal
injection of murine leukemia viruses (MuLV) and designated as lymphoproliferative bone
marrow 5 (LP-BM5) [111]. The induction of MAIDS is dependent on the infected strain of mice.
For instance, BALB/c mice are more resistant to MAIDS development than C57BL/6 and take
over a year to progress to late-stage MAIDS [5, 117]. The MAIDS model of immunosuppression
differs in many ways from that of corticosteroid-induced immunosuppression. One of the more
prominent differences is the timing it takes to establish immune suppression. MAIDS have a
slow and progressive development, which goes through distinct phases of immune cell
dysfunction over several weeks. Also different is the presence and functionality of the immune
cell populations throughout the course of infection. For instance, macrophage populations show a
dramatic difference between the two models of immunosuppression. In MAIDS mice,
macrophage populations decrease and change their phenotypic function towards the later stages
of the disease, which is in direct contrast to the rapid loss of macrophage numbers within days
following corticosteroid-induced immunosuppression [115]. Additionally, MAIDS results in an
unusual proliferation of B and T cells [118], which are rendered dysfunctional by the retrovirus
[5, 110, 119]. Furthermore, natural killer cells [120] and neutrophils [118] are also dysfunctional
during the progression of MAIDS development.
1.7

MAIDS-related MCMV Retinitis
The use of subretinal MCMV infection in susceptible MAIDS mice is a combination

unique to our laboratory [1, 4]. The MAIDS model is a suitable model for this study because
species-specific retroviruses cause both MAIDS and AIDS, and mice with MAIDS share many
immunopathologic features with AIDS patients. These similarities include a characteristic
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progressive development of chronic generalized lymphadenopathy, a polyclonal B cell
activation, and a shift in the levels of Th1 and Th2 CD4+ T-cells with an eventual diminishment
in CD4+ T cell and CD8+ T cell counts and functions [112, 119, 121-123]. Healthy mice and
mice with MAIDS-4 duration (MAIDS-4) or less are resistant to the development of MCMV
retinitis. However, due to the decline in T cell functionality [123, 124], mice subjected to
MAIDS for a duration of eight weeks (MAIDS-8) become susceptible to the development of
MCMV retinitis with full susceptibility (80-100%) by MAIDS of ten-week duration (MAIDS10) [4], as depicted in Figure 1.11. MAIDS-10 mice will then develop retinitis 10 days post
subretinal MCMV injection and exhibit histopathological features similar to that seen in AIDSrelated HCMV retinitis, which include full-thickness retinal necrosis, the presence of
cytomegalic cells, and transition zones between areas of the normal and diseased retina [4, 125]
as depicted in Figure 1.12. Since both MAIDS-4 and MAIDS-10 mice harbor equivalent
amounts of infectious MCMV but MCMV-infected eyes of MAIDS-4 mice fail to develop
retinal necrosis [1], the viral infection alone is not sufficient for the onset and progression of
retinitis.
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Figure 1.11. Progression of MAIDS.
The MAIDS model shares many features similar to the development of AIDS. During the first
few weeks following MAIDS induction, mice experience chronic generalized lymphadenopathy,
a polyclonal B-cell activation, and hypergammaglobulinemia. The progression of MAIDS then
results in a shift in the levels of Th1 and Th2 CD4+ T-cells. Healthy mice and mice with a
MAIDS duration of 4 weeks (MAIDS-4) are resistant to retinitis development. However, as
MAIDS progresses and results in the diminishment in CD4+ T-cell and CD8+ T-cell counts and
functions, mice become susceptible to MCMV retinitis. From [114].
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Figure 1.12. Histopathology of experimental MAIDS-related MCMV retinitis.
Hematoxalin and eosin (H&E)-stained cross-sections of eyes during retinitis development 8 days
following subretinal MCMV infection. (A) full-thickness retinal necrosis, (B) section showing
the presence of cytomegalic cells, and (C) transition zones between intact retina (with areas of
retinal folding) and full-thickness retinitis. Photomicrographs from [4], original magnification
200×.
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1.7.1

MAIDS-related MCMV Retinitis

Over the last several years, our lab has extensively studied several mechanisms that may
be involved in the pathogenesis of MAIDS-related MCMV retinitis. Briefly, we have found that
the expression of anti-inflammatory cytokines, interleukin (IL)-4 and IL-10, are upregulated
during the onset and progression of experimental MCMV retinitis and may mediate the
inflammatory response following MCMV infection. However, it has been demonstrated that the
systemic deletion of either of these cytokines is insufficient to improve the developed retinitis
[126]. Interestingly, the pro-inflammatory cytokine, IL-17, which is constitutively expressed
intraocularly, is downregulated by MCMV during MAIDS-related MCMV retinitis. It is thought
that this downregulation of IL-17 is mediated through the stimulation of the suppressor of
cytokine signaling (SOCS)1 and SOCS3, which are both stimulated during the pathogenesis of
MAIDS-related MCMV retinitis [127]. Although tumor necrosis factor alpha (TNF-α) is
considerably upregulated following ocular MCMV infection of MAIDS-10 mice, this cytokine
may be playing a dual role mediating either apoptosis or the anti-apoptotic pathway as the
receptors for TNF-α, TNFR1 and TNFR2 are also stimulated following MCMV infection and
diverge towards either pathway [6].
A major area of focus of our lab, the pathogenesis of experimental MAIDS-related
MCMV retinitis, is the involvement of multiple cell death pathways. In addition to the
stimulation of TNF-α, TNFR1, and TNFR2 being stimulated during experimental MCMV
retinitis, activated caspase-3 and activated caspase-8 are also upregulated. Interestingly,
however, neither apoptosome-related molecules, cytochrome c, apoptotic protease activating
factor 1 (Apaf-1), nor caspase-9 are stimulated in MCMV-infected eyes, and histopathology has
suggested that apoptosis-related cell death only constitutes about 8% of the dead cells during
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retinitis. RIPK1 and MLKL molecules related to the inflammatory cell death pathway,
necroptosis, are stimulated during MAIDS-related MCMV retinitis, suggesting the involvement
of this mode of cell death may be associated with the retinal destruction seen in this model.
Additionally, pyroptosis-associated molecules—caspase-1, caspase-11, IL-1β, and IL-18—and
several inflammasome components are also stimulated during MAIDS-related MCMV retinitis.
This suggests that multiple cell death pathways may operate simultaneously following ocular
infection of MCMV in MAIDS-10 mice [6].
1.8

MAIDS-related MCMV Retinitis and the Stimulation of Cell Death Pathways
1.8.1

Apoptosis

Due to the discovery that MCMV-infected eyes of MAIDS-4 and MAIDS-10 mice harbor
equivalent amounts of infectious MCMV despite MAIDS-4 mice being resistant to the
development of retinal necrosis, it was concluded that virus alone is not sufficient for the onset
and progression of retinal destruction in MCMV-infected eyes of MAIDS-10 mice [103]. It was
therefore hypothesized that other mechanisms must be responsible for the retinal necrosis seen
following MCMV infection. Bigger et al. [128] first detected apoptotic cells by TUNEL assay in
retinal tissues of MCMV-infected eyes from immunocompetent BALB/c mice and
methylprednisolone acetate-immunosuppressed BALB/c mice. As a result of this work,
apoptosis, a programmed form of cell death, was considered the predominant mechanism of
retinal pathology of AIDS-related HCMV retinitis, and its involvement in MCMV-infected eyes
of MAIDS mice was investigated.
Apoptosis is often initiated by TNF-ɑ. TNF-ɑ is a proinflammatory cytokine that induces
diverse cellular responses by binding to the receptors TNFR1 and TNFR2. Binding of TNF-ɑ to
its receptor results in the cleavage and activation of caspase-3 and caspase-8, leading to
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apoptosis and cell death [129, 130]. TNF-ɑ was shown to be ocularly expressed during AIDSrelated HCMV retinitis [131], suggesting the infiltrating macrophages were a source of TNF-ɑ
[98]. Using the MAIDS model for MCMV retinitis, it was shown that key TNF-ɑ-induced
apoptotic molecules, TNF-ɑ, TNFR1, TNFR2, caspase-8, and caspase-3 are not upregulated in
MCMV-infected eyes of MAIDS-4 mice resistant to retinitis when compared to the mediainjected contralateral control eye but that these molecules are highly stimulated in MCMVinfected eyes of MAIDS-10 mice that are susceptible to retinitis. This stimulation showed a peak
of mRNA for all molecules occurring at day 6 post-infection before the development of severe
retinal destruction seen at day 10 post-infection. The production of TNF-ɑ was detected in
several cell types, including infiltrating macrophages and neutrophils, as well as resident Müller
cells and microglia. Using knock-out (KO) mice, it was shown that mice deficient in TNF-ɑ,
TNFR1, and TNFR2 showed a reduction in the frequency of retinitis in MCMV-infected
MAIDS-10 mice when compared to MCMV-infected eyes of wild-type (WT) MAIDS-10 mice,
suggesting that TNF-ɑ and its receptors are important for the development of retinitis in this
model. However, neither of these KO mice exhibited a change in the ocular levels of infectious
MCMV, indicating that these molecules are not responsible for controlling the viral levels of
MCMV, and also strengthening the idea that it is not solely the level of infectious virus that is
responsible for the retinitis. This work suggests that TNF-ɑ-induced apoptosis could be
contributing to the retinal destruction seen during MAIDS-related MCMV retinitis [6].
Apoptosis is not limited to being induced by one signaling pathway and can be stimulated
by several signaling proteins with specific death receptors (Figure 1.13) [132]. To help determine
if apoptosis induced by stimuli other than TNF-ɑ plays a role in the pathogenesis of MAIDSrelated MCMV retinitis, other apoptotic pathways were investigated. TNF-related apoptosis-
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inducing ligand (TRAIL) induces apoptosis via a caspase-8-dependent pathway after binding to
death receptors (DR) 4 or DR5 (TRAIL-R) [133, 134]. Additionally, FasL can induce apoptosis
via a caspase-independent pathway after binding to the Fas receptor [133, 135-137]. Similar to
what was seen for TNF-ɑ, mRNA for TRAIL, TRAIL-R (DR5), Fas, and FasL were all
upregulated in MCMV-infected eyes of MAIDS-10 mice, but not MAIDS-4, when compared to
media-injected control eyes, with a peak stimulation at day 6 post-infection. This indicated that
apoptosis initiated through other pathways might also be stimulated during the pathogenesis of
MAIDS-related MCMV retinitis. Surprisingly, however, mRNA for caspase-9, cytochrome c,
and Apaf-1 were not upregulated in MCMV-infected eyes of MAIDS-4 or MAIDS-10 mice.
These molecules are known to participate in apoptosis induced by the apoptosome [138, 139],
and the absence of their stimulation suggests no significant role for the mitochondrion-associated
mechanism of apoptosis during MAIDS-related MCMV retinitis. It is possible that the MCMV
gene m38.5, which encodes vIBO, might be inhibiting apoptosis at the mitochondrial level [140].
To further elucidate the involvement of apoptosis in the retinal destruction, a study was done to
detect the number and localization of TUNEL-positive cells in the MCMV-infected retina.
Following MCMV infection of MAIDS-10 mice, sparse TUNEL-positive cells were detected at
day 3 post-infection, and a substantial increase was seen at day 6 post-infection, with a
distribution showing localization within the RPE layer as well as the neurosensory retina. At day
10 post-infection, the TUNEL-positive cells displayed a diffuse distribution within the retina.
However, quantification revealed that only ~8% of retinal cells were found to be TUNEL
positive after MCMV infection, suggesting that although apoptosis may contribute to retinal
tissue destruction, its pathogenic contribution was relatively minimal [6].

34
Although mRNA for the ligands and receptors of the Fas and TRAIL-related apoptosis
pathway, as well as mRNA for caspase-3 and caspase-8, were increased in MCMV-infected
eyes, other molecules associated with apoptosis, including cytochrome c and Apaf-1, were not
upregulated in MCMV-infected eyes when compared to the media-injected, contralateral control
eyes. This may explain why apoptosis appears to only contribute minimally to the retinal damage
seen during MAIDS-related MCMV retinitis. It has been shown that TNF-ɑ- induced apoptosis
is expressed at elevated levels within the eyes of patients with AIDS-related HCMV retinitis [98,
131], and TNF-ɑ and its respective receptors were found to be upregulated in MCMV-infected
eyes of MAIDS-10 mice. Since apoptosis may only contribute minimally to the retinal damage, it
is also possible that the increase in TNF-ɑ seen in MCMV-infected eyes could be related to that
of another cell death pathway induced by TNF-ɑ, such as necroptosis.
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Figure 1.13. Apoptosis cell death signaling pathway.
The apoptosis pathway is a form of cell death that can be induced through either the extrinsic
pathway, the intrinsic pathway, or the granzyme pathway. Induction through either of these
pathways result in the activation of either caspase-8 or caspase-9 which both results in the
activation of caspase-3, which leads to apoptotic death of the cell. Apoptosis results in
mitochondrial membrane permeabilization, chromatin condensation, and DNA fragmentation.
This results in smaller cells and apoptotic bodies that are phagocytized. Figure from [141].
1.8.2

Necroptosis

Necroptosis is a form of TNF-ɑ induced programmed cell death that results in membrane
and organelle swelling followed by cell lysis [17-19]. Necroptosis is induced when apoptosis is
inhibited by blocking caspase-8 activity, such as by uncleaved caspase-8/cellular FLICE
inhibitory protein (cFLIP) heterodimer formation [20]. Unlike apoptosis, necroptosis cell lysis
results in the release of damage-associated-molecular patterns (DAMPs) that trigger a highly
inflammatory response [21]. The necroptotic pathway is caspase-independent and initiated when
ligand binding induces the recruitment of adaptor proteins Fas-associated protein with death
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domain (FADD), tumor necrosis factor receptor type 1-associated death domain (TRADD) or
TIR-domain-containing adapter-inducing interferon-β (TRIF) associated with various accessory
proteins, in addition to receptor-interacting serine/threonine-protein kinase 1 (RIPK1), forming a
death complex. The upregulation of the de-ubiquitinating enzyme CYLD or the cellular inhibitor
of apoptosis protein 1 (cIAP1) causes RIPK1 to dissociate from the initial death complex and
form a second death complex associated with caspase-8. When caspase-8 is inactivated, either
directly by a pathogen or during anti-apoptosis signaling, RIPK1 recruits another receptorinteracting serine/threonine-protein kinase, RIPK3, through its RIP homotypic interaction motif
(RHIM) domain. Both proteins are phosphorylated and form the necrosome [22, 23].
Subsequently, the formation of the necrosome recruits mixed-lineage kinase-like domain
(MLKL) protein, and it too is phosphorylated. Activated MLKL forms an oligomer complex that
associates with the cell membrane and forms a pore, resulting in cell lysis and the release of proinflammatory molecules (shown in Figure 1.14) [24].
To determine if necroptosis plays a role in the pathogenesis of MCMV retinitis, MCMVinfected eyes of MAIDS-4 and MAIDS-10 mice were compared to media-injected contralateral
control eyes for the upregulation of crucial necroptosis molecules, RIPK1 and RIPK3. RIPK1
was found upregulated in MCMV-infected eyes of MAIDS-10 mice with a peak at day 6 postinfection but not in MCMV-infected eyes of mice with MAIDS-4. RIPK3, however, was not
significantly upregulated in MCMV-infected eyes with either MAIDS-4 or MAIDS-10 duration
[7]. The stimulation of RIPK1, but not RIPK3, following MCMV infection suggests that
necroptosis may be playing a role in MAIDS-related MCMV retinitis, in a manner independent
of RIPK3.
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Figure 1.14. Necroptosis cell death signaling pathway.
TNFR1 can mediate either cell survival, apoptosis, or necroptosis pathways. Binding of TNFR1
with TNFα leads to the formation of complex I which consists of TRADD, TRAF2, RIP1, and
cIAP1. Left: Polyubiquitination of RIP1 by cIAP1, leads to the recruitment of IKK complex and
TAK1, activating the NF-κB and MAPK survival pathways. Middle: If cIAP1 does not
polyubiquitinate RIP1, then RIP1, associates with FADD and caspase-8 to form cytosolic
complex IIa which induces apoptosis. Right: If caspase-8 activity is inhibited, RIP1 interacts
with RIP3 and MLKL to form complex Iib. RIP3 and MLKL are phosphorylated and translocate
to the plasma membrane, mediating membrane permeabilization and resulting in cell death via
necroptosis. Figure from [142].
1.8.3

Pyroptosis

In addition to the TNF-α-induced cell death pathways, there are other programmed cell
death pathways that do not rely on TNF-α, such as pyroptosis. Pyroptosis is a highly
inflammatory form of programmed cell death [143] that can be induced by both pathogenassociated molecular patterns (PAMPs) and DAMPs. During pyroptosis, there is a net increase of
osmotic pressure, cell swelling, and lysis, followed by a mass release of cellular contents,
including active IL-1β and IL-18 [144]. Alternatively, the noncanonical pathway involves the
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activation of caspase-11 (murine), which can also cleave gasdermin D (GSDMD) and is thought
to function independently of inflammasomes [145]. In addition to the upregulation of several
apoptosis-and necroptosis-related molecules, it was shown that MCMV-infected eyes of
MAIDS-10 mice highly upregulates mRNA expression of caspase-1, IL-1β, and IL-18,
collectively peaking 6 days following subretinal MCMV infection, but no upregulation was seen
in MCMV-infected eyes of MAIDS-4 mice [6]. Similar trends were seen for the upregulation of
mRNA for several inflammasomes in the MCMV-infected eyes of MAIDS-10 mice but not those
of MAIDS-4. Additionally, it was seen that the protein levels of cleaved caspase-11 were also
significantly elevated at 6 days following MCMV infection [100]. Taken together, these results
suggest that both the canonical and noncanonical pathways of pyroptosis may be playing a role
in the pathogenesis of MAIDS-related MCMV retinitis.
1.9

Pyroptosis Pathway and Inflammasomes
1.9.1

Canonical Pyroptosis Pathway

The canonical pathway of pyroptosis occurs with the initiation and assembly of an
inflammasome complex. The inflammasome is a multiprotein oligomer responsible for the
activation of inflammatory responses by promoting the maturation and secretion of proinflammatory cytokines IL-1β and IL-18. Once active, the inflammasome binds to pro-caspase-1
either homotypically via its own caspase-activation and recruitment domain (CARD), or via the
CARD of the adaptor protein, associated speck-like protein containing CARD (ASC), which it
binds to during inflammasome formation. The clustering of many p45 pro-caspase-1 molecules
together induces their autocatalytic cleavage allowing caspase-1 to then assemble into its active
form consisting of two heterodimers each with a p20 and p10 subunit. Once active, caspase-1
then cleaves and activates pro-IL-1β and pro-IL-18 to induce interferon (IFN)-γ secretion
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and natural killer cell activation [146]. Caspase-1 also cleaves the cytoplasmic protein, GSDMD,
which localizes to the membrane where it is responsible for forming pores. These pores result in
a net increase in osmotic pressure, water influx, swelling, and osmotic lysis, allowing for the
release of IL-1β and IL-18 (Figure 1.15) [144].

Figure 1.15. Pyroptosis cell death signaling pathway.
The canonical pyroptosis pathway results after intracellular danger signals initiate the assembly
of an inflammasome, which then recruits and activates procaspase-1. Active caspase-1 is then
able to cleave pro-inflammatory cytokines IL-1β and IL-18 as well as the cytosolic protein
GSDMD which forms holes in the plasma membrane resulting in the release of cellular contents.
GSDMD can also be cleaved by caspase-11 through the noncanonical pyroptosis pathway. Figure
from [147].
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Caspase-1. Caspase-1 is an evolutionarily conserved protease that, like other caspases, is
produced as a biologically inactive zymogen that requires cleavage by other caspase-members,
or themselves, to become active (reviewed in [148]). The structure of caspase-1 contains two
heterodimers of cleaved subunits, p20 and p10, and is also composed of a catalytic domain [149]
as well as a CARD domain. The CARD domain can interact with CARD domains on other
proteins, such as the ASC-adapter protein associated with activated inflammasomes or directly
with the CARD domain of the inflammasome [150, 151]. This interaction results in the selfcleavage of caspase-1 resulting in its activation. Cleaved caspase-1 is then able to cleave and
activate the pro-inflammatory cytokines IL-1β and IL-18 [152].
IL-1β. IL-1β is a pro-inflammatory, fever producing cytokine, which is a member of the
IL-1 family. The IL-1 family includes several cytokines that are either pro-inflammatory
agonists— IL-1α, IL-1β, IL-18, IL-33, IL-36α, IL-36β, IL-36γ—or IL-1R antagonist (IL-1Ra)—
IL-36Ra, IL-37, and IL-38—that exert anti-inflammatory activities. Many of these cytokines
play a critical role in response to pathogens [153]. Pro-IL-1β is produced by activated
macrophages as a biologically inactive protein that must be cleaved to become activated.
Because IL-1β invokes a potent inflammatory response, its secretion is tightly regulated. The
transcription of the inactive precursor is induced by activation of toll-like receptor (TLR)
activation, TNF, or IL-1 receptor activation by cleaved IL-1β. In order for this mature form to be
secreted and engage in the stimulation of these receptors, a second signal is needed in the form of
inflammasome activation. The formation of the inflammasome then results in the activation of
caspase-1, which results in the proteolytic processing of IL-1β. Cleavage of IL-1β by activated
caspase-1 allows for IL-1β to fulfill its functions as part of the inflammatory response, as well as
cellular activities, such as cell proliferation and differentiation. Caspase-1 is not the only
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protease that can cleave pro-IL-1β, as neutrophil serine proteases proteinase 3 and elastase, and
the mast cell-derived serine protease, chymase, also have this ability [154, 155].
IL-18. IL-18 is a pro-inflammatory cytokine notorious for the induction of IFN-γ
production from Th1 cells, non-polarized T cells, natural killer cells, natural killer T cells, B
cells, dendritic cells, and macrophages in the presence of IL-12. IL-18 also display other
functions, including the induction of IL-2 production, the facilitation of the expression of IL-2
receptor on Th1 cells, and the activation of natural killer cells. In conjunction with IL-3, IL-18 is
able to facilitate the production of IL-4 and IL-33 from mast cells and basophils (reviewed in
[156]). Murine IL-18 proteins consist of 192 amino acids, and the homology of this sequence to
IL-1β results in its classification as a member of the IL-1 family [157, 158]. Like IL-1β, IL-18 is
produced as a biologically inactive precursor, pro-IL-18, which requires proteolytic processing to
become active via caspase-1 [159].
Gasdermin D. GSDMD is the best-understood member belonging to the gasdermin
family, and its role in pyroptosis has been well characterized [160]. The GSDMD protein
consists of two domains, the N-terminal and C-terminal, with a cleavage site at D276 between
the two domains. This cleavage site is mainly targeted by caspase-1 following inflammasome
activation, while caspase-11 is also able to cleave GSDMD independent of canonical
inflammasome activation [161]. Recently, however, it has been shown that caspase-8 is also
capable of cleaving GSDMD, but the drive to cleave GSDMD by this caspase-is weaker than
caspase-1, and thus it is thought that cleavage by caspase-8 is more of a backup measure in
situations where the other caspases are unable to cleave GSDMD [162]. Additionally, both the
neutrophil specific elastase [163] and cathepsin G [164] were shown to be sufficient in cleaving
GSDMD at a site upstream of that cleaved by the caspases. Once cleaved, the two domains of
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GSDMD serve different functions. The C-domain (p20) functions as an intrinsic inhibitor of the
molecule while the N-terminal domain translocates to the plasma membrane where it
oligomerizes and inserts itself into the membrane, forming a pore. It is the development of this
pore that results in the loss of osmotic homeostasis, cell swelling, and mass release of
inflammatory cytokines, including IL-1β and IL-18 [165-168]. Interestingly, it has been shown
that cleavage of GSDMD by caspase-3 at D88 in the N-terminal domain can decrease the
induction of pyroptosis by inhibiting oligomerization and pore formation [169, 170] that could be
used as regulatory mechanisms against unwarranted cell death.
1.9.2

Inflammasomes

Characteristic of the canonical pathway of pyroptosis is the activation of inflammasomes.
Inflammasomes are high-molecular-weight, multi-protein complexes that are found in the
cytosol of immune cells and regulate the activation of inflammatory responses [171]. There are
multiple types of inflammasomes, and each of their distinct assemblies is determined by a unique
pattern-recognition receptor (PPR) in response to specific PAMPs or danger signals present in
the host’s cytosol. Once activated by the inflammatory ligand, the central domain of the
inflammasome undergoes oligomerization, resulting in the recruitment of adaptor proteins, such
as ASC, to the effector and variable N-terminal domain, which is composed of a pyrin domain
(PYD) and a CARD domain. The CARD domain, on either the inflammasome or ASC binds and
activates pro-caspase-1 to initiate an inflammatory response [172]. There are several types of
inflammasome proteins known to date, including the nucleotide-binding oligomerization domain
(NOD), leucine-rich repeat (LRR)-containing protein (NLR) family members, NLRP3, NLRP1b,
and NLRC4, as well as the protein absent in melanoma 2 (AIM2) (Figure 1.16) [161].
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NLRP3. NLRP3 is the more well-characterized inflammasome of the NLR subset
of inflammasomes. Like all members of the NLR family, NLRP3 has a three-domain structure:
An N-terminal homotypic interaction domain that contains CARD and PYD, a central NOD-like
domain crucial for activation, and a series LRRs on the C-terminal which are presumed to be
responsible for the recognition of NLR ligands. NLRP3 is known to respond to a variety of
stimuli: particulate matter, such as uric acid crystals [173], silica and asbestos [174], extracellular
ATP [175], toxins [176], and several viral [177], bacterial [178, 179], fungal [180] and protozoal
[181] pathogens. Due to the diversity of these stimuli, a cellular event common to all these
stimuli has been suggested to be the inducer for NLRP3. Possible triggers include potassium
efflux [182], mitochondrial dysfunction [183], or reactive oxygen species [184], but no unified
mechanism has yet to be determined.
NLRP1b. Although not as well characterized as NLRP3, NLRP1 was the first
NLR shown to form an inflammasome complex [171]. Unique to NLRP1 is the presence of a
function-to-find domain (FIIND) motif, which is flanked by the CARD domain at its C-terminal
end, and aids in the recruitment of ASC. Although human NLRP1 contains a PYD, this is
missing in murine paralogues, such as NLRP1b. While information is available on the
involvement of NLRP1b with the lethal toxin of B. anthracis [185], much is still unknown
regarding NLRP1b and other possible stimuli.
NLRC4. Unlike the other NLR family members, NLRC4 contains only a CARD
domain that can interact with the CARD domain of caspase-1 resulting in direct activation of
caspase-1 by NLRC4. Whereas the association with the adapter protein ASC enhances this
activation of caspase-1, unlike the other inflammasomes, this interaction is not necessary for
caspase-1 activation by NLRC4 [186]. NLRC4 can interact with different neuronal apoptosis
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inhibitory protein (NAIP) members, and the combination of the different NAIPs may determine
ligand specificity [187]. The NLRC4 inflammasome is often associated with bacterial infections
[188-192], but the involvement of NLRC4 in non-alcoholic steatohepatitis supports the notion
that stimuli other than bacteria can induce the activation of the NLRC4 inflammasome [193].
AIM2. AIM2 is independent of the NLR protein family, contains an N-terminal
PYD domain and a C- hematopoietic interferon-inducible nuclear antigens with 200 amino acid
repeats (HIN-200) domain [194], and senses and binds foreign cytoplasmic double-stranded
DNA [195]. The PYD domain interacts with other PYD domains, such as that on the ASC
protein, via highly specific, homotypical PYD-PYD interactions [196, 197]. As seen with
NLRP3, the AIM2 inflammasome requires an initial pro-inflammatory signal to promote the
expression of its substrates. For NLRP3, this priming is mostly mediated by NF-κB
transcriptional activation, but for AIM2, this signal is type I interferon induction, a response
typical of viral infections [198], including MCMV [195].
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Figure 1.16. Inflammasomes sensors and potential activators.
Inflammasomes are multiprotein complexes that are activated in response to intracellular danger
signals. Once activated, the inflammasome recruits and binds pro-caspase-1 through either a
caspase-activation and recruitment domain (CARD) or a pyrin domain (PYD), and may also
contain an adaptor proteins like the apoptosis speck-like protein with a CARD domain (ASC).
The NLR subset of inflammasomes contain a central nucleotide-binding domain (NBD) as well a
C-terminal leucine-rich repeat (LRR) domain. Unique to NLRP1b (far left) is the presence of a
function-to-find domain (FIIND) presumably for the inflammasome activation. The AIM2
inflammasome (right) contains a C-terminal hematopoietic interferon (IFN)-inducible nuclear
protein with 200-amino acid repeat (HIN-200) domain. Modified from [199]
1.9.3

Noncanonical Inflammasome Pyroptosis Pathway

In addition to the canonical pyroptosis pathway that is dependent on the activation of
either NLRP3, NLRP1b, NLRC4, or AIM2 inflammasomes to recruit and activate caspase-1,
there is also the noncanonical pathway mediated by caspase-11. In 2011, it was discovered that
caspase-11 could trigger the maturation of IL-1β and subsequent pyroptosis in
lipopolysaccharide (LPS)-primed mouse macrophages in an NLRP3-ASC-caspase-1
inflammasome-dependent pathway [200]. Additionally, the human homologs of caspase-11,
caspase-4/5, were shown to have the ability to bind to intracellular LPS [188] directly, and the
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caspase-4/5/11-LPS complex has since been referred to as the noncanonical inflammasome.
Although activated caspase-11 can induce pyroptosis by cleaving GSDMD [165, 166], it is
unable to promote the maturation of pro-IL-1β and pro-IL-18 by direct interaction and must do
so through the stimulation of the NLRP3-ASC-caspase-1 noncanonical pathway [201]. Although
much focus has been centered on the presence of lipopolysaccharide (LPS) to stimulate caspase11, saturated fatty acids [202] and lipid peroxidation [203] have been shown to trigger caspase11 mediated pyroptosis in vitro, suggesting that LPS is not the only ligand needed for caspase-11
induction of pyroptosis. Studies have suggested that caspase-11 does have a role in the murine
host defenses against Aspergillus fumigatus [204] and may have a role in the murine host
defenses against influenza A viruses [177, 205, 206], the rabies virus [207], and MCMV [6].
1.9.4

Pyroptosis and Inflammasomes in Ocular Disease

The stimulation of pyroptosis-associated molecules is not limited to MAIDS-related
MCMV retinitis and has been associated with the pathogenesis of several other ocular diseases
and ailments. Of note are the recent discoveries centered on the extent to which inflammasomes
and/or pyroptosis plays a role in several ocular disorders. Age-related macular degeneration
(AMD) is a sight-threatening, progressive disorder of the retina that specifically targets and
damages the macula, the part of the retina responsible for sharp, central vision. Recently,
elevated levels of the NLRP3 inflammasome, IL-1β, and IL-18 expression were found in AMD
macular lesions [208]. The destructive effects of AMD can also be seen by resultant RPE
thinning or depigmentation, which can lead to RPE atrophy and death of photoreceptors. The
NLRP3 inflammasome was found to be upregulated in the RPE during the pathogenesis of
advanced AMD following RPE atrophy [209]. Inhibition of the NLRP3 inflammasome
components prevented RPE degeneration in a model of AMD [210], providing evidence for
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NLRP3-driven pyroptosis in the pathophysiology of AMD. Analysis of photoreceptor cell death
in a model of retinal degeneration showed an upregulation of NLRP3, caspase-1, IL-1β, and IL18 in cone photoreceptors but not rod photoreceptors [211], suggesting that the overall induction
of pyroptosis in the retina may be unique to specific cell populations or influenced by the
mechanism leading to cell death.
Additionally, an association between pyroptosis and oxidative stress has been established,
which is one factor that leads to the formation of cataracts. Human lens epithelium cells that
were treated with H2O2 showed in a significant increase of caspase-1 and IL-1β mRNA and
protein expression when compared to the control cells. This involvement was ablated by the
addition of a caspase-1 inhibitor, implicating the role of these molecules in cataract formation
[212]. Another ocular disease manifestation of oxidative stress is the formation of proliferating
fibrovascular tissue on the cornea of the eye, known as pterygium. NLRP3, caspase-1, IL-1β, and
IL-18 were all expressed in human pterygium samples, as well as an experimental cell model of
pterygium, suggesting the involvement of this pathway in the process of pterygium formation
and progression [213]. Additionally, an experimental model of ocular hypertension, brought on
by mechanical stress and hypoxia, demonstrated the activation of the NLRP1, NLRP3, and
AIM2 inflammasome complexes, as well as caspase-1 activation and subsequent IL-1β release
and formation of GSDMD pores. These results thus provide evidence for inflammasome-driven
pyroptosis in retinas damaged by ocular hypertension [214].
Pyroptosis induction has also been demonstrated in experimental models of diabeticrelated diseases. One study looking at diabetic retinopathy determined that exogenous addition of
a high level of glucose resulted in increased expression of NLRP3, NLRP1, caspase-1, and IL1β. Furthermore, the downregulation of host miR-590-3p boosted pyroptosis by targeting

48
NLRP1 and activating the NOX4 signaling pathway [215]. Another study investigated the
association of pyroptosis in diabetic corneal endothelial keratopathy. Their studies demonstrated
that the long noncoding RNA KCNQ1OT1, associated with diabetic complications, was
triggered in diabetic human and rat corneal endothelium, while the expression of miR-214 was
downregulated. Further investigation revealed that KCNQ1OT1 may bind miR-214 to regulate
the expression of caspase-1. Additionally, pyroptosis was promoted with the suppression of miR214 and suppressed with the silencing of KCNQ1OT1. Therefore, their results suggest that
KCNQ1OT1-mediated pyroptosis is induced by high glucose via targeting of miR-214 [216].
Taken together, these results emphasize the involvement of pyroptosis in ocular complications of
diabetes and provide potential targets responsible for this induction.
The overwhelming association of pyroptosis-associated molecules with ocular disease
underscores the importance of understanding the mechanisms behind pyroptosis induction in the
ocular microenvironment. The advancement of this knowledge is critical for the development of
treatment strategies that may help prevent the onset of ocular disease rather than in response to
symptoms of this damage. Investigating the role of pyroptosis in the retinal destruction seen
during MAIDS-related MCMV retinitis will not only expand the knowledge of the pathogenesis
of this disease but will also provide valuable insight into the advancement of ocular research.
1.10 Goals of this Dissertation
We have previously shown that the NLRP3, NLRP1b, NLRC4, and AIM2 inflammasome
mRNA is stimulated in MCMV-infected eyes MAIDS-10 mice but not in MCMV-infected eyes
of MAIDS-4 mice [93] as shown in Figure 1.17. Additionally, canonical pyroptosis-associated
mRNA (caspase-1, IL-1β, and IL-18) are also stimulated in MCMV-infected eyes of MAIDS-10
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but not in MAIDS-4 mice [6] (Figure 1.18), while the activated, cleaved, noncanonical caspase11 proteins were also expressed in MCMV-infected eyes of MAIDS-10 mice [93] (Figure 1.19).
To advance our understanding of the ocular expression of inflammasome-driven
pyroptosis in MAIDS-related MCMV retinitis, this study focused on the role that MCMV has on
the induction of pyroptosis and explored the extent to which pyroptosis effects retinal damage
during MCMV-retinitis. One important focus is on the degree that MCMV infection results in
the stimulation of GSDMD. As GSDMD is considered the executioner of pyroptosis, it is
imperative to determine the involvement of GSDMD in the pathogenesis of MAIDS-related
MCMV retinitis prior to attempting to attribute the associated retinal destruction with the
induction of pyroptosis. If pyroptosis is directly responsible for the destruction seen during
MAIDS-related MCMV retinitis, then pyroptosis-associated molecules are not likely to be
stimulated in MCMV-infected eyes of mice that are not susceptible to the development of
MCMV retinitis. Furthermore, the expression of these pyroptosis-associated molecules would
likely have to be stimulated in other models of immunosuppression that confer susceptibility to
the development of MCMV retinitis. Ultimately, if the inflammasome and pyroptosis-associated
molecules are necessary for the onset and progression of retinal destruction seen during MAIDSrelated MCMV retinitis, then the loss or suppression of these genes should ultimately spare the
retina from destruction following ocular infection of MCMV.
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Figure 1.17. Intraocular inflammasome mRNA are highly stimulated in the MCMVinfected eyes of retinitis-susceptible MAIDS-10 mice, but not retinitis-resistant MAIDS-4
mice.
C57BL/6 mice with MAIDS-4 or MAIDS-10 were subretinally injected with 10^4 PFU of
MCMV (left eye) or media (right eyes) and assessed for AIM2, NLRP1b, NLRP3, and NLRC4
inflammasome mRNA at 3, 6, and 10 days post-infection and depicted as a fold-change of
MCMV infected eyes compared with media-injected control eyes. Adapted from [100]
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Figure 1.18. Intraocular pyroptosis-associated mRNA is highly stimulated in the MCMVinfected eyes of retinitis-susceptible MAIDS-10 mice, but not retinitis-resistant MAIDS-4
mice.
MCMV-infected eyes collected from groups of MAIDS-4 mice and MAIDS-10 mice at 3, 6, and
10 days after subretinal MCMV injection compared with mock-infected eyes. Levels (foldchange) of caspase-1 mRNA (A), IL-1β mRNA (B), and IL-18 mRNA (C) were determined by
quantitative RT-PCR assay. Bars indicate standard errors (*, P < 0.05; **, P < 0.001). From [6]
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Figure 1.19. Figure 1.19: Intraocular cleaved caspase-11 protein is clearly abundant at day
6 post-infection in MCMV infected eyes of MAIDS-10 mice.
C57BL/6 mice with MAIDS-10 were subretinally injected with 10^4 PFU of MCMV (left eye)
or media (right eyes) and assessed by western blot for cleaved caspase-11 protein at 3, 6, and 10
days post-infection. Adapted from [100]
Also, as whole eyes are being evaluated for the appearance of molecules connected with
retinal destruction, it is possible that the stimulation of pyroptosis-associated molecules within
the eye results from a multitude of stimuli following MCMV infection and may not be actually
stimulated in the cells directly infected with MCMV. Therefore, it is crucial to determine
whether or not CMV is capable of directly stimulating pyroptosis-associated molecules in
infected cells and elucidating whether or not this stimulation requires viral replication.
As we have previously demonstrated that multiple facets of the immune response to
infection are stimulated following subretinal injection of MCMV retinitis in MAIDS-10 mice
[205], a multitude of factors may be interplaying with one another to contribute to the retinal
destruction seen during MCMV retinitis. This, therefore, begs the question: What other factors
are stimulated following MCMV infection of MAIDS-10 mice that may be contributing to the
pathogenesis of MAIDS-related MCMV retinitis?
The central hypothesis that pyroptosis-associated molecules and associated
inflammasomes contribute to the onset and progression of retinal damage during MAIDS-related
MCMV retinitis was investigated by the use of three specific aims.

53
Specific Aim 1 will test the hypothesis that pyroptosis and associated
inflammasomes are stimulated by MCMV during immunosuppression, contributing to the
onset and development of MCMV retinitis. Pyroptosis-associated molecules, caspase-1, IL-1β,
and IL-18, and inflammasomes NLRP3, NLRP1b, NLRC4, and AIM2 mRNA was significantly
upregulated during experimental MAIDS-related MCMV retinitis but not in MAIDS-4 mice
resistant to the development of MCMV retinitis [6] (Figure 1.18). As GSDMD is considered the
executioner of pyroptosis, due to its ability to form pores resulting in the change in osmotic
pressure and mass release of pro-inflammatory cytokines, we further support the notion that
pyroptosis may be present during the onset of retinal destruction by determining whether
GSDMD is stimulated following MCMV retinitis in MAIDS-10 mice. If pyroptosis is directly
responsible for the destruction seen during MAIDS-related MCMV retinitis, then pyroptosisassociated molecules are not likely to be stimulated in MCMV-infected eyes of mice that are not
susceptible to the development of MCMV retinitis. To deem the necessity of these pyroptosisrelated molecules and associated inflammasomes for the development of CMV retinitis, we
measured the frequency of retinitis in mice lacking one of the following genes: caspase-1,
GSDMD, IL-18, IL-1R1, NLRP3, NLRP1b, and AIM2. If pyroptosis-related molecules and
associated inflammasomes do play a role in the development of MCMV retinitis in mice with
MAIDS, the expression of these pyroptosis-associated molecules would likely have to be
stimulated in other models of immunosuppression that confer susceptibility to the development
of MCMV retinitis, such as corticosteroid-induced immune suppression. Through the completion
of these experiments, we will determine whether pyroptosis-related molecules and associated
inflammasomes play a role in the development of MCMV retinitis is mice with
immunosuppression.
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Specific Aim 2 will test the hypothesis that MCMV replication directly stimulates
pyroptosis in infected cells. Pyroptosis-related molecules were significantly upregulated in
whole eyes infected with MCMV during experimental MAIDS-related MCMV retinitis [6]
(Figure 1.18). As pyroptosis can be signaled by both PAMPs and DAMPs, it is uncertain if the
stimulation of these pyroptosis-associated molecules during the pathogenesis of MAIDS-related
MCMV retinitis is in direct response to MCMV replication in the cells or brought on indirectly
by the host response to viral infection. To determine whether pyroptosis is directly stimulated by
infection of cells by CMV, the stimulation of pyroptosis-associated molecules in response to
MCMV replication was measured in IC-21 mouse macrophages and mouse embryonic
fibroblasts (MEFs). HCMV-induced stimulation of pyroptosis-related molecules was measured
in HCMV-infected ARPE-19 cells and MRC-5 fibroblasts. To determine the viral mechanisms
responsible for any observed stimulation in infected cells, monolayers were infected with UVinactived CMV. UV treatment damages the CMV genome preventing viral replication but allows
for attachment and adsorption of the viral to host cells and the subsequent release of tegument
proteins.
Specific Aim 3 will test the hypothesis that other immune response genes or
pathways are stimulated during the pathogenesis of MAIDS-related MCMV retinitis.
Previous studies by us has demonstrated the involvement of several cell death pathways
and cytokine signaling during MAIDS-related MCMV-retinitis. To determine what other factors
might be involved during the onset and development of retinitis we looked at the stimulation of
multiple additional immune response pathways between MAIDS-4 and MAIDS-10 mice. If
pertinent, these findings could help shape the future focus of our investigation on the
mechanisms underlying the pathogenesis of MAIDS-related MCMV retinitis.
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2.1

MATERIALS AND METHODS

Cell Lines and Stocks
C57BL/6 MEF cells obtained from ATCC (Manassas, VA, No. SCRC-1002) were grown

in Dulbecco’s modified eagle medium (DMEM) supplemented with 15% fetal bovine serum
(FBS), 4 mM L-glutamine, 1% penicillin/streptomycin, 0.1 mg/mL gentamicin, and 1.5 g/L
sodium bicarbonate and maintained according to ATCC recommendations. These cells were used
for titration of MCMV stocks and in some experiments.
IC-21 mouse macrophages (ATCC, Manassas, VA, No. TIB-186) were maintained
according to ATCC recommendations and sustained in RPMI-1640 medium supplemented with
10% FBS, 1% penicillin/streptomycin, and 0.1 mg/mL gentamicin. This cell line was
transformed with a simian virus 40 (SV40) [217] and is commonly used in cell culture studies
with MCMV infection [32, 218-221].
MRC-5 (human fetal lung fibroblast obtained from ATCC, Manassas, VA, No. CCL-171)
cells were cultured according to ATCC recommendations and in DMEM supplemented with
10% FBS, 4 mM L-glutamine, 1% penicillin/streptomycin, 0.1 mg/mL gentamicin, and 1.5 g/L
sodium bicarbonate.
Human retinal pigmented epithelial cells, ARPE-19 (ATCC, Manassas, VA, No. CRL2302), were grown in DMEM: F12 containing 10% FBS, 1% penicillin/streptomycin, and 0.1
mg/mL gentamicin and cultured as recommended by ATCC.
SC-1 fibroblasts (ATCC, Manassas, VA, No. CRL-1404) and SC-1/MuLV LP-BM5 cells
[106] provided by the AIDS Research and Reference Reagent Program, Division of AIDS,
NIAID, NIH (Germantown, MD) and were maintained in DMEM containing 10% FBS, 24 mM
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L-glutamine, 1% penicillin/streptomycin, and 0.1 mg/mL gentamicin. These cell lines were used
for propagation of the mouse retrovirus mixture used to induce MAIDS.
2.2

Viral Stocks
Propagation of CMV. MCMV (Smith) stocks were propagated via passage through

salivary glands of adult female BALB/c mice (Harlan Laboratories, USA) as previously
described [4, 222, 223]. The use of these BALB/c mice was conducted with the approval of the
Georgia State University Institutional Animal Care and Use Committee (IACUC) and in
compliance with the Association for Research in Vision and Ophthalmology (ARVO) statement
for Use of Animals in Ophthalmic and Vision Research. The Towne strain of HCMV was
propagated through (MRC-5) cells acquired from the American Type Culture Collection (ATCC,
Manassas, VA, No. CCL-171). Stocks of viruses were centrifuged to remove cellular debris and
frozen in liquid nitrogen. Viral titers for the MCMV and HCMV stocks were quantified by
standard plaque assay in C57BL/6 MEFs and MRC-5, respectively.
Propagation of mouse retrovirus mixture for MAIDS induction. Stocks of murine
retrovirus (LP-BM5 murine leukemia virus [MuLV]) were prepared in SC-1 fibroblasts and SC1/MuLV LP-BM5 cells [106] provided by the AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH (Germantown, MD). To prepare each stock, the two cell lines
were seeded in a 1:1 ratio and maintained for six days. The cells were then scraped into a
complete SC-1 medium and stored at -80°C. Aliquots of stocks were thawed and clarified by
centrifugation prior to each use.
UV-inactivation of MCMV. For experiments utilizing UV-inactivation of the virus, a
portion of MCMV from the same stock of each experiment was exposed to DNA-damaging UV
light (UVi-MCMV) [224]. UV-inactivation was achieved by placing approximately 1 mL of the
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virus stock in an uncovered dish on ice approximately 5-cm from the UV light for three hours
[99]. Aliquots of UVi-MCMV were titered to ensure complete inactivation.
2.3

Animals
Adult female BALB/c mice, used for MCMV propagation, were purchased from Harlan

Laboratories (Indianapolis, IN, USA). Wild-type female C57BL/6 mice used for experiments
were purchased from Jackson Laboratory (Bar Harbor, ME, USA). All mice were housed in the
Georgia State University vivarium with 12-hr light/dark cycles with unrestricted access to
standard diet and water. All animal procedures were conducted in compliance with Georgia State
University IACUC protocols and with the ARVO statement for Use of Animals in Ophthalmic
and Vision Research.
Induction of MAIDS. MAIDS was induced in WT C57BL/6 mice and in various groups
of knockout mice (B6.129S6-Nlrp3 tm1Bhk/J, B6.129S6-Nlrp1b tm1Bhk/J, and B6.129P2Aim2Gt(CSG445) Byg/J, B6N.129S2-Casp 1tm1Flv/J, B6.129S7-Il1r1tm1Imx/J, B6.129P2-Il18tm1Aki/J,
and C57BL/6J-Gsdmdem1Vnce/J) by intraperitoneal injection of 1.0 ml of inoculum containing
approximately 5 × 103 infectious LP-BM5 murine leukemia retrovirus. The retrovirus mixture
was allowed to progress to MAIDS-4 or to MAIDS-10.
Corticosteroid-induced Immunosuppression. For the corticosteroid-induced
immunosuppression experiments, corticosteroid-induced immunosuppression was established in
adult female C57BL/6 mice, as previously described [109, 225, 226] via intramuscular injection
of methylprednisolone acetate (2mg/mouse, ~40 mg/kg) every three days starting two days prior
to MCMV infection. All mice were age matched to groups of female adult mice,
immunosuppressed for MAIDS.
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Subretinal MCMV Injections. Prior to subretinal injections of MCMV, all groups of
mice eyes were first dilated with atropine and tropicamide eye drops. Mice were then
anesthetized by intramuscular injection of 0.1 mL xylazine (1.72 mg/mL) and 0.1 mL
acepromazine (0.28 mg/mL), followed by intraperitoneal injection of 0.1–0.2 mL ketamine (8.58
mg/mL). Once mice were confirmed to be under deep anesthesia, both eyes were injected with 2
μL of DMEM containing approximately 104 plaque-forming units (PFU) of MCMV. Three, six,
or ten days following infection, mice were anesthetized with isoflurane, euthanized, and whole
eyes were harvested. The eyes were either frozen in liquid nitrogen for protein analysis and
quantification of ocular MCMV or stored in a 10% buffered formalin solution for histology.
2.4

Quantification of Infectious MCMV
Infectious MCMV was quantified in each eye by individually homogenizing the MCMV-

infected eyes in a 2 mL Tenbroeck tissue grinder (Wheaton, Millville, NJ) with 1 mL phosphatebuffered saline (PBS). The virus was clarified from the tissue by centrifugation. The resultant
aliquots underwent a freeze-thaw cycle and were then serially diluted and inoculated onto
monolayers of ~90% confluency MEFs in duplicate. After a 1-hour incubation at 37°C, infected
wells were then overlaid with 2% methylcellulose in DMEM and incubated for another six days.
Individual plaques were counted with an inverted light microscope, and MCMV titers for whole
eyes were reported as PFU/mL/eye.
2.5

Histology
The frequency of retinitis in all mice (n = >3) was measured after euthanizing and

harvesting eyes ten days post-MCMV infection. Harvested eyes were stored at 4°C for at least
five days in a 10% buffered formalin solution. After fixation, eyes were then embedded in
paraffin, cut into 5-μm-thick transverse sections, and stained with hematoxylin and eosin by the
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Pathology Department of the Emory Eye Center. Every sixth section of each eye was evaluated
under light microscopy for the presence or absence of retinitis
2.6

Western Blot Analysis
MCMV-infected eyes frozen in liquid nitrogen were thawed and homogenized in PBS

containing a protease inhibitor cocktail (Sigma, St. Louis, MO). Samples were subjected to
sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (SDS-PAGE) and transferred
to a 0.2-μm-pore polyvinylidene fluoride membrane blocked in 5% bovine serum albumin.
Target proteins were completed using rabbit anti-mouse IL-1β antibody (1:250) (Abcam,
Toronto, ON), rabbit anti-mouse IL-18 antibody (1:250) (Abcam), rabbit anti-mouse GSDMD
(1:500) (Abcam), rabbit anti-mouse caspase-1 (1:500) (Abcam), rabbit anti-mouse caspase-11
(1:500) (Abcam), rabbit anti-mouse RIPK1 (1:500), rabbit anti-mouse RIPK3 (1:500), rabbit
anti-mouse MLKL (1:500), rabbit anti-mouse TNFα (1:1000), rabbit anti-mouse beclin-1
(1:1000), rabbit anti-mouse LC3B (1:1000), rabbit anti-mouse GAPDH antibody (1:1,000)
(Abcam), or rabbit anti-mouse β-actin antibody (1:1,000) (Abcam) as primary antibodies. Goat
anti-rabbit IgG antibody (heavy plus light chains [H+L]) conjugated with horseradish peroxidase
(Thermo Scientific, Pittsburgh, PA) was chosen as a secondary antibody (1:5,000). Probed
nitrocellulose membranes (Bio-Rad, Hercules, CA) were treated with Clarity Western ECL
Substrate (Biorad) and exposed to HyBlot film (Denville, Holliston, MA) for band detection.
2.7

Immunofluorescence Staining
Immunofluorescence (IF) staining was performed in MEFs grown in 24-well dishes infected

with 0.5 mL per well of either MCMV (multiplicity of infection (MOI) = 3 PFU/cell), UViMCMV from the same stock, or control medium. At 6 and 24 hpi, wells were fixed in ice-cold
methanol, blocked in 5% bovine serum albumin, and probed for rabbit-anti-mouse caspase-1, IL-
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1β, IL-18, gasdermin D primary antibodies (Santa Cruz Biotechnology, Inc., Dallas, TX). Goatanti-rabbit IgG Fab’ fragment antibody conjugated with FITC (green) (Jackson
ImmunoResearch, West Grove, PA) was used as the secondary antibody. Cell nuclei were
counterstained with 4', 6-diamidino-2-phenylindole (DAPI) in Vectashield® mounting solution
(Vector Laboratories, Burlingame, CA). Cells were then observed using a Keyence microscope.
2.8

RNA Extraction and Real-Time RT PCR
RNA extraction from tissue samples. Whole MCMV-infected eyes and mock infected

eyes were collected at the indicated time points following subretinal injection and stored at 4°C
in RNAlater solution (Ambion, Austin, TX). Following collection at all time points, eyes were
then individually homogenized in 1mL of TRIzol® reagent (Invitrogen Life Technologies,
Carlsbad, CA) using a 2-ml Ten Broeck tissue grinder (Wheaton, Millville, NJ). Total RNA was
extracted in chloroform and purified using the PureLink® RNA Mini Kit according to the
manufacturer’s instructions (Ambion/ThermoFisher). RNA concentrations were determined
using a Nanodrop™ 2000 spectrophotometer (Thermo Scientific, Pittsburgh, PA) and
normalized for each sample.
RNA extraction from cell monolayers. Monolayers of cells were harvested at indicated
time points in TRIzol® reagent (Ambion/ThermoFisher Scientific, Waltham, MA, USA) at
indicated time points. Total RNA was extracted with chloroform and purified over PureLink®
RNA Mini Kit spin cartridge filters according to the manufacturer’s instructions
(Ambion/ThermoFisher). RNA concentrations were determined using a Nanodrop 2000
spectrophotometer (Thermo Scientific, Pittsburgh, PA) and normalized for each sample.
Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR). The RNA
for all sample types was then reverse-transcribed into cDNA using SuperScript™ III First-Strand
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Synthesis Kit reagents according to the manufacturer’s instructions (Invitrogen/ThermoFisher).
Detection and quantification of target gene expression were performed via real-time RT-PCR
using Applied Biosystems 7500 Fast Real-Time PCR System hardware and software in
conjunction with Power SYBR Green Master Mix (Applied Biosystems, Foster City, CA).
Mouse-specific primers for caspase-1, caspase-11, IL-1β, IL-18, GSDMD, NLRP3, NLRP1b,
NLRC4, AIM2, and GAPDH were obtained from QIAgen (Valencia, CA). Samples were run
under the following thermocycling parameters: 10 min at 95°C followed by 40 cycles consisting
of 15 seconds at 94°C, 31 seconds at 55°C, and 35 seconds at 70°C. Cycles to the threshold (CT)
for each target gene were determined, and the ΔCT value for each sample was normalized by
subtracting the CT value of their own endogenous housekeeping gene (GAPDH) from the CT
value of the target gene. The ΔCT values of each target gene mRNA of MCMV-infected eyes
were compared with mock infected control eyes by the 2-ΔΔCt method to determine the change
in gene expression, yielding a relative fold-change in mRNA expression for each group. Data
points represent mean fold-changes ± standard deviations (SD) of at least duplicate experimental
repeats.
2.9

NanoString Analysis
Whole MCMV-infected eyes and mock infected eyes were collected at indicated time

points and stored at 4°C in RNAlater solution (Ambion, Austin, TX). Eyes were then
homogenized in 1 mL of TRIzol® reagent (Invitrogen Life Technologies, Carlsbad, CA) using a
2-ml Ten Broeck tissue grinder (Wheaton, Millville, NJ). Total RNA was extracted in
chloroform and purified using the PureLink® RNA Mini Kit according to the manufacturer’s
instructions (Ambion/ThermoFisher). The extracted RNA from each group and respective time
points were pooled together, and the RNA concentrations were determined using a Nanodrop
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2000 spectrophotometer (Thermo Scientific, Pittsburgh, PA). Approximately 100 ng of the
purified total RNA was hybridized to a reporter and capture probe prior to being added to the
NanoString panels for analysis of raw RNA counts. The nCounter murine immunology panel
designed by NanoString Technology (Nanostring, Seattle, WA, USA) was used to analyze the
expression of 561 genes, including several internal references and housekeeping genes. A
custom-made panel including 30 genes of interest and 3 housekeeping genes was also loaded to
explore the expression of RNA associated with several genes not specific to the murine
nCounter Immunology Panel. All data were analyzed using the NanoString nSolver 4.0
software (Nanostring, Seattle, WA, USA).
2.10 Statistical Analyses
All statistical analyses were performed with a significance level (α) set to 0.05. P-values
of < 0.05 were considered statistically significant and were denoted by asterisks in figures where
appropriate: * p<0.05, ** p<0.01, and *** p<0.001. Statistical tests were performed as
appropriate for each study as specified below.
Statistical analysis for in vivo studies. All quantitative data obtained from real-time RTPCR were performed with a significance level (α) set to 0.05 so that p-values of <0.05 were
considered statistically significant and expressed as means ± SD. At least two independent
experiments were performed for each study. Statistical analysis was performed by comparing
MCMV-infected eyes with mock infected control eyes by paired, two-tailed Student’s t-test.
Statistical analysis for in vitro studies. Statistical analysis was performed using
GraphPad Prism® v8.2.1 software with a significance level (α) set to 0.05, so that p-values of
<0.05 were considered statistically significant. Experimental groups were compared with
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respective control groups at the same time points using a two-way analysis of variance
(ANOVA) with Bonferroni posthoc analysis.
Statistical analysis for ocular titers. All quantitative data obtained for ocular titers were
performed with a significance level (α) set to 0.05 so that p-values of <0.05 were considered
statistically significant and expressed as means ± SD. At least two independent experiments were
performed for each study. Statistical analysis was performed by comparing MCMV-infected eyes
of WT MAIDS-10 mice to each knockout MAIDS-10 mouse by unpaired, two-tailed Student’s ttest.
Statistical analysis for NanoString studies. Two independent experiments were
performed for each study and ran independently through the NanoString software. Any p-values
obtained were done on fold-changes of raw RNA counts as determined by the NanoString
nSolver software and performed with a significance level (α) set to 0.05 so that p-values of
<0.05 were considered statistically significant. Statistical analysis was performed by comparing
MCMV-infected eyes with mock infected control eyes by unpaired, two-tailed Student t-test, and
values were expressed as means ± SD.
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SPECIFIC AIM 1

Specific Aim 1: Test the Hypothesis That Pyroptosis and Associated Inflammasomes are
Stimulated by MCMV during Immunosuppression, Contributing to the Onset and
Development of MCMV Retinitis
3.1

GSDMD and Caspase-11 Expression during MAIDS-related MCMV Retinitis
Expression and translation of GSDMD during MAIDS-related MCMV retinitis. We

reported previously that MCMV-infected eyes of MAIDS-10 mice show high stimulation of
mRNA expression of pyroptosis-associated molecules, caspase-1, IL-1β, and IL-18, collectively
peaking 6 days following subretinal MCMV inoculation. To further confirm a role for pyroptosis
in the pathogenesis of MAIDS-related MCMV retinitis, we assessed whether protein and/or
mRNA of the pore-forming molecule, GSDMD, increased following ocular MCMV infection in
MAIDS-10 mice. We found that MCMV-infected eyes of MAIDS-10 mice showed upregulation
of both GSDMD mRNA transcripts (Fig. 3.1A) and protein (Fig. 3.1B). However, unlike
caspase-1, IL-1β, and IL-18 mRNA transcripts that showed a peak upregulation at 6 days postinfection, GSDMD mRNA appeared to be consistently upregulated days 3, 6, and 10 following
MCMV inoculation. Protein levels for full-length GSDMD were robustly increased in MCMVinfected eyes when compared to the media control eyes at all days post-infection while a
substantial stimulation of cleaved GSDMD protein was seen at 10 days post-infection.
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Figure 3.1. Intraocular GSDMD mRNA and protein expression were highly expressed in
the MCMV infected eyes of retinitis-susceptible MAIDS-10 mice.
Whole eyes were collected at 3, 6, and 10 days following subretinal injection of MCMV (left
eyes) or media control (right eyes) from groups (n=3-5) of MAIDS-10 mice. Homogenized eyes
were assessed for GSDMD mRNA (A) or protein expression, with GAPDH used as a loading
control. *p<0.05, MCMV groups compared with media group at the same time point.
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Expression and translation of caspase-11 during MAIDS-related MCMV retinitis.
We previously saw that protein levels of cleaved caspase-11 was also significantly stimulated at
6 days following MCMV injection of MAIDS-10 mice [6]. Since we have not previously
characterized the expression of caspase-11 mRNA, we assessed whether this was also stimulated
during the onset and progression of MAIDS-related MCMV retinitis. Like GSDMD, mRNA
levels of caspase-11 (Fig. 3.2A) were also stimulated in MCMV-infected eyes of MAIDS-10
consistently at days 3, 6, and 10, following ocular MCMV infection. Assessing levels of the
zymogen version of caspase-11 revealed that procaspase-11 protein was also stimulated at days 3
and 6 post-MCMV infection (Fig.3.2B). The locus of caspase-11 has been shown to encode two
polypeptides of 43 and 38 kDa [227] in which the p20 cleavage product of procaspase-11
appears to be derived from the 43 kDa species [228]. Interestingly, at day 3 post-infection, the 43
kDa band of procaspase-11 was highly expressed, while the 38 kDa band was more highly
expressed at day 6 post-infection. Taken together, these results suggest that MCMV stimulates
both GSDMD and caspase-11 mRNA and protein following ocular infection of MCMV in
MAIDS-10 mice.
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Figure 3.2. Intraocular caspase-11 mRNA and protein expression were highly stimulated in
the MCMV infected eyes of retinitis-susceptible MAIDS-10 mice.
Whole eyes were collected at 3, 6, and 10 days following subretinal injection of MCMV (left
eyes) or media control (right eyes) from groups (n=3-5) of MAIDS-10 mice. Homogenized eyes
were assessed for caspase-11 mRNA (A) or protein expression, with GAPDH used as a loading
control. *p<0.05, MCMV groups compared with media group at the same time point.
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3.2

GSDMD and Caspase-11 Expression Following MCMV Infection in MAIDS-4 Mice
Expression and translation of GSDMD following MCMV infection of retinitis

resistant MAIDS-4 mice. We reported previously that MCMV-infected eyes of MAIDS-10 but
not MAIDS-4 mice showed mRNA expression of pyroptosis-associated molecules, caspase-1,
IL-1β, and IL-18. To determine if GSDMD expression follows this pattern, we assessed whether
the mRNA and/or protein of GSDMD was expressed following ocular infection of MCMV in
retinitis resistant MAIDS-4 mice. Interestingly, expression of GSDMD during MCMV infection
of MAIDS-4 eyes showed a substantial increase in fold-change of mRNA when compared to the
mock infected control eyes at each time point during viral infection (Fig.3.3A). The pattern of
mRNA production of GSDMD at MAIDS-4 was different from that at MAIDS-10 (Fig. 3.3B).
MAIDS-4 mice showed a peak in mRNA production at day 6 post-infection that reached the
relative level seen in MAIDS-10 infected eyes. Both at days 3 and 10 post-infection, however,
there was less GSDMD transcript production than the corresponding days of MAIDS-10
MCMV-infected eyes. The pattern of protein expression for full-length GSDMD protein was
similar at MAIDS-4 as it was at MAIDS-10, in which the protein was stimulated in MCMVinfected eyes at all days post-infection with higher expression at day 6 post-infection (Fig. 3.3C).
Interestingly, cleaved GSDMD protein was expressed only at day 6 post-infection in MCMVinfected eyes of mice with MAIDS-4 while MAIDS-10 mice showed expression only at day 10
post-infection, which correlates with the presence of retinitis.

69

Figure 3.3. Intraocular GSDMD mRNA and protein were stimulated in MCMV infected
eyes of both retinitis susceptible MAIDS-10 mice and retinitis-resistant MAIDS-4 mice.
Whole eyes were collected at 3, 6, and 10 days post-infection (dpi) and from MCMV infected
eyes and media control eyes from groups (n=3-5) of MAIDS-4 and MAIDS-10 mice.
Homogenized eyes were assessed for GSDMD mRNA from the MAIDS-4 mice (A) and the
MAIDS-10 mice (B). Western blot analysis (C) was performed to assess ocular GSDMD protein
expression in MAIDS-4 mice with GAPDH used as a loading control. *p<0.05 and **p<0.01,
MCMV groups compared with media control at the same time points.
Expression and translation of caspase-11 following MCMV infection of retinitis
resistant MAIDS-4 mice. We previously saw that protein levels of cleaved caspase-11 were also
significantly stimulated at 6 days following MCMV injection of MAIDS-10 mice [6]. Since we
had not previously characterized the expression of caspase-11 mRNA during MAIDS-4, we
assessed whether caspase-11 mRNA was also stimulated in MAIDS-4 mice resistant to MCMV
retinitis. Like GSDMD, mRNA levels of caspase-11 was stimulated in MCMV-infected eyes of
both MAIDS-4 (Fig. 3.4A) and MAIDS-10 (Fig. 3.4B) mice. mRNA expression in MAIDS-4
mice, however, exhibited an initially high upregulation at day 3 post-infection which resulted in
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an almost linear decrease in production continuing through 6- and 10-days post-infection.
Similar to the protein levels seen at MAIDS-10, procaspase-11 protein levels showed a
stimulation at day 6 post-infection in MCMV-infected eyes of MAIDS-4 mice, which decreased
by day 10 post-infection, whereas media-injected eyes did not stimulate caspase-11 protein
production at any days post-infection (Fig. 3.4C). However, unlike MCMV-infected eyes of
MAIDS-10 mice, procaspase-11 protein was not expressed 3 days post-infection in MCMVinfected eyes of MAIDS-4 mice. Taken together, these results suggest that MCMV stimulates
both GSDMD and caspase-11 following ocular infection in both retinitis susceptible MAIDS-10
mice and retinitis resistant MAIDS-4 mice.

Figure 3.4. Intraocular caspase-11 mRNA and protein were stimulated in MCMV infected
eyes of both retinitis susceptible MAIDS-10 mice and retinitis-resistant MAIDS-4 mice.
Whole eyes were collected at 3, 6, and 10 days post-infection (dpi) and from MCMV infected
eyes and media control eyes from groups (n=3-5) of MAIDS-4 and MAIDS-10 mice.
Homogenized eyes were assessed for caspase-11 mRNA from the MAIDS-4 mice (A) and the
MAIDS-10 mice (B). Western blot analysis (C) was performed to assess ocular procaspase-11
protein expression in MAIDS-4 mice with GAPDH used as a loading control. *p<0.05 and
**p<0.01, MCMV groups compared with media control at the same time points.
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3.3

Effect of the Loss of the Pyroptosis Pathway or Associated Inflammasomes on the
Development of MAIDS-related MCMV Retinitis
3.3.1

The Loss of the Pyroptosis Pathway and MAIDS-related MCMV Retinitis

We have previously reported that mRNA for caspase-1, IL-1β, and IL-18 are stimulated
during the onset and development of MAIDS-related MCMV retinitis [6]. To continue our
investigations on the involvement of pyroptosis-associated proteins in the retinal destruction seen
during this disease, we employed several mice knocked-out of either caspase-1, GSDMD, IL1R1, or IL-18 to determine the necessity of these proteins in the development of retinitis.
MCMV-infected eyes of caspase-1 KO mice with MAIDS, GSDMD KO mice with
MAIDS, IL-1R1 KO mice with MAIDS, and IL-18 KO mice MAIDS show patterns of
protein synthesis that are relatively similar to those of MCMV-infected eyes of wildtype
mice with MAIDS. We next embarked on a comprehensive investigation of MCMV retinitis
pathogenesis using mice with MAIDS that were deficient in one of four pyroptosis-associated
genes to define with greater precision the contribution of pyroptosis toward the onset and
progression of MAIDS-related MCMV retinitis. This investigation included a gene deficiency in
the production of either caspase-1, GSDMD, IL-1R1, or IL-18. All caspase-1 KO mice, GSDMD
KO mice, IL-1R1 KO mice, and IL-18 KO mice infected with the immunosuppressive murine
retrovirus mixture (LP-BM5 MuLV) developed MAIDS as assessed by their development of a
number of MAIDS-related physical and immunologic characteristics (data not shown) described
by us previously [100].
Prior to assessing possible virologic, pathogenic, and histopathologic differences
during the development of MCMV retinitis among MAIDS mice with a pyroptosis-associated
gene deficiency when compared with the development of MCMV retinitis in wildtype MAIDS
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mice, we investigated the patterns of pyroptosis-associated proteins of the canonical and
noncanonical pyroptosis pathways for possible alterations in their pattern of synthesis with
particular attention given to cleavage events. Western blot analysis of MCMV-infected eyes
collected from caspase-1KO mice with MAIDS, GSDMD KO mice with MAIDS, IL-1R1 KO
mice with MAIDS, and IL-18 KO mice with MAIDS at 10 days after subretinal MCMV
inoculation showed relatively similar patterns of protein production for corresponding proteins
associated with the canonical and noncanonical pyroptosis pathways when compared with the
patterns of protein production collected from MCMV-infected eyes of wildtype MAIDS mice
(Fig. 3.5). Some notable exceptions were observed, however. A deficiency in either capsase-1
production during MAIDS or IL-1R1 production during MAIDS resulted in an absence of
cleaved caspase-11 of the noncanonical pyroptosis pathway despite evidence for pro-caspase-11
production (Fig 3.5A and 3.5C). Similarly, a deficiency in IL-1R1 production during MAIDS
also resulted in a marked decrease in cleaved GSDMD protein of the canonical pyroptosis
pathway (Fig 3.5B).

73

Figure 3.5. Expression of pyroptosis-associated proteins in MCMV infected eyes of
wildtype MAIDS mice and caspase-1KO, GSDMD KO, IL-1R1KO, and IL-18KO micewith
MAIDS.
WT MAIDS mice and groups of caspase-1 KO (A), GSDMD KO (B), IL-1R1 KO (C), and IL18 KO (D) mice with MAIDS (n= 4- 6 mice/group) were subretinally infected with 10^4 PFU
MCMV. Whole eyes were collected and at 10 dpi and assessed for ocular expression of the
known pyroptosis-associated markers by western blot with beta-actin serving as a loading
control.

74

MCMV-infected eyes of wildtype mice with MAIDS and MCMV-infected eyes of
mice with MAIDS deficient in the production of a pyroptosis-associated protein harbor
equivalent amounts of infectious MCMV. We showed previously that MCMV-infected eyes of
retinitis-susceptible wildtype mice with MAIDS harbor significantly high amounts of infectious
virus at 10 days after subretinal MCMV inoculation when compared with retinitis-resistant
MCMV-infected eyes of healthy mice similarly inoculated with virus [6, 103]. To determine if
loss of the canonical pyroptosis pathway (defined as a deficiency in the production of a key
pyroptosis-associated protein) resulted in reduced intraocular virus replication during the
development of MAIDS-related MCMV retinitis, whole MCMV-infected eyes were collected
from groups of wildtype MAIDS mice, caspase-1KO mice with MAIDS, GSDMD KO mice with
MAIDS, IL-1R1KO mice with MAIDS, and IL-18KO mice with MAIDS at 10 days after
subretinal MCMV inoculation (n = 4 – 6 per group) and were individually homogenized and
subjected to standard plaque assay to quantify infectious MCMV. Results are shown in Fig 3.6.
In agreement with previous findings [6, 103, 226], MCMV-infected eyes of retinitis-susceptible
wildtype mice with MAIDS were found to contain high amounts of infectious MCMV (4.3
x104). In comparison, MCMV-infected eyes of mice with MAIDS with a deficiency in either
caspase-1, GSDMD, IL-1R1, or IL-18 also showed high amounts of infectious virus and at levels
equivalent to that found within MCMV-infected eyes of wildtype mice with MAIDS with
amounts ranging from 4.8 x104 to 4.4 x104. While there was a trend for the MCMV-infected eyes
collected from pyroptosis-deficient MAIDS mice to exhibit greater amounts of infectious
MCMV when compared with wildtype MAIDS mice, this difference was not statistically
significant. Thus, loss of the canonical pyroptosis pathway during MAIDS did not affect the
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intraocular replication of MCMV when compared with wildtype animals with MAIDS at 10 days
following subretinal MCMV inoculation.

Figure 3.6. WT MAIDS mice and groups of MAIDS mice deficient in the production of a
pyroptosis-associated protein harbored equivalent amounts of infectious MCMV.
MCMV-infected eyes were collected 10 dpi following intraocular MCMV injection from
wildtype MAIDS mice and MAIDS mice deficient in either caspase-1, IL-1R1, IL-18, and
GSDMD. Amount of infectious MCMV were detected in whole eyes by standard plaque assay
(n=4-6).
The frequency of full-thickness retinal necrosis is significantly reduced within
MCMV-infected eyes of MAIDS mice deficient in the production of a pyroptosis-associated
protein when compared with the frequency of full-thickness retinal necrosis MCMVinfected eyes of wildtype MAIDS mice. Our finding that MCMV-infected mice with MAIDS
with a deficiency in the pyroptosis pathway harbor high amounts of infectious MCMV led us to
suspect that these animals would also develop full-thickness retinal necrosis at a frequency of 80
to 100% as observed by us previously for wildtype mice with MAIDS [6, 103, 226]. To confirm
this suspicion, the eyes of groups of mice with MAIDS lacking either caspase-1, GSDMD, IL-
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1R1, or IL-18 were inoculated subretinally with MCMV, collected 10 days later, subjected to
histopathologic analysis, and scored for the frequency of full-thickness retinal necrosis. The
MCMV-infected eyes of groups of wildtype mice with MAIDS included in each experiment
served as controls. As reported previously, the frequency of full-thickness retinal necrosis for
mice with MAIDS was 100% in each experiment. Surprisingly, however, none (0%) of the
MCMV-infected eyes of mice with MAIDS with a deficiency in either caspase-1, GSDMD, IL1R1, or IL-18 developed full-thickness retinal necrosis. Despite high amounts of intraocular
infectious MCMV at levels observed within MCMV-infected eyes of wildtype mice that
consistently developed full-thickness retinal necrosis, MCMV-infected eyes of MAIDS mice
deficient in a gene essential for pyroptosis consistently failed to develop full-thickness retinal
necrosis.
MCMV-infected eyes of MAIDS mice deficient in the production of a pyroptosisassociated protein consistently show prominent RPE proliferation but with relative
preservation of the neurosensory retina. In an attempt to resolve the apparent discrepancy of
high and equivalent amounts of intraocular infectious virus but without expected full-thickness
retinal necrosis development within MCMV-infected eyes of pyroptosis-deficient MAIDS mice
when compared MCMV-infected eyes of wildtype MAIDS mice, a detailed histopathologic
analysis was performed to define with greater precision the patterns of retinal disease among the
different animal groups at 10 days after subretinal MCMV inoculation. Results are shown in Fig
3.7. As expected, histopathologic examination of sections of MCMV-infected eyes collected
from wildtype mice with MAIDS showed areas of full-thickness retinal necrosis containing
virus-induced inclusions and cytomegalic cells in agreement with several previous publications
by us [103]. In sharp contrast, however, histopathologic analysis of MCMV-infected eyes of
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groups of caspase-1 KO mice with MAIDS, GSDMD KO mice with MAIDS, IL-1R1 KO mice
with MAIDS, and IL-18 KO mice with MAIDS when paired experimentally with MCMVinfected eyes of groups of wildtype mice with MAIDS as controls in separate experiments
revealed two major findings. One was an atypical histopathologic feature characterized by
widespread RPE proliferation accompanied by detection of virus-induced inclusions. The second
was a relative preservation of the neurosensory retina with loss of photoreceptors in some cases
but without detection of virus-induced inclusions or cytomegalic cells and without the
development of full-thickness retinal necrosis. Moreover, it is noteworthy that this pattern of
histopathologic changes was relatively consistent among all groups of animals with MAIDS
deficient in the canonical pyroptosis pathway whether loss of caspase-1, GSDMD, IL-1R1, or
IL-18 gene activity. Instead, MCMV-infected eyes from caspase-1 KO mice with MAIDS,
GSDMD KO mice with MAIDS, IL-1R1 KO mice with MAIDS, and IL-18 KO mice with
MAIDS exhibited an unexpected abnormal histopathologic outcome quite different from the of
full-thickness retinal necrosis.
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Figure 3.7. MCMV-infected eyes from groups of MAIDS mice deficient in the production
of a pyroptosis-associated protein showed prominent RPE proliferation but preservation of
the neurosensory retina.
MCMV-infected eyes were collected 10 dpi following intraocular MCMV injection from
wildtype MAIDS mice and MAIDS mice deficient in either caspase-1, IL-1R1, IL-18, and
GSDMD. H & E staining was done to histopathologically evaluate the presence of retinitis and
changes in the retinal architecture.
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Loss of pyroptosis-associated genes for caspase-1, GSDMD, IL-1R1, and IL-18 does
not entirely abolish the expression of necroptosis-associated proteins in MCMV-infected
eyes of MAIDS-10 mice. Necroptosis is another form of programmed cell death pathway that
results in a disruption in the membrane integrity, leading to the release of cellular components
and resulting in inflammation. During necroptosis, RIPK1 and RIPK3, promoted by TNF-α, are
recruited and activated [229-231]. This activation leads to the recruitment and phosphorylation
of MLKL, which forms an oligomer complex and migrates to the plasma membrane [230]. Once
at the membrane, MLKL forms a pore resulting in the rupture of the cell and subsequent release
of DAMPs, triggering a highly pro-inflammatory response [232]. Like inflammasomes and
pyroptosis-associated proteins, these necroptosis-related proteins have also been seen stimulated
in MAIDS-related MCMV retinitis. To determine if the preservation in the neurosensory retinas
in these KO mice had anything to do with the downregulation of necroptosis proteins in the
absence of pyroptosis-associated genes, western blot analysis was utilized to detect the presence
of necroptosis-associated proteins in caspase-1, GSDMD, IL-1R1, and IL-18 KO MAIDS mice.
Western blot analysis was done on the MCMV-infected eyes of WT MAIDS mice and
MAIDS mice deficient in either caspase-1 (Fig. 3.8A), GSDMD (Fig. 3.8B), IL-1R1 (Fig. 3.8C)
or IL-18 (Fig. 3.8D) for molecules essential to the necroptosis pathway. For all KO MAIDS
mice, RIPK1 and RIPK3 expression in MCMV-infected eyes was relatively similar to that seen
in MCMV-infected eyes of WT MAIDS mice. MLKL protein expression and the
phosphorylation of MLKL was also expressed in the MCMV-infected eyes of MAIDS mice,
either WT or KO. Protein analysis for TNF-α revealed that the unprocessed protein [233] and
cleaved form of TNF-α were both expressed in KO MAIDS mice and that this level of
expression was the same as the WT MAIDS mice for all KO MAIDS mice except for mice
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deficient in GSDMD. This suggests that GSDMD expression may have an influence on the
expression of TNF-α in MCMV-infected eyes of MAIDS-10 mice.
The Effect of the Loss of Pyroptosis-associated Proteins on the Expression of
Autophagy Proteins in MCMV-infected Eyes of MAIDS-10 Mice. Western blots were also
done to determine the level of expression of autophagy-related proteins, beclin-1, and LC3B.
Unlike pyroptosis and necroptosis, autophagy is a non-inflammatory form of cell death induced
under times of cellular stress [234]. Previously, we have shown that autophagy is not expressed
in MAIDS-10 mice with MCMV retinitis. We were then interested in determining if the lack of
retinitis in these KO mice was due to the stimulation of autophagy proteins as a means of
protecting the retina. Western blots showed that there was no substantial difference seen in both
beclin-1 and LC3B between WT MAIDS mice and Casp 1 KO MAIDS mice (Fig. 3.8A),
GSDMD KO MAIDS mice (Figure 3.8B), IL-1R1 KO MAIDS mice (Fig. 3.8C), and IL-18 KO
MAIDS mice (Fig. 3.8D). This suggests that the loss of these pyroptosis-associated proteins does
not result in the upregulation of autophagy markers to preserve the retina from damage following
MCMV infection.
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Figure 3.8. Expression of necroptosis- and autophagy-related proteins following ocular
MCMV infection in mice deficient in key pyroptosis-associated molecules.
Western blot analysis was performed to visualize ocular expression of necroptosis-associated
proteins and autophagy-associated proteins in MCMV infected eyes of WT MAIDS mice and
either caspase-1 KO mice (A), GSDMD (B) IL-1R1 KO mice (C), or IL-18 KO mice (D) with
the presence or absence of MCMV and/or MAIDS, with GAPDH used as a loading control.
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3.3.2

The Loss of Inflammasomes and MAIDS-related MCMV Retinitis

Inflammasomes are high-molecular-weight, multi-protein complexes, that are found in
the cytosol of immune cells and regulate the activation of inflammatory responses [171]. There
are multiple types of inflammasomes, and each of their distinct assemblies is determined by a
unique PPR in response to specific PAMPs or danger signals present in the host’s cytosol. Once
activated by the inflammatory ligand, the central domain of the inflammasome undergoes
oligomerization, resulting in the recruitment of adaptor proteins, such as ASC, to the effector and
variable N-terminal domain, which is composed of a PYD and a CARD. The CARD domain, on
either the inflammasome or ASC, binds and activates pro-caspase-1 to invoke an inflammatory
response [172]. There are several types of inflammasome proteins known to date, including the
NLR family members, NLRP1 and NLRP3, as well as AIM2 [161]. The NLRP3 inflammasome
[235-250], the NLRP1 inflammasome [251-253] and the AIM2 [214] are well-characterized
inflammasomes that have been shown to play a role in several ocular diseases. As we have
previously shown that mRNA production of these inflammasomes are highly stimulated in
MCMV-infected eyes of MAIDS-10 mice [100], we wanted to define with greater precision the
contribution of the NLRP3 inflammasome towards the onset and progression of MCMV retinitis
during MAIDS-10.
MCMV-infected eyes of NLRP3KO mice with MAIDS, NLRP1b KO mice with
MAIDS, and AIM2 KO mice with MAIDS show patterns of protein synthesis that are
relatively similar to those of MCMV-infected eyes of wildtype mice with MAIDS. We
continued our comprehensive investigation of MCMV retinitis pathogenesis using mice with
MAIDS who were deficient in the production of one of three inflammasomes, either NLRP3,
NLRP1b, or AIM2. All groups of KO mice infected with the immunosuppressive murine
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retrovirus mixture (LP-BM5 MuLV) developed MAIDS as assessed by their development of a
number of MAIDS-related physical and immunologic characteristics (data not shown) described
by us previously [100].
Again, we investigated the patterns of pyroptosis-associated proteins of the
canonical and noncanonical pyroptosis pathways for possible alterations in their pattern of
synthesis. Western blot analysis of MCMV-infected eyes collected from NLRP3KO mice with
MAIDS, NLRP1b KO mice with MAIDS, and AIM2 KO mice with MAIDS at 10 days after
subretinal MCMV inoculation showed relatively similar patterns of protein production for
corresponding proteins associated with the canonical and noncanonical pyroptosis pathways
when compared with the patterns of protein production collected from MCMV-infected eyes of
WT MAIDS mice (Fig. 3.9). Some notable exceptions were observed, however. A deficiency in
either NLRP1b production during MAIDS or AIM2 production during MAIDS resulted in an
increased in the cleaved caspase-1 protein (Fig 3.9B and 3.9C) but no real changes in the cleaved
caspase-11 protein production. Similarly, a deficiency in NLRP1b production during MAIDS
also resulted in a slight increase in cleaved GSDMD protein.
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Figure 3.9. Expression of pyroptosis-associated proteins MCMV infected eyes of wildtype
MAIDS mice, NLRP3KO, NLRP1b KO, and AIM2KO mice with MAIDS.
WT MAIDS mice and groups of NLRP3KO, NLRP1b KO, and AIM2KO mice with MAIDS (n=
3 - 7 mice/group) were subretinally infected with 104 PFU MCMV. Whole eyes were collected
and at 10 dpi and assessed for ocular expression of the known pyroptosis-associated markers by
western blot with beta-actin serving as a loading control.
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MCMV-infected eyes of wildtype mice with MAIDS and MCMV-infected eyes of
mice with MAIDS deficient in the production of an inflammasome protein harbor
equivalent amounts of infectious MCMV. To determine if loss of any inflammasome resulted
in reduced intraocular virus replication during the development of MAIDS-related MCMV
retinitis, whole MCMV-infected eyes were collected from groups of WT MAIDS mice, NLPR3
KO mice with MAIDS, NLRP1b KO mice with MAIDS, and AIM2 KO mice with MAIDS at 10
days after subretinal MCMV inoculation (n = 4 – 9 per group) are were individually
homogenized and subjected to standard plaque assay to quantify infectious MCMV. Results are
shown in Fig 3.10. In agreement with previous findings [6, 103, 226], MCMV-infected eyes of
retinitis-susceptible wildtype mice with MAIDS were found to contain high amounts of
infectious MCMV (2.96 x104). However, the level of infectious virus was significantly lower in
the different group of KO MAIDS mice, with amounts ranging from 1.61 x104 to 1.75 x104.
Thus, loss of either of these inflammasomes during MAIDS did affect the intraocular replication
of MCMV when compared with WT mice with MAIDS at 10 days following subretinal MCMV
inoculation.
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Figure 3.10. WT MAIDS mice and groups of MAIDS mice deficient in the production of an
inflammasome-associated protein harbored a decreased amount of infectious MCMV.
MCMV-infected eyes were collected 10 dpi following intraocular MCMV injection from
wildtype MAIDS mice and MAIDS mice deficient in either, NLRP3, NLRP1b, or AIM2.
Amount of infectious MCMV were detected in whole eyes by standard plaque assay (n=3 - 9).
The frequency of full-thickness retinal necrosis is significantly reduced within
MCMV-infected eyes of MAIDS mice deficient in the production of an inflammasome
protein when compared with the frequency of full-thickness retinal necrosis MCMVinfected eyes of wildtype MAIDS mice. Our finding that MCMV-infected mice with MAIDS
with a deficiency in one of several inflammasomes harbor high amounts of infectious MCMV,
despite the significantly lower levels seen in the WT mice with MAIDS, led us to question
whether these animals would also develop full-thickness retinal necrosis at a frequency of 80 to
100% like previously seen in WT mice with MAIDS mice or fail to develop this full-thickness
retinal necrosis as seen with the MAIDS mice deficient in a key pyroptosis protein. To confirm
this, the eyes of groups of mice with MAIDS lacking either NLRP3, NLRP1b, or AIM2 were
inoculated subretinally with MCMV, collected 10 days later, subjected to histopathologic
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analysis, and scored for the frequency of full-thickness retinal necrosis. The MCMV-infected
eyes of groups of WT mice with MAIDS included in each experiment served as controls. As
reported previously, the frequency of full-thickness retinal necrosis for mice with MAIDS was
between 89-100% in each experiment. Surprisingly, however, none (0%) of the MCMV-infected
eyes of mice with MAIDS with a deficiency in either NLRP3 or AIM2 developed full-thickness
retinal necrosis, and only 25% of mice (2/8) developed a full-thickness retinal necrosis. Despite
high amounts of intraocular infectious MCMV, MCMV-infected eyes of MAIDS mice deficient
in an inflammasome gene consistently showed a reduction in its ability to develop full-thickness
retinal necrosis.
MCMV-infected eyes of MAIDS mice deficient in the production of an
inflammasome-related protein consistently show prominent RPE proliferation but with
relative preservation of the neurosensory retina. A detailed histopathologic analysis was
performed to define with greater precision the patterns of retinal disease among the different
animal groups at 10 days after subretinal MCMV inoculation. Results are shown in Fig 3.11. As
expected, histopathologic examination of sections of MCMV-infected eyes collected from
wildtype mice with MAIDS showed areas of full-thickness retinal necrosis containing virusinduced inclusions and cytomegalic cells. In sharp contrast, however, histopathologic analysis of
MCMV-infected eyes of groups of KO MAIDS mice revealed the same two major findings as
seen in the pyroptosis KO MAIDS mice, when paired experimentally with MCMV-infected eyes
of groups of WT MAIDS mice. This includes the atypical histopathologic feature characterized
by widespread RPE proliferation accompanied by detection of virus-induced inclusions as well
as a relative preservation of the neurosensory retina with loss of photoreceptors in some cases
but without detection of virus-induced inclusions or cytomegalic cells and without the
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development of full-thickness retinal necrosis (the exception being the two NLRP1b KO mice
with MAIDS that did show the development of a full-thickness retinal necrosis).

Figure 3.11. MCMV-infected eyes from groups of MAIDS mice deficient in the production
of an inflammasome-associated protein showed prominent RPE proliferation but
preservation of the neurosensory retina.
MCMV-infected eyes were collected 10 dpi following intraocular MCMV injection from
wildtype MAIDS mice and MAIDS mice deficient in either NLRP3, NLRP1b, or AIM2. H & E
staining was done to histopathologically evaluate the presence of retinitis and changes in the
retinal architecture.
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Loss of genes for inflammasomes NLRP3, NLRP1b, and AIM2 does not entirely
abolish the expression of necroptosis-associated proteins in MCMV-infected eyes of
MAIDS-10 mice. Western blot analysis was done on the MCMV-infected eyes of WT MAIDS
mice and MAIDS mice deficient in either NLRP3 (Fig. 3.12A), NLRP1b (Fig. 3.128B), or AIM2
(Fig. 3.12C) for molecules essential to the necroptosis pathway. For all KO MAIDS mice,
RIPK1 and RIPK3 expression in MCMV-infected eyes was relatively similar to MCMV-infected
eyes of WT MAIDS mice. MLKL protein expression and the phosphorylation of MLKL were
also similarly expressed in the MCMV-infected eyes of the groups of KO MAIDS mice when
compared to the WT MAIDS mice. Protein analysis for TNF-α revealed that the unprocessed
protein and cleaved form of TNF-α were both expressed in KO MAIDS mice and that this level
of expression was the same as the WT MAIDS mice for all groups of KO MAIDS mice.
Loss of genes for inflammasomes NLRP3, NLRP1b, and AIM2 does not entirely abolish
the expression of autophagy-associated proteins in MCMV-infected eyes of MAIDS-10
mice. Next, we sought to determine if the preservation of the retina during MCMV infection in
the eyes of the inflammasome KO MAIDS mice had anything to do with the upregulation of
autophagy proteins, LC3B, and beclin-1. Western blots showed that there was no substantial
difference seen in both beclin-1 and LC3B among WT MAIDS mice and NLRP3 KO MAIDS
mice (Fig. 3.12A), NLRP1b KO MAIDS mice (Fig. 3.12B), and AIM2 KO MAIDS mice (Fig.
3.12C). This suggests that the loss of these pyroptosis-associated proteins does not result in the
upregulation of autophagy markers to preserve the retina from damage following MCMV
infection.
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Figure 3.12. Expression of necroptosis- and autophagy-related proteins following ocular
MCMV infection in mice deficient in several inflammasomes.
Western blot analysis was performed to visualize ocular expression of necroptosis-associated
proteins and autophagy-associated proteins in MCMV infected eyes of WT MAIDS mice and
either NLRP3 KO mice (A), NLRP1b KO mice (B), or AIM2 KO mice (C) with the presence or
absence of MCMV and/or MAIDS, with GAPDH used as a loading control.
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3.4

Ocular MCMV Infection during Corticosteroid-Induced Immunosuppression
The development of MAIDS in C57BL/6 mice shows many immunopathological features

like this seen with the maturation of AIDS in HIV-1 infected patients. Additionally, MCMV
infection in mice with late stage MAIDS produces retinitis that exhibits histopathologic features
that mimic those seen in patients with AIDS-related HCMV retinitis [254]. However, the
MAIDS model is not the only model available to study MCMV retinitis. Other researchers have
shown that MCMV-infected eyes of C57BL/6 mice immunosuppressed by corticosteroid
treatment also results in the development of MCMV retinitis. However, there are several
differences between this model of retinitis and the MAIDS model of MCMV retinitis. One
significant difference is the development of retinitis in C57BL/6 mice with corticosteroidinduced immunosuppression is at a frequency of only ~50% [109] as opposed to the 80 to 100%
frequency seen in MAIDS-related MCMV retinitis. This may be related to the vast difference in
the type of immunosuppression between these two models. MAIDS has a slow and progressive
development, which goes through distinct phases of immune cell dysfunction over the course of
several weeks. Corticosteroid-induced immunosuppression, however, results in a rapid, acute
decline in the immune system, which develops over the course of a few days and shows a
difference in immune cell populations, particularly macrophages and cytokine response to
infection [115, 116]. Recently, our lab has shown that the expression of SOCS1 and SOCS3,
which are highly expressed in MAIDS-related MCMV retinitis, are only mildly stimulated in
MCMV-infected eyes of corticosteroid-induced immunosuppression [226]. This reduction in
SOCS1 and SOCS3 expression is correlated to a less severe retinitis development along with a
reduction in ocular viral titer when compared to previously established MAIDS studies [4, 6,
103, 126].
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Because of these vast differences in the two immunosuppression models, we were
interested in seeing if there were any other differences in molecules known to be stimulated
during MAIDS-related MCMV retinitis. As we have repeatedly established that pyroptosisassociated molecules are upregulated in MCMV-infected eyes of MAIDS-10 mice, we sought to
determine if these molecules are also stimulated in MCMV-infected eyes of mice with
corticosteroid-induced immunosuppression. Theoretically, if these molecules play a role in the
pathogenesis of MCMV retinitis, then they should be stimulated in multiple models of this
disease.
3.4.1

Pyroptosis Expression during Corticosteroid-induced Immunosuppression

Expression and translation of caspase-1 mRNA in MCMV-infected eyes of mice
with corticosteroid-induced immunosuppression. mRNA analysis showed that caspase-1 was
significantly stimulated in MCMV-infected eyes of mice with corticosteroid-induced
immunosuppression (Fig. 3.13A). Although the level of mRNA stimulation was similar at day 3
post-infection as that seen in MAIDS-10 mice (Fig. 3.13B), there was a slight dip in mRNA
expression at day 6 post-infection prior to peak expression seen at day 10 post-infection. Western
blot analysis showed that pro-caspase-1 was greatly expressed in MCMV-infected eyes of mice
with corticosteroid-induced immunosuppression at all days post-infection with a gradual increase
in overall protein levels as the infection progressed. Pro-caspase-1 was also greatly expressed in
MCMV-infected eyes of MAIDS-10 mice at all days post-infection, with a slight increase at 6
days post-infection. The appearance of pro-caspase-1 seemed slightly higher in MCMV-infected
eyes of MAIDS-10 mice at 3 and 6 days post-infection when compared to the corticosteroidinduced immunosuppressed mice, while the levels of protein expression were reasonably similar
at 10 days post-infection between both models of immunosuppression. Although not as greatly
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stimulated, the mature caspase-1 protein followed the same trend of stimulation as pro-caspase-1
in MCMV-infected eyes of both MAIDS-10 and corticosteroid-induced immunosuppressed mice
(Fig. 3.14).
Expression and translation of caspase-11 mRNA in MCMV-infected eyes of mice
with corticosteroid-induced immunosuppression. MCMV-infected eyes of mice with
corticosteroid-induced immunosuppression showed substantial stimulation of caspase-11 mRNA
at all days post-infection (Fig. 3.13C). The level of expression at 3 days post-infection was only
half that seen, at the respective time, in MCMV-infected eye of MAIDS-10 mice (Fig. 3.13D).
However, mRNA production for caspase-11 continued to increase in MCMV-infected eyes of
mice with corticosteroid-induced immunosuppression from day 6 to day 10 post-infection, where
it reached levels not significantly different that that seen in MCMV-infected eyes of MAIDS-10
mice. Protein levels for pro-caspase-11 and cleaved caspase-11 showed similar levels of
expression in MCMV-infected eyes between both models of immunosuppression. The main
difference seen in caspase-11 protein expression was that MCMV-infected eyes of mice with
corticosteroid-induced immunosuppression showed appearance of both pro-caspase-11 and
cleaved caspase-11 at day 10 post-infection, whereas the expression of caspase-11 in MCMVinfected eyes of MAIDS-10 was only seen at days 3 and 6 post-infection (Fig. 3.14).
Expression and translation of GSDMD mRNA in MCMV-infected eyes of mice with
corticosteroid-induced immunosuppression. Expression of GSDMD mRNA transcripts were
significantly stimulated in MCMV-infected eyes of mice with corticosteroid-induced
immunosuppression at all days post-infection (Fig 3.13E). Although there was a slight decrease
in expression at day 6 post-infection, there was not significant difference in the stimulation of
GSDMD mRNA at any day post-infection in mice with corticosteroid-induced
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immunosuppression and MAIDS-10 mice (Fig. 3.13F). Protein for the full-length precursor
GSDMD was abundant in MCMV-infected eyes of corticosteroid-induced immunosuppressed
mice when compared to the mock-treated eyes. The level of expression was greater at days 6 and
10 post-infection. There was a difference in the trend in the expression of GSDMD seen in
MCMV-infected eyes of MAIDS-10 mice in which there was greater at days 3 and 6 postinfection. Cleaved GSDMD protein was also higher in MCMV-infected eyes of mice with
corticosteroid-induced immunosuppression at 3 and 6 days post-infection with a slight drop in
expression at 10 days post-infection. Similar trends were seen for the cleaved form of GSDMD,
in MCMV-infected eyes of MAIDS-10 mice (Fig. 3.14).
Expression and translation of IL-1β mRNA in MCMV-infected eyes of mice with
corticosteroid-induced immunosuppression IL-1β mRNA expression following MCMV
infection of mice with corticosteroid-induced immunosuppression was greatly stimulated at 3
days post-infection. The level of mRNA expression dramatically decreased by 6 days postinfection, and by 10 days post-infection, there was no significant stimulation over the media
control eyes (Fig 3.13G). This trend in mRNA expression was similar to that seen in the MCMVinfected eyes of MAIDS-10 mice (Fig. 3.13H), and there was no significance difference in
mRNA stimulation between the two groups of mice. Western blot analysis showed that there was
a slight appearance of IL-1β protein in MCMV-infected eyes of corticosteroid-induced
immunosuppressed mice when compared to the mock injected eyes. This difference was slightly
greater at 6 days post-infection. However, there was a greater level of expression in MCMVinfected eyes of MAIDS-10 mice when compared to mock-treated eyes at 3 and 6 days postinfection. There appeared to be no significant differences between the protein levels of MCMV-
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infected eyes of mice with either corticosteroid-induced immunosuppression or MAIDS-10 (Fig.
3.14).
Expression and translation of IL-18 mRNA in MCMV-infected eyes of mice with
corticosteroid-induced immunosuppression. Although similar levels of IL-18 mRNA
stimulation were seen at 3 and 10 days post-infection between mice with corticosteroid-induced
immunosuppression (Fig. 3.13I) and MAIDS-10 mice (Fig. 3.13J), the IL-18 mRNA production
was slightly greater in MCMV-infected eyes of MAIDS-10 mice at 6 days post-infection.
MCMV-infected eyes of corticosteroid-induced immunosuppression mice saw a greater
expression of IL-18 protein at all days post-infection when compared to the mock-treated eyes.
Not surprisingly, a similar trend was seen in MAIDS-10 mice with possibly a slight increase in
protein at 6 days post-infection when compared to mice with corticosteroid-induced
immunosuppression (Fig. 3.14), findings that correlated with the trend seen in mRNA
production.
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Figure 3.13. Pyroptosis-associated mRNA is stimulated in mice with either corticosteroidinduced immunosuppression (CS-IS) or MAIDS-10.
Homogenized whole eyes of mice with CS-IS and MAIDS-10 were assessed at 3, 6, and 10 dpi
for caspase-1 (A and B), caspase-11 (C and D), GSDMD (E and F), IL-1beta (G and H), and IL18 (I and J) mRNA, with MCMV samples compared back to media controls per day (n=3-5
mice/group). *p<0.05, **p<0.01, and ***p<0.001, MCMV groups compared with media
controls at the same time points.
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Figure 3.14. Pyroptosis-associated proteins was stimulated in mice with either
corticosteroid-induced immunosuppression (CS-IS) or MAIDS-10.
Western blot analysis was performed to assess ocular expression of pyroptosis-associated
proteins in groups of mice with corticosteroid-induced immunosuppression (left) or MAIDS-10
mice (right) of both MCMV infected and media control eyes at days 3, 6, and 10 post-infection.
GAPDH used as a loading control and a ladder was loaded in the well separating the two groups
of mice.
3.4.2

Inflammasome Expression during Corticosteroid-induced Immunosuppression

NLRP1b, but not other inflammasomes, showed a marked reduction in mRNA
production of MCMV-infected eyes of mice with corticosteroid-induced
immunosuppression when compared to MAIDS-10 mice. Since we have previously shown
that the NLRP3, NLRP1b, NLRC4, and AIM2 inflammasomes are stimulated in MCMVinfected eyes of MAIDS-10 mice, we sought to determine if the mRNA of these inflammasomes

98
were also stimulated in mice immunosuppressed with corticosteroids. mRNA stimulation of
NLRP3 in MCMV-infected eyes was highest at 3 days post-infection, dropped off by 6 days
post-infection and stayed relatively similar at 10 days post-infection (Fig. 3.15A). No major
differences were seen with the level of NLRP3 stimulation in MCMV-infected eyes of MAIDS10 mice except at 10 days post-infection, when mice with corticosteroid-induced
immunosuppression showed a significantly greater level of expression of NLRP3 (Fig. 3.15B).
mRNA production for NLRP1b showed a slight significant increase in MCMV-infected eyes
over media control eyes that stayed a consistent level at all days post-infection (Fig. 3.15C). This
differed from the mRNA production seen in MCMV-infected eyes of MAIDS-10 mice that
showed a greater level of stimulation at days 3 and 6 post-infection (Fig. 3.15D). When
investigating the NLRC4 inflammasome, it was interesting to see that the levels of stimulations
were similar in mice with corticosteroid-induced immunosuppression (Fig. 3.15E) and mice with
MAIDS-10 (Fig. 3.15F). However, mice with MAIDS-10 did show a greater stimulation in
mRNA expression of NLRC4 at day 3 post-infection when compared to the MCMV-infected
eyes of mice with corticosteroid-induced immunosuppression. Although there was a slight
difference in the trends of mRNA expression for AIM2 between mice with corticosteroidinduced immunosuppression (Fig. 3.15G) and MAIDS-10 mice (Fig. 3.15H) during the course of
infection, no significant difference was seen between the two groups of mice at any days postinfection.
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Figure 3.15. Inflammasome mRNA was stimulated in mice with either corticosteroidinduced immunosuppression (CS-IS) or MAIDS-10.
Homogenized whole eyes of mice with corticosteroid-induced immunosuppression and MAIDS10 were assessed at 3, 6, and 10 dpi for NLRP3 (A and B), NLRP1b (C and D), NLRC4 (E and
F), and AIM2 (G and H) mRNA, with MCMV samples compared back to media controls per day
(n=3-5 mice/group). *p<0.05, **p<0.01, and ***p<0.001, MCMV groups compared with media
controls at the same time points.
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3.5

Ocular Expression Following Needle Stick or in Unmanipulated Eyes
Although the expression of our target inflammatory markers is consistently significantly

higher in MCMV-infected eyes when compared to the media control eyes, there does seem to be
slight stimulation of several of these proteins in eyes injected with media only. To determine the
extent that the the needle stick into the subretinal space, or the administration of fluids (void of
virus), has on the induction of the inflammatory response, we compared the mRNA expression of
the pyroptosis-associated mRNA, caspase-1, caspase-11, GSDMD, IL-1β, and IL-18 (Fig.
3.16A-E), as well as NLRP3, NLRP1b, NLRC4, AIM2 inflammasomes (Fig. 3.17A-D), among
groups of mice that received the MCMV infection, the standard media control injection, eyes that
were simple poked by the needle without any injection, and eyes that were unmanipulated at all.
Six days following the subretinal injections, all eyes were harvested and assessed for target
mRNA expression. mRNA analysis of the eyes showed no major stimulation of any target
pyroptosis-related and associated inflammasome mRNA in mice without manipulation to their
eyes, or with those that received only the needle stick without an injection of fluid. Although a
few molecules (caspase-1, GSDMD, IL-18, and NLRP1b) may have seen a slight trend in
increased expression in media-injected eyes, these levels were not statistically different from
either the unmanipulated eyes or those that were merely poked with the needle. On the contrary,
the eyes that received a subretinal injection of MCMV showed a dramatic, statistically
significant increases in mRNA expression of all target transcripts when compared to the media
treated eyes, the eyes that underwent a simple needle stick into the subretinal space, and the
unmanipulated eyes. Therefore, the results suggest that the stimulation of these pyroptosisassociated molecules and associated inflammasomes is substantially enhanced by MCMV, and
the needle stick itself is not contributing to this expression.
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Figure 3.16. Pyroptosis-associated mRNA was not stimulated in unmanipulated eyes, or
eyes not infected with MCMV.
MAIDS-10 mice were either injected with MCMV or media, poked with a media without
injection of any fluid (poke), or not manipulated with a needle (unman) . At six dpi, whole eyes
of each group (n=5) were harvested and assessed for caspase-1 (A), caspase-11 (B), GSDMD
(D), IL-1beta (B), and IL-18 (E) mRNA. *p<0.05, **p<0.01, and ***p<0.001, MCMV
compared back to other groups as indicated with brackets.

102

Figure 3.17. Inflammasome mRNA was not stimulated in unmanipulated eyes, or eyes not
infected with MCMV.
MAIDS-10 mice were either injected with MCMV or media, poked with a media without
injection of any fluid (poke), or not manipulated with a needle (unman) . At six dpi, whole eyes
of each group (n=5) were harvested and assessed for NLRP3 (A), NLRP1b (B), NLRC4 (C), and
AIM2 (D) mRNA. *p<0.05 and **p<0.01, MCMV compared back to other groups as indicated
with brackets.
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4

SP ECIFIC AIM 2

Specific Aim 2: Test the Hypothesis that MCMV Replication directly Stimulates
Pyroptosis in Infected Cells.
HCMV and MCMV both undergo a temporal, step-wise viral gene expression and
replication cascade [12]. The interaction of glycoproteins on the envelope of the virus and host
receptors, mediates fusion or endocytosis of the virion into the host cell [25]. Viral tegument
proteins are then released into the cell, and some are believed to be transported to the nucleus of
the host cell via interactions with the host microtubule machinery. These tegument proteins are
bound to capsids, and once in the nucleus, viral transcription, genome replication, and
encapsidation occur [26-28]. The transcription and subsequent translation of viral genes follow a
specific sequence, starting with IE genes followed by E genes, which results in viral DNA
synthesis and expression of L genes. This then allows for the assembly of progeny virions, which
egress from the cell. If pyroptosis directly results from CMV infection of the host cell, then at
least one of these virologic events may drive the host cell expression of pyroptosis-associated
mRNA or protein production.
4.1

Pyroptosis-Associated Expression Kinetics Following MCMV Infection in IC-21 or
MEF Cells
Several pyroptosis-associated mRNA transcripts were stimulated in MCMV-

infected IC-21 mouse macrophages. We have previously demonstrated that pyroptosisassociated mRNA and protein are stimulated in MCMV-infected eyes during the onset and
progression of MCMV retinitis in mice with retroviral-induced immunosuppression [6]. It is
unclear, however, if this stimulation of pyroptosis was from direct cellular infection with MCMV
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within the retina, or if it was induced by a host response following MCMV infection. Following
acute infection, MCMV will establish latency in monocytes and has repeatedly been shown to
replicate in macrophages [255, 256]. Therefore, we sought to determine if MCMV infection
would stimulate the production of pyroptosis-associated mRNA transcripts in IC-21 mouse
macrophages. Monolayers of IC-21 mouse macrophages were infected with MCMV at a moi of
3 and allowed to propagate for up to 72 hpi. MCMV infected IC-21 monolayers showed a
statistically significant upregulation of mRNA transcripts for caspase-1 (Fig 4.1A), GSDMD
(Fig 4.1B), and IL-1β (Fig 4.1C) at early time-points following infection. Peak expression for
these transcripts occurred between 2-4 hpi, which correlates to a relatively early time during
productive MCMV infection following viral attachment, adsorption, and release of tegument
protein, as well as transcription and translation of MCMV IE gene in macrophages [41].
Interestingly, however, IL-18 mRNA production showed no stimulation in MCMV infected cells
when compared to the media treated cells at 1-4 hpi (Fig. 4.1D).
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Figure 4.1. MCMV infection stimulated pyroptosis-related mRNA in mouse macrophages.
IC-21 mouse macrophages infected with MCMV (moi = 3 PFU/cell) or treated with media
control. At indicated time points, cells were harvested and assessed for caspase-1 mRNA (A),
GSDMD mRNA (B), IL-1beta mRNA (C) or IL-18 mRNA (D) by real-time RT-PCR assay using
-ΔΔCt
method, with all samples compared back to the media group at the same
the comparative 2
time point. Means ±SD of duplicate experimental repeats are shown. * p<0.05, ** p<0.01, and
*** p<0.001, compared with respective media controls at the same time points as determined by
one-way ANOVA
Most pyroptosis-associated mRNA transcripts were stimulated in MCMV-infected
MEF cells. As it has been shown that MCMV replication kinetics differ between macrophages
and fibroblasts [257], we sought to determine if the stimulation in pyroptosis-associate mRNA
transcripts would also differ between these cell lines following MCMV infection. MEF
monolayers were infected with MCMV, at a moi of 3, and allowed to propagate for up to 3 days.
Similar to what was seen for IC-21 mouse macrophages, caspase-1 (Fig 4.2A), GSDMD (Fig
4.2B), and IL-1β (Fig 4.2C), but not IL-18 (Fig 4.2D) mRNA transcripts showed significant
stimulation in MCMV-infected MEFs. Interestingly, the stimulation seen following MCMV
infection in MEFs was more robust than that seen during infection of IC-21 mouse macrophages
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and continued for a longer duration. Stimulation of both caspase-1 and IL-1β mRNA expression
showed an upregulation starting as early as 30 minutes following MCMV infection and
continued to be highly stimulated until approximately 6 hpi. GSDMD mRNA upregulation
begins a little later in MEF cells with peak stimulation occurring between 4-8 hpi. This duration
of stimulation correlates not only with the viral attachment, adsorption, release of tegument
protein, and transcription of MCMV IE gene in macrophages [41], but also the transcription of
MCMV E gene. A biphasic upregulation of caspase-1 started to emerge at 24 hpi which could be
associated with the transcription and translation of MCMV L gene during productive infection.

Figure 4.2. Infection of MEFs with MCMV stimulated pyroptosis-associated mRNA
transcripts.
MEFs were infected with MCMV (moi = 3 PFU/cell) or treated with media control. At indicated
time points, cells were harvested and assessed for caspase-1 mRNA (A), GSDMD mRNA (B),
IL-1beta mRNA (C) or IL-18 mRNA (D) by real-time RT-PCR assay using the comparative 2
ΔΔCt
method, with all samples compared back to the media group at the same time point. Means
±SD of duplicate experimental repeats are shown. * p<0.05, ** p<0.01, and *** p<0.001,
compared with respective media controls at the same time points as determined by one-way
ANOVA.
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4.2

Pyroptosis-Associated Expression Following Infection with UV-inactivated MCMV in
MEF cells
UV-inactivated MCMV does not significantly stimulate pyroptosis-associated

mRNA expression in MEF cells. MCMV infection of MEF cells showed the greatest
upregulation of the pyroptosis-associated mRNA when compared to the stimulation seen within
infected IC-21 mouse macrophages. To determine if the different stages of MCMV gene
transcription were responsible for the stimulation of these pyroptosis-related mRNA transcripts,
or if early virologic events of attachment, adsorption, and release of tegument proteins were
sufficient for this stimulation, we infected monolayers of MEF cells with MCMV inactivated by
ultraviolet light (UVi-MCMV). This inactivation leaves glycoproteins and immunologic
components of MCMV intact although the virus is unable to undergo viral gene expression and
replication in the infected cell [224]. Contrary to the notable upregulation of caspase-1 (Fig
4.3A), GSDMD (Fig 4.3B), IL-1β (Fig 4.3C), and IL-18 (Fig 4.3D) mRNA in MEF cells at early
time points following MCMV infection, UVi-MCMV infected cells did not show any
upregulation of these mRNA transcripts at any time point.
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Figure 4.3. UV-inactivation of MCMV abrogated MCMV-related stimulation of pyroptosis
mRNA transcripts in MEFs.
MEFs were infected with MCMV (moi = 3 PFU/cell) or treated with either media (control) or
equal volume of UVi-MCMV. At indicated time points, cells were harvested and assessed for
caspase-1 mRNA (A), GSDMD mRNA (B), IL-1beta mRNA (C) or IL-18 mRNA (D) by real-ΔΔCt
method, with all samples compared back to the
time RT-PCR assay using the comparative 2
media group at the same time point. Means ±SD of duplicate experimental repeats are shown. *
p<0.05, ** p<0.01, and *** p<0.001, compared with respective media controls at the same time
points as determined by one-way ANOVA. No statistically significant differences were found
between the media controls and the UV-MCMV groups at any time point.
To determine if expression of pyroptosis-associated proteins are substantially stimulated
in MEF cells following MCMV infection but not UVi-MCMV infection, immunofluorescence
(IF) was done on MCMV-infected and UVi-treated monolayers and assessed for expression of
pyroptosis-associated proteins at 6 and 24 hpi. At 6 hpi, caspase-1 (Fig 4.4A) and GSDMD (Fig
4.4B) protein of MCMV-infected cells showed a stark level of protein expression not seen in
media treated cells. Although there was some expression of caspase-1 and GSDMD in UVi-
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MCMV infected cells, this level was nowhere near the level of expression seen in the MCMV
infected cells. IL-1β protein expression was also substantially greater in MCMV-infected cells
than seen for media treated cells at 6 hpi (Fig. 4.4C), while no real expression was seen
following UVi-MCMV infection. Despite the lack of mRNA upregulation seen during MCMV
infection of MEFs at any time point except 1 hpi, IL-18 protein did show a robust level at 6 hpi
when compared to the lack of expression seen of IL-18 in the media treated cells (Fig. 4.4D).
This expression was ablated in MEF cells treated with UVi-MCMV.

Figure 4.4. UV-inactivation of MCMV reduced MCMV-related stimulation of pyroptosisrelated protein in MEFs at 6 hpi.
MEFs MEFs were infected with MCMV (moi = 3 PFU/cell) or treated with either media
(control) or equal volume of UVi-MCMV. All 6 hpi all groups were fixed and assessed by
immunofluorescent staining for caspase-1 (A), GSDMD (B), IL-1beta (C), or IL-18 (D) protein
(green), counterstained with DAPI (blue). Original magnification, 100x.
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At 24 hpi, protein expression for caspase-1 (Fig 4.5A), GSDMD (Fig 4.5B), and IL-1β
(Fig 4.5C), but not IL-18 (Fig 4.5D) of MCMV-infected cells was greater than that seen at 6 hpi,
which were all still remarkably higher than the protein expression seen in the media treated cells.
Expression of these proteins were still seen in cells treated with UVi-MCMV when compared to
the media treated controls, but the level of stimulation appeared substantially less than that seen
in the respective MCMV-infected cells at 24 hpi.

Figure 4.5. UV-inactivation of MCMV reduced MCMV-related stimulation of pyroptosisrelated protein in MEFs at 24 hpi.
MEFs MEFs were infected with MCMV (moi = 3 PFU/cell) or treated with either media
(control) or equal volume of UVi-MCMV. All 24 hpi all groups were fixed and assessed by
immunofluorescent staining for caspase-1 (A), GSDMD (B), IL-1beta (C), or IL-18 (D) protein
(green), counterstained with DAPI (blue). Original magnification, 100x.
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4.3

Pyroptosis-Associated Expression Kinetics Following HCMV Infection in ARPE-19
or MRC-5 Cells
Pyroptosis-associated mRNA transcripts were not stimulated upon HCMV infection

of ARPE-19 or MRC-5 cells. Following our confirmation that MCMV-infected cells can
directly stimulate the expression of pyroptosis-related mRNA and/or proteins in an individual
cell line, it is feasible to suggest that the stimulation of these mRNA transcripts and proteins seen
during our experimental model of MCMV retinitis could be from the direct stimulation of
MCMV-infected cells rather than host response to infection. If this is true, then it is likely that
the same may be true of HCMV infected cells of individuals with AIDS-related HCMV retinitis
as HCMV has been shown to penetrate all layers of the retina and the contiguous RPE where it
can actively replicate, as demonstrated by the formation of cytomegalic cells and inclusion
bodies throughout necrotic retinal tissue [98, 99]. Therefore, to test our hypothesis that HCMV
infection can directly result in the stimulation of pyroptosis-related mRNA transcripts, we
infected ARPE-19 cells, a human RPE cell line, with HCMV and measured the production of
pyroptosis-associated mRNA transcripts. Monolayers of ARPE-19 cells were infected with
HCMV, at a moi of 3, and allowed to propagate for 3 days. At all measured time points, HCMV
failed to stimulate mRNA production of caspase-1 (Fig. 4.6A), GSDMD (Fig. 4.6B), IL-1β (Fig.
4.6C), or IL-18 (Fig. 4.6D) at any time post-infection above that seen for the media treated cells.
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Figure 4.6. Pyroptosis-associated mRNA transcripts were not stimulated in HCMVinfected ARPE-19 cells.
ARPE-19 cells were infected with HCMV (moi = 3 PFU/cell) or treated with media control. At
indicated time points, cells were harvested and assessed for caspase-1 mRNA (A), GSDMD
mRNA (B), IL-1beta mRNA (C) or IL-18 mRNA (D) by real-time RT-PCR assay using the
comparative 2-ΔΔCt method, with all samples compared back to the media group at the same time
point. Means ±SD of duplicate experimental repeats are shown. * p<0.05, ** p<0.01, and ***
p<0.001, compared with respective media controls at the same time points as determined by oneway ANOVA.

Since RPE cells have so many protective functions aimed at protecting the retina to
maintain the visual cycle, we thought it might be possible that this cell type could be actively
suppressing this type of programmed cell death or inflammation to avoid provoking an
inflammatory response directly adjacent to the retina. Therefore, we wanted to see if cell type
made a difference in HCMV stimulation of inflammation and programmed cell death. Since
MRC-5 cells are often used to titer HCMV, we knew that HCMV is able to replicate in this cell
line. Therefore, MRC-5 fibroblasts were also infected with HCMV at a moi of 3, and infection
was allowed to progress for 3 days. Similar to ARPE-19 cells, no mRNA production of caspase-

113
1 (Fig. 4.7A), GSDMD (Fig. 4.7B), IL-1β (Fig. 4.7C), or IL-18 (Fig. 4.7D) was shown,
suggesting that HCMV infection alone may not be enough to stimulate a pro-inflammatory cell
death response in these cells.

Figure 4.7. MRC-5 cells infected with HCMV did not show stimulation of pyroptosisassociated mRNA transcripts.
MRC-5 cells were infected with HCMV (moi = 3 PFU/cell) or treated with media control. At
indicated time points, cells were harvested and assessed for caspase-1 mRNA (A), GSDMD
mRNA (B), IL-1beta mRNA (C) or IL-18 mRNA (D) by real-time RT-PCR assay using the
comparative 2-ΔΔCt method, with all samples compared back to the media group at the same time
point. Means ±SD of duplicate experimental repeats are shown. * p<0.05, ** p<0.01, and ***
p<0.001, compared with respective media controls at the same time points as determined by oneway ANOVA.
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Specific Aim 3

Specific Aim 3: Test the Hypothesis that Other Immune Response Genes or Pathways are
Stimulated during the Pathogenesis of MAIDS-related MCMV Retinitis
In addition to the research obtained through the completion of these two specific aims,
other experimental endpoints were determined on MAIDS-4 and MAIDS-10 mice to further
advance our understanding past these well-known pyroptosis-related molecules and associated
inflammasomes. If pertinent, the findings we determined from these studies could help shape the
future focus of our investigation on the mechanisms underlying the pathogenesis of MAIDSrelated MCMV retinitis.
5.1

Expression of IFI204 during MAIDS-related MCMV Retinitis
Interferon-gamma-inducible protein 16 (IFI16) is a PYD-containing HIN-200 protein that

is constitutively expressed in lymphoid cells [258] and acts as a nuclear innate DNA sensor that
results in inflammasome activation. Although we have never studied the involvement of the
murine homolog of IFI16, IFI204, during MAIDS-related MCMV retinitis, IFI16 has been
associated with several human herpesvirus infections [259-264], and the knockdown of IFI204 in
corneal epithelium was shown to lead to susceptibility to HSV-1 infection [265]. Therefore, we
sought to determine the extent by which IFI204 is stimulated in both MAIDS-4 and MAIDS-10
mice to determine whether IFI204 may also be contributing to MCMV retinitis. mRNA analysis
showed that in MAIDS-4 mice (Fig. 5.1A), MCMV-infected eyes saw a slight stimulation of
IFI204 that was greater at 3 days post-infection and subsequently decreased by day 10 postinfection when compared to media-injected control eyes. In retinitis susceptible MAIDS-10 mice
(Fig. 5.1B), IFI204 mRNA expression showed peak expression at 6 days post-infection that was
statistically significant compared to media-injected eyes and was also similar to the highest fold-
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change seen in MAIDS-4 mice. Western blot analysis showed a substantial stimulation of IFI204
protein in MCMV-infected eyes of MAIDS-4 mice at both 3 and 6 days post-infection, which
had greatly reduced by 10 days post-infection (Fig. 5.1C). MAIDS-10 mice showed an increase
in IFI204 protein expression in MCMV-infected eyes when compared to media-injected eyes at
all time points, and this trend of expression was similar to that seen during MAIDS-4 (Fig.
5.1D). These results suggest that while IFI204 inflammasomes may be activated in response to
MCMV infection, it may not be contributing substantially to the pathogenesis of MCMV retinitis
seen in MAIDS-10 mice, possibly due to the stimulation of other inflammasomes that may
directly result in the onset of pyroptosis.

Figure 5.1. Intraocular IFI204 mRNA and protein were moderately stimulated in MCMV
infected eyes of both retinitis susceptible MAIDS-10 mice and retinitis-resistant MAIDS-4
mice.
Whole eyes were collected at 3, 6, and 10 days post-infection (dpi) from MCMV infected eyes
and media control eyes from groups (n=3-5) of MAIDS-4 and MAIDS-10 mice. Homogenized
eyes were assessed for IFI204 mRNA from the MAIDS-4 mice (A) and the MAIDS-10 mice (B).
Western blot analysis (C) was performed to assess ocular IFI204 protein expression in MAIDS-4
mice (C) and MAIDS-10 mice (D) with GAPDH used as a loading control. *p<0.05, MCMV
groups compared with media control at the same time points.
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5.2

Role of Autophagy during MAIDS-related MCMV Retinitis
Unlike pyroptosis and necroptosis, autophagy is a non-inflammatory form of cell death

that is largely a protective process-induced under stress conditions by which cells engulf
damaged organelles or large portions of their cytoplasm [234]. Recently, a link between
autophagy and pyroptosis has emerged in which there is thought to be an interplay between the
induction of autophagy and the inhibition of pyroptosis. Induction of autophagy in host cells in
response to infection may be a means of protecting the cells from cell death [266]. Autophagy is
known to play a protective role in the eye, including regulating the homeostasis of the RPE
[267]. However, it was recently shown that MCMV might contain a mechanism to inhibit latestage autophagy in RPE cells [268]. As evidence for multiple cell death pathways has been
shown to be stimulated in MAIDS-related MCMV retinitis, it is possible that the induction of
cell death may be related to inhibition or downregulation of autophagy. To determine the extent
that autophagy was affected in MCMV-infected eyes during the pathogenesis of MCMV
retinitis, mRNA analysis for beclin-1 was assessed. Beclin-1 mRNA was not significantly
stimulated at 3, 6, and 10 days post-infection in MCMV-infected eyes of both retinitis resistant
MAIDS-4 (Fig. 5.2A) mice and retinitis susceptible MAIDS-10 mice (Fig. 5.2B) when compared
with uninfected control eyes. Western blot analysis showed that beclin-1 protein was expressed
at 3, 6, and 10 days post-infection within MCMV-infected eyes of both MAIDS-4 (Fig. 5.2C)
and MAIDS-10 (Fig. 5.2D) mice, however, the protein expression was substantially more in
those of MAIDS-4 eyes than MAIDS-10 eyes. To determine the presence of autophagosome
formation, a known hallmark of autophagy, LC3B-I, and LC3B-II protein expression was
measured. No significant difference was seen for LCB-I protein expression between infected and
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uninfected control eyes of both MAIDS-4 and MAIDS-10 mice at days 3, 6, and 10 days postinfection. However, LC3-I protein expression within MCMV-infected MAIDS-4 eyes was
substantially increased when compared to LC3B-I protein expression within MCMV-infected
MAIDS-10 eyes. Whereas LCB-II formation was detected within both MCMV-infected and
media-injected control eyes at days 3, 6, and 10 post-infection, LCB-II formation was not
detected within MCMV-infected eyes of MAIDS-10 mice. Taken together, these results suggest
that autophagy may play a protective role in the eye that is mitigated during the development of
MCMV retinitis in MAIDS-10 mice.

Figure 5.2. Intraocular beclin-1 mRNA and protein were moderately stimulated in MCMV
infected eyes of both retinitis susceptible MAIDS-10 mice and retinitis-resistant MAIDS-4
mice.
Whole eyes were collected at 3, 6, and 10 days post-infection (dpi) from MCMV infected eyes
and media control eyes from groups (n=3-5) of MAIDS-4 and MAIDS-10 mice. Homogenized
eyes were assessed for beclin 1 mRNA from the MAIDS-4 mice (A) and the MAIDS-10 mice
(B). Western blot analysis (C) was performed to assess ocular beclin 1 and LC3B protein
expression in MAIDS-4 mice (C) and MAIDS-10 mice (D) with GAPDH used as a loading
control. *p<0.05, MCMV groups compared with media control at the same time points.
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5.3

Transcriptional Analysis of Immune Response Genes During Pathogenesis of
MAIDS-related MCMV retinitis
It is evident through our previous studies that several factors contribute to the

pathogenesis of MAIDS-related MCMV retinitis. Although extensive, our previous work has
only scratched the surface of the events employed during this disease progression. Therefore, we
opted to use an ultrasensitive technology, NanoString, to investigate hundreds of genes that span
several pathways associated with the immune response, following MCMV infection throughout
the course of MAIDS development. The goal of this study was to find other potential
immunological pathways or targets that could be contributing to the retinal destruction seen
during the pathogenesis of experimental MAIDS-related MCMV retinitis.
NanoString technology is a unique technique used to analyze the expression of hundreds
of genes simultaneously and has been extensively used to investigate a variety of diseases [269271]. The multiplexed probe library is made with two probes that are specific to each gene of
interest. One probe is the capture probe that contains approximately 50 base pair sequence
complementary to a specific target mRNA and is coupled with biotin as an affinity tag. The other
probe is the reporter probe that contains approximately 50 base pairs complementary to the target
mRNA and is also coupled to a color-coded tag. This color-coded tag is labeled explicitly with
specific fluorophores used for detection. The order of the colors on the tag provides a unique
barcode for each of the genes of interest, which are scanned by the Nanostring nCounter
system, allowing the system to get a raw count of all the target RNA hybridized to the probes
[270]. Utilizing this technology, we were able to get an overview of the involvement of more
than 500 genes during the onset and progression of retinitis in MCMV-infected eyes of MAIDS-
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10 mice and compare that to the expression of the same genes in both MAIDS-4 and healthy
mice, both resistant to retinitis.
Hierarchical Clustering Analysis of 561 Immune Response Gene Transcripts Within
MCMV-Infected Eyes of Healthy Mice, MAIDS-4 Mice, and MAIDS-10 Mice. We have
previously shown that the upregulation or downregulation of several pathways is involved during
the pathogenesis of MAIDS-related MCMV retinitis, yet the knowledge we gained in these past
studies have not been at the depth needed to identify and compare the extraordinary number of
immune response genes expressed simultaneously within the ocular compartment at critical
times during the evolution of MAIDS-related MCMV retinitis Initial studies were performed to
determine the overall upregulation or downregulation of 561 immune defense genes during the
pathogenesis of MCMV retinitis. This was accomplished using a commercial NanoString
nCounter Murine Immunology Panel that included 15 additional internal reference and
housekeeping genes. The left eyes of groups of healthy mice, MAIDS-4 mice, and MAIDS-10
mice (n = 3 – 5) were inoculated with MCMV; the contralateral right eyes of each animal group
were mock-infected with maintenance medium only and served as internal controls. At 3, 6, and
10 days after intraocular inoculation, individual MCMV-infected and mock-infected eyes were
collected from all animal groups, subjected to total RNA extraction, pooled by groups, and
subjected to NanoString nCounter analysis.
Hierarchical clustering analysis showing the upregulation (blue), downregulation
(yellow), or no change (black) in the expression of each of the 561 immune response gene
transcripts analyzed for each group of MCMV-infected eyes or mock-infected eyes are shown on
Fig 5.3. Inspection of data shows that patterns of gene expression differed greatly when
comparing mock-infected and MCMV-infected eyes at each time point examined. More
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importantly, the patterns of immune response gene expression were remarkably distinct for each
animal group, reflecting resistance or the degree of susceptibility to MCMV retinitis
development. The MCMV-infected eyes of healthy mice without MAIDS that show absolute
resistance to retinitis development nonetheless exhibited active gene expression (Fig 5.3A). At
least some of this transcriptional activity might be attributed to an intraocular trauma created in
response to the needle stick that takes place during mock infection. In comparison, MCMVinfected eyes of MAIDS-4 mice and MAIDS-10 mice also showed active gene expression but
with increased upregulation of genes when compared with MCMV-infected eyes of healthy
mice. Of interest, MCMV-infected eyes of MAIDS-4 mice that fail to develop full-thickness
retinal necrosis but nonetheless exhibit RPE proliferation showed an unexpected and extensive
upregulation of a majority of the 561 immune response genes investigated at day 6 after virus
inoculation (Fig 5.3B) when compared with retinitis-susceptible MCMV-infected eyes of
MAIDS-10 mice at day 6 after virus inoculation (Fig 5.3C). This outcome was particularly
surprising because of our previous observation that the MCMV-infected eyes of both animal
groups harbor high and equivalent amounts of infectious virus. When compared at day 10 when
full-thickness retinal necrosis develops within the MCMV-infected eyes of MAIDS-10 mice (but
not within MCMV-infected eyes of MAIDS-4 mice), distinctly different patterns of upregulation
or downregulation of individual immune response genes were observed.
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Figure 5.3. Hierarchical clustering analysis of 561 immunology related genes on healthy,
MAIDS-4, and MAIDS-10 mice.
MCMV infected eyes and eyes injected with media were collected 3, 6, and 10 dpi from healthy
(a), MAIDS-4 (b), and MAIDS-10 (c) mice. RNA was extracted from each eye (n= 3-5
mice/group), and total RNA was pooled for each group. 100ng of RNA from each group was
loaded onto the NanoString nCounter immunology panel. Hierarchical clustering analysis was
done using the nSolver software. The columns represent the specified groups, and the lines
represent each of the 561 genes on the immunology panel. Yellow color indicates low RNA
expression and blue color indicates high RNA expression.
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Comparison of MCMV-infected eyes of healthy mice, MAIDS-4 mice, and MAIDS10 mice for the expression of genes associated with distinct immunologic pathways. We next
processed the hierarchical clustering analysis of the 561 immune response gene transcripts from
MCMV-infected eyes of healthy mice, MAIDS-4 mice, and MAIDS-10 mice at all time points
examined for their involvement in 32 distinct immunologic pathways using the NanoString
nSolver software. After determining the fold-change upregulation or downregulation for
differentially expressed immune-response genes of MCMV-infected eyes when compared with
mock-infected eyes for each animal group, a fold-change of less than two was used to exclude
that particular gene from further analysis. This approach revealed 17 genes upregulated and 15
genes downregulated within MCMV-infected eyes of healthy mice, 83 genes upregulated and 4
genes downregulated within MCMV-infected eyes of MAIDS-4 mice, and 92 genes upregulated
and 54 genes downregulated within MCMV-infected eyes of MAIDS-10 mice (Fig 5.4). A
growing increase in immune response gene activity within MCMV-infected eyes during
increased susceptibility to the development of full-thickness retinal necrosis (when analysis
proceeded from healthy mice to MAIDS-4 mice to MAIDS-10 mice) was expected as suggested
by prior heatmap findings.
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Figure 5.4. Number of upregulated and downregulated genes of MCMV-infected eyes of
healthy, MAIDS-4, and MAIDS-10 mice.
Analysis of the differentially expressed genes with a fold-change of higher than two revealed the
number of genes that were upregulated and downregulated in groups of healthy, MAIDS-4, and
MAIDS-10 mice. Of the 561 genes on the immunology panel 17 genes were upregulated and 15
genes downregulated within MCMV-infected eyes of healthy mice, 83 genes were upregulated
and 4 genes were downregulated within MCMV-infected eyes of MAIDS-4 mice, and 92 genes
were upregulated and 54 genes were downregulated within MCMV-infected eyes of MAIDS-10
mice.
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This trend also continued when the differentially expressed immune response genes
showing upregulation of activity were organized into NanoString-defined immunologic
pathways for each animal group with the understanding that each gene could be involved with
multiple pathways. Categorization into immunologic pathways revealed that five of the 32
NanoString-defined pathways exhibited relatively substantial stimulation of gene activity within
MCMV-infected eyes when compared with other pathways of MCMV-infected eyes of healthy
mice, MAIDS-4 mice, and MAIDS-10 mice during progressive susceptibility to MCMV retinitis.
Those pathways showing the most robust stimulation gene activity included pathways associated
with the broad categories of adaptive immunity, innate immunity, host-pathogen interactions,
cytokine signaling, and lymphocyte activation (Fig. 5.5A-E). More functionally focused
pathways such as those involved with NF-kB signaling, toll-like receptor signaling, NOD-like
receptor signaling, chemokine signaling, type 1 interferon signaling, type 2 interferon signaling,
tumor necrosis factor (TNF) family signaling, MHC class I antigen presentation, and
phagocytosis and degradation also showed less robust but nonetheless heightened gene activity
when comparing MCMV-infected eyes of MAIDS-4 and MAIDS-10 mice with MCMV-infected
eyes of healthy mice (Fig 5.5F-N). Overall, these findings demonstrated that gene activity
associated with immunologic pathways become progressively and dramatically more active in
numbers and functions as MCMV-infected eyes become progressively more susceptible to the
onset and development of full-thickness retinal necrosis as retrovirus-induced
immunosuppression ensues. Moreover, this progressive gene activity is far more complex than
originally thought and involved a large number of immune pathways of which several were
never considered by us to be involved in the evolution of cytomegalovirus retinitis in retrovirusimmunosuppressed hosts.
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Figure 5.5. Number of upregulated genes associated with different pathways in MCMVinfected eyes of healthy, MAIDS-4, and MAIDS-10 mice.
Analysis of the differentially expressed genes with a fold-change higher than two were classified
into the different NanoString-defined pathways. The number of upregulated genes associated
with each pathway was graphed for healthy, MAIDS-4, and MAIDS-10 mice at days 3, 6, and 10
postinfection. A-E) Represents the pathways that had the most robust stimulation and included
broad pathways associated with adaptive immunity, innate immunity, host-pathogen interactions,
cytokine signaling, and lymphocyte activation. F-N) Represents more functionally focused
pathways including those involved with NF-kB signaling, toll-like receptor signaling, NOD-like
receptor signaling, chemokine signaling, type 1 interferon signaling, type 2 interferon signaling,
tumor necrosis factor (TNF) family signaling, MHC class I antigen presentation, and
phagocytosis and degradation which also showed a substantial numbers of stimulated genes.
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A comparison of the top 15 differentially expressed immunologic-associated genes
within MCMV-infected eyes of healthy mice, MAIDS-4 mice, and MAIDS-10 mice. In an
attempt to provide a more quantitative analysis of differences in the expression activity of the
561 individual immune response genes analyzed within MCMV-infected eyes of mice showing
progressive susceptibility to retinitis development, we focused on 15 differentially expressed
genes showing the greatest upregulation at peak levels of expression at 3, 6, or 10 days after
intraocular MCMV inoculation and compared them with mock-infected eyes for groups of
healthy mice, MAIDS-4 mice, and MAIDS-10 mice. Table 5.1, Table 5.2, and Table 5.3
summarizes our findings for MCMV-infected eyes for each animal group (healthy, MAIDS-4,
and MAIDS-10, respectively) with respect to individual genes, their known function(s) [226,
272-313], their overall fold-change at peak expression, and their p values when compared with
mock-infected eyes. The fold-change for stimulation of the top 15 individual genes within
MCMV-infected eyes appeared to increase markedly from healthy mice to MAIDS-4 mice and
MAIDS-10 mice as a reflection of increased susceptibility to the onset and development of
MCMV retinitis among these animal groups, especially MAIDS-4 animals when compared with
MAIDS-10 animals. While the average fold increase for peak expression in activity of these 15
genes was 3.04 for MCMV-infected eyes of healthy mice, the average fold increase for peak
expression in activity increased to 20.14 and 20.74 for MCMV-infected eyes of MAIDS-4 mice
and MAIDS-10 mice, respectively, suggesting a far more dynamic intraocular gene transcription
activity in response to MCMV infection during progressive retrovirus-induced
immunosuppression than during immunocompetence. It is also noteworthy that a subset of
individual genes exhibited remarkable transcription activity, such as ccl5, a gene encoding for a
chemokine associated with inflammation which showed an 83.32-fold increase in activity within
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MCMV-infected eyes of MAIDS-10 mice susceptible to full-thickness retinal necrosis
development.
Table 5.1: Top 15 genes differentially expressed in MCMV-infected eyes of healthy mice.

Table 5.2: Top 15 genes differentially expressed in MCMV-infected eyes of MAIDS-4 mice.

Table 5.3: Top 15 genes differentially expressed in MCMV-infected eyes of MAIDS-10 mice.
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A detailed comparison of the top 15 immune response genes activated within MCMVinfected eyes of healthy mice, MAIDS-4 mice, and MAIDS-10 mice also revealed that some
upregulated gene activities were exclusive to each animal group whereas some upregulated gene
activities were shared between groups. This is depicted in the Venn diagram shown in Fig 5.6.
Whereas the top 15 upregulated genes of the eyes of MCMV-infected mice of healthy mice that
are absolutely resistant to MCMV retinitis development were found to be exclusive to this
animal group, 4 of the top 15 upregulated genes of the eyes of MCMV-infected mice of MAIDS4 and MAIDS-10 groups were shared between these animal groups. This observation, however,
should not diminish the observation that 11 of the top 15 upregulated genes of the MCMVinfected eyes of these animal groups were exclusive to MAIDS-4 mice and MAIDS-10 mice,
animals that exhibit remarkably distinct patterns of MCMV-induced retinal disease.
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Figure 5.6. Venn diagram comparing the shared expression of the top 15 differentially
expressed genes between healthy, MAIDS-4, and MAIDS-10 mice.
The top 15 upregulated genes of MCMV-infected eyes differentially expressed in healthy,
MAIDS-4, and MAIDS-10 mice were compared between groups to see if any genes were
amongst that highest stimulated in more than one group of mice. Of the 15 genes with the highest
RNA fold-changes, only 4 genes are found to be commonly expressed between MAIDS-4 and
MAIDS-10 mice.

Analysis of 14 additional immune response gene transcripts of MCMV-infected eyes
of healthy mice, MAIDS-4 mice, and MAIDS-10 mice associated with programmed cell
death pathways. Use of the commercially available NanoString nCounter Murine Immunology
Panel provided a wealth of new and at times unexpected knowledge on the upregulation or
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downregulation of 561 immune response genes during the onset and development of MAIDSrelated MCMV retinitis. Given our present interest in programmed cell death pathways and their
relative roles in the pathogenesis of MCMV-induced full-thickness retinal necrosis in MAIDS-10
mice, we created a custom panel consisting of 14 genes. These included 3 genes associated with
autophagy, 3 genes associated with necroptosis, 2 genes associated with parthanatos, and 6 genes
associated with pyroptosis and inflammasomes. Importantly, gene transcription analysis using
this custom gene panel for cell death pathways was performed using the same samples collected
from MCMV-infected eyes of healthy mice, MAIDS-4 mice, and MAIDS-10 mice that were
used above to generate data using the commercially available murine immunology gene panel.
Genes associated with apoptosis were excluded from this custom panel because we have already
determined previously and with confidence, using mice with MAIDS deficient in key apoptosisassociated genes, that this programmed cell death pathway contributes only minimally to the
pathogenesis of MAIDS-related MCMV retinitis.
A summary of the upregulation or downregulation for each of the 14 immune response
genes within MCMV-infected eyes of each animal group at 3, 6, and 10 days after intraocular
MCMV inoculation, their overall positive (upregulated) or negative (downregulated) fold-change
at peak expression, and their p values when compared with mock-infected eyes is shown in Table
5.4, Table 5.5, and Table 5.6 for healthy mice, MAIDS-4 mice, and MAIDS-10 mice
respectively. Due to the relatively small size of 14 genes being analyzed in this experiment, a
two-fold-change in gene activity was not used to exclude some genes for analysis as was done
for the 561 immune response genes analyzed above. The MCMV-infected eyes of healthy mice
absolutely resistant to the development of MCMV retinitis exhibited a pattern of cell death
pathway-associated gene activity that suggested significant quiescence of activity for each
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pathway at all days post-infection examined. In fact, downregulation of gene activity was
consistently observed for all 3 necroptosis genes and all 6 pyroptosis and associated
inflammasome genes at 3, 6, and 10 days post-infection. Gene activities for autopathy and
parthanatos were also found to be either downregulated or only minimally upregulated (< 2-fold
increase) within MCMV-infected eyes of healthy mice at all days post-infection examined. As
MCMV-infected eyes of animals at different stages of MAIDS development became more
susceptible to the development of retinal disease, however, genes associated with some but not
all cell death pathways under investigation became increasingly active. This was apparent within
the MCMV-infected eyes of MAIDS-4 mice and MAIDS-10 mice for necroptosis and pyroptosis
and pyroptosis-associated inflammasomes but not for autophagy and parthanatos.
Table 5.4: RNA expression of MCMV-infected eyes of healthy mice for genes on a custom
NanoString panel.
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Table 5.5: RNA expression of MCMV-infected eyes of MAIDS-4 mice for genes on a custom
NanoString panel.

Table 5.6: RNA expression of MCMV-infected eyes of MAIDS-10 mice for genes on a custom
NanoString panel.
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6
6.1

DISCUSSION AND CONCLUSION

Specific Aim 1: Pyroptosis and Inflammasome Expression during MCMV Infection
Specific Aim 1: Test the Hypothesis that Pyroptosis and Associated Inflammasomes

are Stimulated by MCMV during Immunosuppression, Contributing to the Onset and
Development of MCMV Retinitis
Our finding that GSDMD was upregulated in MCMV-infected eyes of MAIDS-10 but
not MAIDS-4 mice provides further evidence of a role for pyroptosis in MAIDS-related MCMV
retinitis. Therefore, we want to determine the role that pyroptosis-related genes and associated
inflammasomes have on the development of full-thickness retinal necrosis by inducing MAIDS
in mice devoid of one of these molecules and determining the affect ocular MCMV infection has
on retinitis development. Further evidence for the involvement of this pathway in the
development was assessed by inducing MCMV retinitis in another model of immunosuppression
and checking for the stimulation of these pyroptosis-related molecules and associated
inflammasomes.
6.1.1

GSDMD and Caspase-11 Expression Following MCMV Infection in MAIDS-4
Mice

Whereas mRNA levels of caspase-1, IL-1β, and IL-18 were not previously shown to be
stimulated in the MCMV-infected eyes of MAIDS-4 mice, the mRNA for both GSDMD and
caspase-11 showed similar levels of stimulation in MCMV-infected eyes of MAIDS-4 mice as in
MAIDS-10 mice when compared to their relative mock infected control eyes. Despite being
considered part of the noncanonical pathway, caspase-11 is like caspase-1 in its ability to cleave
and activate GSDMD. Therefore, it is not surprising that a consistent pattern of GSDMD mRNA
upregulation throughout the course of viral infection in both MAIDS-4 and MAIDS-10 mice
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mirrors that seen for caspase-11. While the increase in expression of both caspase-11 and
GSDMD at MAIDS-4 suggests the activation of the noncanonical pathway of pyroptosis,
MAIDS-4 mice are resistant to retinitis, and it appears that only with the stimulation of the
canonical pathway during MAIDS-10 is there resulting retinal damage. This could be attributed
to caspase-11 being unable to directly cleave IL-1β and IL-18 [267], thereby preventing the
release of the active forms of these cytokines, which may be the driving force behind retinal
necrosis. Therefore, the role caspase-11, and its cleavage of GSDMD independent of
inflammasomes, plays prior to the onset of retinitis remains to be explored.
6.1.2

The Loss of the Pyroptosis Pathway and MAIDS-related MCMV Retinitis

Inflammasomes and their downstream effector, pyroptosis, are increasingly becoming a topic
of interest in ocular disease. Pyroptosis was first described as an alternative cell death pathway
involving inflammation [143], a feature that distinguishes it entirely from apoptosis (reviewed in
[314]). For this reason, inflammasome driven pyroptosis [315] and its implication in various
diseases are of interest. Of note are the recent discoveries centered on the extent to which
inflammasomes and/or pyroptosis play a role in several ocular disorders. AMD is a sightthreatening, progressive disorder of the retina that specifically targets and damages the macula,
the part of the retina responsible for sharp, central vision. Recently, elevated levels of the NLRP3
inflammasome, IL-1β, and IL-18 expression were found in AMD macular lesions [208]. The
destructive effects of AMD can also be seen by resultant RPE thinning or depigmentation, which
can lead to RPE atrophy and death of photoreceptors. The NLRP3 inflammasome was found to
be upregulated in the RPE during the pathogenesis of advanced AMD following RPE atrophy
[209]. Inhibition of the NLRP3 inflammasome components prevented RPE degeneration in a
model of AMD [210], providing evidence for NLRP3 driven pyroptosis in the pathophysiology
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of AMD. Analysis of photoreceptor cell death in a model of retinal degeneration showed the
upregulation of NLRP3, caspase-1, IL-1β, and IL-18 in cone photoreceptors but not rod
photoreceptors [211], suggesting that the overall induction of pyroptosis in the retina may be
unique to specific cell populations, or influenced by the mechanism leading to cell death. As
AIDS-related HCMV-retinitis is also associated with retinal destruction and RPE pathology, it is
not surprising that pyroptosis-related molecules, caspase-1, IL-1β, and IL-18, along with several
inflammasomes, were previously shown to be stimulated in our mouse model of experimental
MAIDS-related MCMV retinitis.
The pyroptosis pathway and several inflammasomes have a profound impact on the
development of full-thickness retinal necrosis in MCMV-infected eyes of MAIDS mice.
Herein we provide new information showing that pyroptosis and associated inflammasomes
indeed play a prominent role in the progression of classic cytomegalovirus retinitis during
retrovirus-induced immunosuppression. Our findings provide new evidence: (i) whereas a
deficiency in the canonical pyroptosis pathway during MAIDS does not result in a reduction in
the amount of infectious virus produced within MCMV-infected eyes when compared with
MCMV-infected eyes of wildtype MAIDS animals, the frequency of full-thickness retinal
necrosis is significantly reduced to zero within MCMV-infected eyes of pyroptosis-deficient
mice with MAIDS when compared with a frequency of 100% within MCMV-infected eyes of
wildtype MAIDS mice (ii) a deficiency in several inflammasomes result in a significant
reduction in the amount of infectious MCMV produced in infected eyes when compared to
wildtype MAIDS mice, but this value is still substantially higher than seen in MCMV-infected
eyes of healthy mice; and (iii) the retinas of MCMV-infected eyes of pyroptosis-deficient and
inflammasome-deficient mice with MAIDS consistently exhibit abnormal histopathologic
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features characterized by RPE proliferation but with relative preservation of the neurosensory
retina regardless of which pyroptosis-associated gene of the canonical pyroptosis pathway is
compromised.
It is important to note that IL-1R1KO micewere used for this study instead of mice deficient
in IL-1β, as these mice are not commercially available from the vendor used for all previous and
concurrent studies. IL-1R1 is a cytokine receptor that binds IL-1 which then initiates intracellular
signal transduction resulting in the activation of inflammatory mediators [316]. Although mice
lacking the IL-1R1 gene are still capable of producing IL-1β, the receptor is imperative for the
biological actions of IL-1β do not respond to the IL-1β produced [317].
The RPE is the likely the source for the high amounts of infectious virus. Because
MCMV-infected eyes of all animal groups with MAIDS that were deficient in different genes of
the pyroptosis pathway or inflammasomes consistently showed prominent RPE proliferation but
without destruction of the neurosensory retina, we postulate that the source for the high amounts
of infectious virus production observed within MCMV-infected eyes of KO mice with MAIDS
was the RPE rather than cells comprising the neurosensory retina. Whereas virus-induced
nuclear inclusions indicative of productive MCMV replication were observed within the RPE of
MCMV-infected eyes of KO mice with MAIDS, virus-induced inclusions were not observed
within the relatively intact neurosensory retinas of these animals. The neurosensory retina was
also devoid of cytomegalic cells that are often prominent within the full-thickness retinal
necrosis of MCMV-infected eyes of wildtype MAIDS mice. This support the notion that the RPE
are initially infected with virus that originates from the blood and supports rounds of virus
replication subsequent to the infection of cells of the neurosensory retina and ultimate
development of full-thickness retinal necrosis.
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The retinal architecture of all KO mice is like that seen in MAIDS-4 mice. Consistent
with other studies that shows a neuroprotective role [318-320] or ocular preservation [243, 246,
252] effects when inhibiting inflammasomes during the course of disease, MAIDS mice deficient
in the NLRP3 and the NLRP1b inflammasomes showed a remarkable reduction in the frequency
of retinitis, albeit there was still evidence of RPE proliferation and retinal folding. The same
resulting architecture was consistent with that seen in all other KO mice utilized throughout this
study. It is interesting to note that that loss of the pyroptosis pathway within the MCMV-infected
eyes of MAIDS-10 mice converted the pattern of retinal disease to that already observed for
MCMV-infected eyes of MAIDS-4 mice. This intriguing observation suggests that pyroptosis is
indeed essential for the development of full-thickness retinal necrosis in mice with MAIDS, and,
more importantly, suggests that pyroptosis as a key contributor to the pathogenesis of MAIDSrelated MCMV retinitis becomes operative later than four weeks after retrovirus infection during
the evolution of MAIDS. It is noteworthy that this would be at a time after a shift in cytokine
production from a Th1 profile to a Th2 profile that has been shown to commence at 3 to 4 weeks
after retrovirus infection during MAIDS development. An identical Th1/Th2 shift in cytokine
production has been identified in HIV-infected patients with AIDS.
6.1.3

Ocular MCMV Infection during Corticosteroid-induced Immunosuppression

The results of our study show that MCMV infection highly stimulates both mRNA and
protein expression of pyroptosis-related molecules caspase-1, caspase-11, GSDMD, IL-1β, and
IL-18, during experimental MCMV retinitis in both retinitis-susceptible MAIDS mice and mice
with corticosteroid-induced immunosuppression. This stimulation correlates with the expression
of several inflammasomes, NLRP3, NLRP1b, NLRC4, and AIM2 which is also significantly
stimulated in both models of immunosuppression. The expression of these proteins in both
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models of MCMV retinitis further implicates that these proteins are involved in the pathogenesis
of MCMV retinitis. The stimulation of the pyroptosis pathway and associated inflammasomes
would invoke large-scale inflammation to the MCMV infection, and this inflammatory response
could attribute for the full-thickness retinal necrosis seen during MCMV retinitis.
Although both the retroviral-induced immunosupression and the corticosteroid-induced
immunosuppression render C57BL/6 mice susceptible to the development of MCMV retinitis,
there are vast differences in the way the immunosuppression develops between these two
models. MAIDS have a slow and progressive development, which goes through distinct phases
of immune cell dysfunction over the course of several weeks. Corticosteroid-induced
immunosuppression, however, results in a rapid, acute decline in the immune system, which
develops over the course of several days and shows a difference in immune cell populations,
particularly macrophages and cytokine response to infection [115, 116]. However, as both
models of immunosuppression results in the development of MCMV retinitis, it is not surprising
that the overall stimulation of these inflammatory molecules are similar between corticosteroidinduced immunosuppression and mice with MAIDS-10. These data provide further evidence that
pyroptosis-related proteins and associated inflammasomes are involved in the onset and
development of experimental MCMV retinitis in susceptible, immunologically suppressed mice.
6.2

Specific Aim 2: Pyroptosis Expression Following MCMV Infection of Cells
Specific Aim 2: Test the Hypothesis That MCMV Replication Directly Stimulates

Pyroptosis In Infected Cells
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6.2.1

Pyroptosis-Associated Expression Kinetics Following MCMV infection in IC-21
or MEF Cells

Pyroptosis-associated molecules are more highly expressed in MCMV-infected
MEFs than in MCMV-infected IC-21 mouse macrophages. We characterized the expression
of pyroptosis-related expression during either MCMV or HCMV infection in cell culture models.
MCMV infection of IC-21 macrophages and MEF cells resulted in stimulation of several
pyroptosis-associated mRNA transcripts. However, despite the early stimulation of caspase-1,
GSDMD, and IL-1β of mRNA transcripts in both IC-21 mouse macrophages and MEFs, the
level of stimulation was substantially higher in MEFs cell and stayed stimulated for a longer
duration. Although, IL-18 mRNA in MEFs showed only a slightly significant stimulation of
mRNA transcripts 1 hpi, protein for IL-18 showed robust expression at 6 hpi and 24 hpi
suggesting that this pro-inflammatory cytokine is stimulated following MCMV-infection in this
cell line. On the contrary, IL-18 mRNA expression was not stimulated following MCMVinfection in IC-21 mouse macrophages and was in fact downregulated at later time-points postinfection. Since IL-18 plays a role in the induction of inflammatory cytokines, TNF-α, IL-6, IL1β, in addition to being a chemoattractant for neutrophils [321] it is possible that this cytokine is
being suppressed by MCMV as an attempt to control inflammation, or prevent destruction by
neutrophils. As this downregulation is not seen following ocular MCMV in MAIDS-10 mice
developing retinitis [6], it is possible this might be a response specific to macrophages as a
means for MCMV to establish latency in these cell types. Further investigation needs to be done
to determine which ocular cell types are directly undergoing pyroptosis following MCMV
infection during the pathogenesis of MAIDS-related MCMV retinitis.
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6.2.2

Pyroptosis-Associated Expression Following Infection with UV-inactivated
MCMV in MEF cells

The stimulation of pyroptosis by MCMV may be dependent on viral replication. The
substantial reduction of pyroptosis-related mRNA and protein stimulation in MEFs infected with
UVi-MCMV suggests that attachment, adsorption, and release of tegument proteins are not
sufficient to stimulate this pathway in MCMV-infected MEFs. Therefore, this proposes that
MCMV viral gene expression is necessary for triggering the expression of these mRNA
transcripts and proteins. The temporal kinetics of MCMV viral replication has previously been
characterized in fibroblasts. It has been determined that MCMV IE gene transcription occurs
between 1-4 hpi in fibroblasts and is seen as early as 1 hpi in macrophages [32]. E genes for
MCMV are detected at about 2 hpi and are seen until about 16 hpi in fibroblasts [33], the point in
which MCMV L gene expression begins and can continue for at least 36 hours [30]. The
transcription of these L genes encodes for most of the viral tegument and glycoproteins which
are involved in capsid assembly, virion maturation, and egress from host cell. Any part of this
stepwise viral gene expression and replication has the potential to invoke a response in the host
cell that may provoke the induction of pyroptosis. Due to the timing of the mRNA production, it
appears as though the induction of caspase-1 and IL-1β mRNA transcription is stimulated
immediately following the start of IE transcription. This may mean that the transcription of
GSDMD mRNA may result following the transcription of mRNA upstream in the pyroptosis
pathway, or it may be that GSDMD mRNA production is directly stimulated by the transcription
of viral E genes. Although no mRNA production of pyroptosis-associated molecules is seen as a
response to infection with UVi-MCMV, there does appear to be slight expression of these
proteins, especially at 24 hpi. Although this expression is nowhere near the level seen for
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MCMV infected cells, it could indicate that the presence of foreign viral proteins responsible for
either attachment, adsorption, or release from the tegument might stimulate the activation of
proteins already expressed by the cell. However, without the stimulation of viral gene
expression, there may not be enough danger signals detected by the cell to induce transcription of
the mRNA transcripts responsible for carrying out pyroptosis.
6.2.3

Pyroptosis-Associated Expression Kinetics Following HCMV Infection in
ARPE-19 or MRC-5 Cells

The lack of stimulation of pyroptosis in HCMV infected ARPE-19 cells may be
dependent on the cell type. It was astonishing to observe that HCMV infection of APRE-did
not result in the stimulation of mRNA transcripts associated with pyroptosis. RPE cells are
polarized epithelial cells that reside between the retina and choroid and provide several functions
necessary for the survival of the neurosensory retina. Some of these functions include
transportating of nutrients to the retina, regulating homeostasis, scavenging free radicals and
reactive oxygen species, and phagocytosis of the rod outer segments following normal circadian
shedding [87]. Damage to the RPE could result in the pathogenesis of several retinal diseases,
and since the viral proliferation of CMV has been found in the RPE layer in CMV retinitis, it is
possible that damage caused by viral infection could lead to the retinitis developed in this model
of ocular disease. The use of primary human RPE cultures are often used to study the RPE
physiology in vitro [322], but this method does not come without limitations. First, primary RPE
cells cultured from different donors may display genetic variability and physiological differences
between donors. Additionally, it is possible that these cells may also lose their ability to
differentiate within a few numbers of passages [323]. Another major disadvantage of primary
RPE cells is the difficulty in obtaining human donors. For this reason, the use of an immortalized
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cell line of RPE, ARPE-19 [324], has been widely used to study the physiology and
characteristics of this tissue. The use of these cells is also not without limitations. A major
concern is that ARPE-19 cells may not preserve the specialized characteristics and functions as
those seen in RPE in vivo. Recently, an RNA-Seq analysis demonstrated that the transcriptome
of ARPE-19 cells, appropriately cultured and with a low-passage number, closely resembles
those of native human RPE. The study shows that the only differences seen in ARPE cells
passaged for 4 months was an increase in genes related to RPE functions, such as visual cycle,
phagocytosis, and pigmentation, while there was a decrease in genes regarding cell cycle and
proliferation, as well as apoptosis [325]. Since pyroptosis shares a few characteristics with
apoptosis, it is feasible that these ARPE-19 cells may also be losing gene transcription that
would engage pyroptosis. However, without transcriptome analysis on signaling specific for
pyroptosis comparing the cells at different passages, it would be hard to say for sure. Duplication
of this study in primary RPE cells obtained from a suitable donor may also help determine if the
results of this experiment are related to culture specifications.
The lack of stimulation of pyroptosis in HCMV infected MRC-5 cells may be
dependent on virologic replication. Regardless of the lack of stimulation of pyroptosis in
ARPE-19 cells, it is rather interesting that infection of MRC-5 cells also did not result in the
stimulation of pyroptosis-associated proteins. Contrary to these findings, one study did show that
max expression of caspase-1 and IL-1β in CMV infected fibroblasts did show fold-changes over
media control cells of 2.4 and 8.9, respectively. However, this study did not specify the kinetics
of this stimulation, and therefore it cannot be said with certainty that this expression was during
the time points investigated in this present study. Several studies have focused on HCMV’s
ability to suppress the induction of cell death pathways as a means to prevent inhibition of their
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replication. Recently, HCMV was shown to be able to block the induction of necroptosis [326].
Although no substantial evidence has demonstrated that HCMV is capable of inhibiting
pyroptosis, one study did suggest that expression of the HCMV gene UL83 was able to reduce
the expression of one inflammasome, AIM2, which has been shown to respond to CMV
infection, and that this reduced expression inhibited the processing of IL-1β in HEK293T cells
[327]. More work needs to be done to investigate if CMV is, in fact, capable of suppressing
pyroptosis as a means to promote replication and to determine if this is preventing the
stimulation of these mRNA transcripts in MRC-5 fibroblasts.
6.3

Specific Aim 3: Additional Immunological Expression and MCMV Infection
Specific Aim 3: Test the Hypothesis that Other Immune Response Genes or Pathways

are Stimulated during the Pathogenesis of MAIDS-related MCMV Retinitis
6.3.1

Expression of IFI204 during MAIDS-related MCMV Retinitis

Inflammasomes are multiprotein complexes that are part of innate immunity and regulate
caspase-dependent inflammation and cell death. Inflammasomes, specifically those belonging to
the NLR subset, have widely been attributed to ocular diseases [227, 228, 236-238, 328]. The
inflammasome-associated protein, IFI16, is a dsDNA sensing protein, and it is well known to be
associated with human herpesviruses, all of which contain a dsDNA genome. HSV-1 has been
shown to have reduced viral titers in the presence of IFI16 [260]. Additionally, the siRNA
mediated knockdown of IFI16 has been shown to result in reactivation of EBV as well as the
enhancement of HCMV replication, while overexpression of IFI16 resulted in decreased viral
loads for both these herpesviruses [261]. Furthermore, the murine homology, IFI204, has also
been shown to be associated with murine models of ocular herpes infection [265]. For this
reason, it is not surprising that IFI204 is upregulated in MCMV-infected eyes of both MAIDS-4
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and MAIDS-10 mice in response to the dsDNA genome of MCMV. As there appears to be no
substantial difference between the stimulation and expression of IFI204 between MCMVinfected eyes of MAIDS-4 mice resistant to retinitis and MAIDS-10 mice susceptible to retinitis,
likely, IFI204 is merely responding to the MCMV infection and may not be contributing to the
onset and progression of MAIDS-related MCMV retinitis, as might be the case with other
previously investigated inflammasomes.
6.3.2

Role of Autophagy during MAIDS-related MCMV Retinitis

Autophagy is a well-conserved pathway that, under normal physiological conditions,
regulates cellular homeostasis by eliminating damaged organelles and proteins. Autophagy can
also serve adaptive mechanisms during cellular stresses, such as starvation, depletion of growth
factor [329], and the removal of intracellular pathogens [329, 330]. Autophagy-related proteins
are strongly expressed in several layers of the retinal— the ganglion cell layer, inner nuclear
layer, outer nuclear layer—as well as the underlying RPE layer, which depend on autophagy
mechanisms to maintain the structure and normal physiological function. Autophagy has been
shown to play a protective role against diseases of the retina and RPE, and dysfunction of
autophagy has been associated with several ocular disorders such as AMD and a model of
photoreceptor degeneration in the rd/rd mouse during light-damage [331]. It can also be activated
to prevent Fas-mediated apoptosis, as seen in the photoreceptors following retina-RPE separation
[332]. As autophagy plays a role in the ocular clearance of several microorganisms such as T.
gondii [333], Pseudomonas aeruginosa [334], and HSV-1 [335], we were interested in seeing the
response of autophagy-related molecules to MCMV ocular infection. Interestingly, there only
appeared to be stimulation of beclin-1 protein in MCMV-infected eyes of both MAIDS-4 and
MAIDS-10 mice when compared to the uninfected control eyes. Controversially, beclin-1
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mRNA, and LC3B protein expression were similar between infected and uninfected eyes of
MAIDS-4 and MAIDS-10 mice, suggesting that autophagy is not induced upon ocular MCMV
infection. Surprisingly, the protein levels of beclin-1, LC3B-I, and LC3B-II were all substantially
higher in MAIDS-4 mice when compared to MAIDS-10 mice, which suggests that retrovirusinduced immunosuppression impacts the expression of autophagy-associated proteins. This
stimulation of autophagy markers within MCMV-infected eyes of MAIDS-4 mice resistant to
retinitis suggests that autophagy may play a protective role that is mitigated during the
development of MCMV retinitis in MAIDS-10 mice, which as shown, may contribute to the
destruction seen from inflammation-related programmed cell death pathways, such as apoptosis
and necroptosis. This is in agreement with other studies that suggest that autophagy protects
against MCMV retinitis pathogenesis by preventing MCMV infection-induced apoptosis [336],
as well as a study that shows that decrease autophagy levels were linked to increased RPE cell
susceptibly to apoptosis in response to stress [267].
6.3.3

Transcriptional Analysis of Immune Response Genes During during MAIDSrelated MCMV Infection

Herein we confirmed and extended our understanding of some of the immunologic events
that take place during the onset and development of cytomegalovirus retinitis in the unique
setting of retrovirus-induced immunosuppression. Our findings show (i) the pathogenesis of
retinal disease in MCMV-infected eyes of MAIDS-10 mice susceptible to full-thickness retinal
necrosis development is associated with the robust upregulation and downregulation of an
extensive number of immune response genes that operate in several distinct immune response
pathways; (ii) the temporal development of MCMV retinitis within the eyes of MAIDS-10 mice
is a dynamic process that involves the upregulation and downregulation of a number of immune
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response genes at different times after intraocular MCMV infection; and (iii) the pattern of
immune response gene activation differs remarkably within MCMV-infected eyes of healthy
mice resistant to retinitis development when compared with MCMV-infected eyes of mice at
different stages of MAIDS that exhibit a profound difference in their susceptibility to fullthickness retinitis development. A more focused companion investigation also provided
compelling evidence for the stimulation of the transcription of multiple genes associated with the
necroptosis and pyroptosis programmed cell death pathways during the development MAIDSrelated MCMV retinitis.
For our investigation of immune response gene expression during the pathogenesis of
MAIDS-related MCMV retinitis, we used the NanoString nCounter assay, a recently developed
platform capable of making without amplification a direct multiplexed measurement of gene
expression within the ocular compartment following intraocular MCMV inoculation of mice for
comparisons during immunocompetence and MAIDS. Although it is a powerful tool that allows
for the quantification of the expression of hundreds of genes simultaneously and thereby provide
a snapshot of gene activity at any one-time during disease pathogenesis, we initiated the
investigation mindful of several limitations using this experimental approach. Firstly, the amount
of data obtained after the performance of a single experiment is overwhelming and requires
thoughtful use of statistical analysis to help provide meaningful conclusions. Secondly,
subsequent performance of quantitative RT-PCR and/or western blot assays is essential to
confirm the upregulation or downregulation of an individual gene under investigation. Thirdly,
the data generated is highly descriptive without providing mechanistic insights into the function
of an individual gene during a pathogenic event. Finally, it has not escaped our attention that the
NanoString nCounter assay provides only fold-change differences in transcription activity that
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may or may not be biologically significant during disease pathogenesis. The quantitative foldchange activity of an individual gene may not be a true reflection of the unique kinetics of that
particular gene’s mRNA and consequently its functional ability. For example, a two-fold
increase in transcriptional activity may be biologically significant for one gene, but another gene
may require a far greater transcriptional increase (and for a greater duration) to be biologically
significant.
Despite these limitations, the NanoString nCounter assay has proven to be a useful tool
to point us quickly in new directions of investigation and thereby expand our knowledge base of
those immune functions that contribute (or not contribute) to the onset of MCMV-induced retinal
disease and progression to full-thickness necrosis during MAIDS. More importantly, however,
use of the NanoString nCounter assay has given us the opportunity to validate previous findings
by us and others on the role of various immune responses toward the pathogenesis of
experimental MCMV retinitis during immunosuppression. Most of the findings presented herein
are in good agreement with findings documented by us in past publications that have focused on
various immune-mediated pathways and/or individual molecules associated with innate or
adaptive immunity vis-a-vis the pathogenesis of MAIDS-related MCMV retinitis. These include
roles for humoral immunity [337], cellular immunity [338, 339] suppressor of cytokine signaling
(SOCS) pathways [126, 226], TNF-α [103], interferon-γ [103], and a number of proinflammatory
cytokines associated with innate immunity [6, 340] as summarized by us in a recent review
[114]. The findings of the present investigation using a custom panel consisting of genes
associated with necroptosis and pyroptosis as well as pyroptosis-related inflammasomes also
confirm our previous reports that these programmed cell death pathways may be involved in the
progression of MCMV retinitis during MAIDS when we used quantitative RT-PCR assays to
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show significant intraocular upregulation of many mRNAs involved in the operation of these
pathways [6].
In summary, our experience using the NanoString nCounter assay to provide a novel
transcriptional analysis of the 575 immune response genes within MCMV-infected eyes of mice
at different stages of MAIDS development compared with MCMV-infected eyes of
immunologically normal mice has provided new, and at times, unexpected information on the
pathogenesis of MAIDS-related MCMV retinitis. By extension, our findings may also improve
our understanding of the pathogenesis AIDS-related HCMV retinitis. While helpful in many
ways, we have also identified areas of caution when using this powerful research tool. Future use
of this technology by us will be directed toward the identification of host genes expressed by
different cell populations of retinal tissues during the onset and progression of MAIDS-related
MCMV retinitis. Moreover, because host RNA constitutes an overwhelming portion of the total
RNA recovered from infected tissue samples when compared with pathogen RNA that usually
comprises a vanishingly small portion of total RNA, this technology will also allow us to
investigate with greater precision the pattern of mRNA synthesis for individual MCMV genes
that are expressed within retinal tissues and retina-related cell populations during the course of
disease development following intraocular MCMV infection of retrovirus-immunosuppressed
mice.
6.4

Future Direction
Clinical inhibition of GSDMD with necrosulfonamide could further signify the

contribution that the execution of pyroptosis has on the development of experimental
MAIDS-related MCMV retinitis. Although mice with systemic knockdown of GSDMD have
recently become available, the demand for these mice are still relatively low, and the duration of
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time needed to breed and supply these mice can take several months. Additionally, while the use
of these mice may demonstrate the necessity for the GSDMD for the development of MAIDSrelated MCMV retinitis, it does not directly translate to whether solely ocular inhibition of
GSDMD, and not systemic treatment, will prevent further retinal damage in AIDS patients
undergoing treatment for AIDS-related HCMV retinitis. Necrosulfonamide (NSA) has recently
been identified as a direct chemical inhibitor of GSDMD to inhibit pyroptosis
pharmacologically. Systemic administration of this drug was shown to be efficacious in a murine
model of sepsis [341], suggesting the potential use of this drug to treat other inflammatory
diseases, such as MAIDS-related MCMV retinitis. As many drugs are incapable of crossing the
blood-retinal-barrier, it is uncertain if systemic administration of NSA will offer ocular
protection against MCMV. Therefore, it would be necessary to establish the effectiveness of
systemic or ocular administration of NSA and whether this would need to be given before
MCMV infection. Determining the effectiveness of inhibiting GSDMD through NSA would help
determine if this could be a pharmacological treatment for AIDS-related HCMV retinitis.
6.5 Clinical Significance
HCMV is an opportunistic infection in individuals with a CD4+ T-cell count below 50
cells/µL and is, therefore, among the most frequent opportunistic infections in individuals with
AIDS. AIDS patients are particularly susceptible to sight-threatening retinitis caused by HCMV
directly infecting the retinal tissues. Factors that contribute to retinal tissue destruction are virusinduced cytopathology, and inflammation mediated by neutrophils and activated macrophages.
Before the availability of cART, 46% of patients with AIDS experienced vision loss and
blindness caused by HCMV retinitis [69-71]. Although treatment with cART has lowered the
number of new cases of HCMV retinitis, AIDS-related MCMV retinitis remains a significant
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ophthalmological problem as access to cART is not readily available worldwide and several
individuals who do have access fail to adhere or respond to treatment [71-73]. Although
vaccination is one of the more effective methods for controlling problematic infectious diseases,
attempts at creating an effective vaccine against HCMV have so far been unsuccessful [74, 75].
HCMV replication can generally be controlled by lifelong administration of antiviral drugs, such
as ganciclovir, cidofovir, or foscarnet, yet these drugs may cause harmful side-effects, do not
eradicate the virus, and merely slows the progression of ocular damage associated with HCMV
infection [76-78]. Although the clinical features of AIDS-related HCMV retinitis are well
established, the direct mechanisms by which the HCMV infection of the retina causes the severe
retinal damage is still unknown.
To investigate the mechanisms responsible for the onset and progression of the retinal
damage seen during AIDS-related HCMV retinitis, our lab uses a clinically relevant mouse
model of MAIDS-related MCMV retinitis. The MAIDS model is a suitable model for this study
because species-specific retroviruses cause both MAIDS and AIDS, and mice with MAIDS share
many immunopathologic features with AIDS patients. This includes a characteristic progressive
development of chronic generalized lymphadenopathy, a polyclonal B-cell activation, and a shift
in the levels of Th1 and Th2 CD4+ T-cells with an eventual diminishment in CD4+ T-cell and
CD8+ T-cell counts and functions [112, 119, 121-123]. Retinitis susceptible MAIDS mice will
then develop retinitis ten days post subretinal MCMV injection, exhibiting histopathological
features similar to those seen in AIDS-related HCMV retinitis, which include full-thickness
retinal necrosis, the presence of cytomegalic cells, and transition zones between areas of the
normal and diseased retina [4, 125].
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By using this model, the work contributing to this study also contributed to the
advancement of ocular research by furthering our fundamental understandings of the
pathogenesis of AIDS-related HCMV retinitis, as well as the potential contribution to the
stimulation of pyroptosis-associated proteins may have on the onset of retinal destruction in
general. If pyroptosis does contribute to the pathogenesis of retinal destruction, prevention of this
pathway may be a target to help improve the treatment and prevention of further damage to
affected eyes and/or offer protection to the contralateral eye from undergoing vision loss. As
several caspases may induce pyroptosis, a pan-caspase-inhibitor, if clinically available, may be
offered as a locally administered treatment option. As other cell death pathways may be caspasedependent, this form of treatment could be a way to mitigate retinal destruction resulting from
multiple cell death pathways. As the activation of GSDMD is ultimately responsible for the
formation of pores in the cells and mass release of inflammatory cytokines, inhibition of
GSDMD by ocular administration of necrosulfonamide, if proven effective, may be another form
of treatment option to combat the retinal destruction seen with AIDS-related HCMV retinitis.
6.6 Summary
Specific Aim 1. The pyroptosis pathway and associated inflammasomes are stimulated
within the ocular compartment of MCMV-infected eyes of retinitis susceptible MAIDS-10 mice.
There is a marked reduction in the activity of the pyroptosis pathway and associated
inflammasomes in MCMV-infected eyes of MAIDS-4 mice resistant to the development of fullthickness retinal necrosis. The presence of viral inclusion bodies in the RPE but not the
neurosensory retina of all KO MAIDS mice suggests that the RPE is the source of the high
amounts of infectious virus in MCMV-infected eyes. The loss of the pyroptosis pathway and
inflammasomes convert the pattern of retinal disease to that seen for MAIDS-4 mice. This
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suggests that pyroptosis is essential for the development of full-thickness retinal necrosis in
MAIDS mice, which becomes operative at least four weeks following retrovirus infection. The
simulation of pyroptosis associated molecules and associated inflammasomes in MCMVinfected eyes of mice immune suppressed with corticosteroids suggests that the pyroptosis
pathway and associated inflammasomes play a role in the development of MCMV retinitis in
different models of immunosuppressed mice.
Specific Aim 2. In summary, pyroptosis-associated expression following MCMV
infection of murine cells lines suggests that pyroptosis-associated molecules are stimulated
directly by MCMV infection. The failure of UVi-MCMV to stimulate pyroptosis-associated
molecules to the same extent as seen following MCMV infection suggests that this stimulation is
largely independent of the attachment, adsorption, or release of viral tegument proteins. CMV
stimulation of pyroptosis-associated mRNA is both species-specific and cell-type dependent
Specific Aim 3. All in all, our additional results suggest that other inflammasomes, such
as IFI204, stimulated following MCMV infection, but may not be directly responsible for the
development of MCMV retinitis. However, the autophagy form of cell death does not appear to
be playing a role in the pathogenesis of this disease. Transcriptional analysis revealed that
MCMV-infected eyes of MAIDS-10 mice susceptible to full-thickness retinal necrosis
development is associated with a robust upregulation and downregulation of an extensive
number of immune response genes that operate in several distinct immune response pathways.
The temporal development of MCMV retinitis within the eyes of MAIDS-10 mice is a dynamic
process that involves the upregulation and downregulation of a number of immune response
genes at different times after intraocular MCMV infection. The pattern of immune response gene
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activation differs remarkably within MCMV-infected eyes of healthy mice resistant to retinitis
development when compared with MCMV-infected eyes of mice at different stages of MAIDS
6.7 Conclusions
The pursuit of these specific aims was to test the central hypothesis that pyroptosis and
associated inflammasomes contribute to the onset and progression of retinal damage during
MAIDS-related MCMV retinitis. Several inflammasomes and pyroptosis-associated molecules
have already been shown to be stimulated during MAIDS-related MCMV retinitis, and the
stimulation of GSDMD during the pathogenesis of MAIDS-related MCMV retinitis further
supports the notion that pyroptosis is stimulated during MCMV retinitis in susceptible mice. The
absence of full-thickness retinal necrosis in mice deficient in pyroptosis-related or
inflammasomes genes suggest the pyroptosis pathway and associated inflammasomes are
essential for the onset and progression of MCMV retinitis in susceptible MAIDS-10 mice. The
simulation of pyroptosis-associated molecules and associated inflammasomes in MCMVinfected eyes of mice immune suppressed with corticosteroids suggests that the pyroptosis
pathway and associated inflammasomes play a role in the development of MCMV retinitis in
different models of immunosuppressed mice. The stimulation of the pyroptosis-associated
molecules appears to be a direct result of infection by MCMV, and the magnitude of stimulation
may be specific to the cell type infected.
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